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1 Introduction 
1.1 Polyketides and non-ribosomal peptides 
For decades natural products have played a major role as biological probes, as 
inspiration for organic chemistry and, most prominent, as an important source for 
therapeutics (Walsh & Fischbach, 2010). Of all small-molecule new chemical entities 
between 1981 and 2006, natural products and derived semisynthetic compounds 
accounted for 68% of antibacterial and 54% of anticancer compounds (Newman & 
Cragg, 2007), and natural product structures have a great impact on the anti-infective 
area. Connecting the products to the genes encoding the biosynthetic machinery has 
stimulated new interest into natural product research. The growing number of 
available genomic data and the application of genome mining technologies contribute 
to the discovery of ever new structures, thus illustrating the lasting importance of 
natural products for drug discovery (Challis, 2008). 
 
Polyketides (PKs) and non-ribosomal peptides (NRPs) represent two of the most 
prominent classes of natural products with an enormous structural and functional 
variety (Meier & Burkhart, 2009), which is reflected by the diversity of producers, 
ranging from bacteria and protozoa to fungi and plants. Although their physiological 
role for the producer is often not clear, it is supposed that they carry out functions as 
pigments, virulence factors, messengers or toxins (Hertweck, 2009). The broad 
spectrum of biological activity of these metabolites makes PKs and NRPs highly 
interesting research fields for new drugs and pharmaceutically relevant compounds.  
 
A number of natural products and their derivatives have found their way into clinical 
use. Amongst them are antibiotics like erythromycin A, tetracyclines or the last resort 
antibiotic daptomycin (Strieker et al., 2010) and anti-tumor agents like bleomycin and 
the epothilones. Bryostatin 1 is another potent cytotoxin against different cancer cell 
lines and in clinical trial phase II and III in combination with other agents (Piel, 2010). 
Anticholesterol compounds like lovastatin or mevastatin and immunosuppressants 
like rapamycin or cyclosporin A further exemplify the outstanding activity spectrum of 
these classes of natural products. 
 
2  Introduction 
 
 
Figure 1-1: Examples of natural products 
Derived from PKS (1 & 2), NRPS (3 & 4) or mixed PKS-NRPS (5 & 6) pathways 
 
PKs and NRPs are the product of huge multienzymes or enzyme complexes termed 
polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS), 
respectively, which belong to the largest proteins known so far and which will be 
described in the following. 
 
1.2 Polyketide synthases 
Polyketide synthases are multifunctional megaenzymes (Piel et al., 2005) that 
synthesize complex structures from simple acyl building blocks by a Claisen-type 
condensation reaction. This biochemistry is shared with fatty acid synthases (FAS) to 
which PKSs are evolutionary related (Smith & Tsai, 2007). In fatty acid synthesis an 
activated starter acetyl unit is extended by malonyl moieties through decarboxylative 
thioester condensation, followed by reduction and dehydration steps to reliably 
produce saturated fatty acids (Staunton & Weissman, 2001). PKS systems, however, 
comprise a greater diversity in their building blocks as well as greater flexibility in the 
erythromycin A (1) 
lovastatin (2) cyclosporin A (3) 
bleomycin A2 (4) 
surfactin (5) 
myxothiazole A (6) 
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reduction state, which is responsible for the great structural diversity of the produced 
compounds.  
 
Since Collie’s first experiments on the synthesis of orcinol (Collie & Myers, 1893), the 
last century has seen a huge progress in the unravelling of the polyketide 
biosynthesis. Today, three types of PKSs have been discovered, each containing 
different subclasses (Shen, 2003). For an exemplary description of the underlying 
logic, participating subunits and enzymatic steps the family of non-iterative PKS type 
I will be described in more detail. 
 
1.2.1 Modular PKS type I 
This PKS type is composed of giant multifunctional enzymes, which consist of one or 
more functional units called module. In the non-iterative subclass each module is 
responsible for the elongation of the growing polyketide chain by one unit and can be 
further subdivided into distinct enzyme domains. The minimal module consists of a β-
ketosynthase (KS), an acyltransferase (AT) and an acyl carrier protein (ACP), which 
are usually organised in a KS-AT-ACP arrangement.  
 
Carrier proteins, also termed thiolation domains (T), are responsible for the covalent 
attachment of the building blocks as thioesters. The substrates are not directly bound 
to the protein itself, but to a 5’-phosphopantetheinyl prosthetic group, which is 
covalently bound to a conserved serine residue. This group is transferred to the ACP 
by the action of specific 5’-phosphopantetheinyl transferases (PPTases) prior to the 
biosynthesis of the polyketide, thus turning the apo-ACP into its active holo-form 
(Lambalot et al., 1996). 
                                   
Figure 1-2: Post-translational priming of carrier proteins 
Transfer of the phosphopantetheinyl arm from coenzyme A (CoA) to the carrier protein (CP) by 
PPTase (from Lai et al., 2006) 
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At the initiation of the biosynthesis, the AT domain loads the primer substrate to the 
first carrier protein, which passes it to a conserved cystein moiety of the KS domain 
of the next module. The KS catalyses a decarboxylative condensation with the 
elongation substrate on the next ACP. Thus, the growing polyketide chain is passed 
from module to module, while always staying covalently bound to the enzymes. After 
the final elongation step, the product is released from the protein by the thioesterase 
(TE) in the termination module. The molecule is either hydrolysed or undergoes 
intramolecular macrocyclisation (Weissman et al., 1998).  
 
                   
Figure 1-3: Central catalytic processes during PK biosynthesis 
Chain elongation by decarboxylative Claisen condensation; T, thiolation domain; KS, 
ketosynthase; AT, acyltransferase (from Walsh & Fischbach, 2006) 
 
Additionally to this minimal set of domains, a module can contain modifying domains, 
such as ketoreductase (KR), dehydratase (DH) and enoylreductase (ER). In fatty acid 
synthesis, the growing chain always undergoes the complete set of reduction steps. 
First, the keto group is reduced to a hydroxyl group by the KR, followed by the 
elimination of water by the DH and the reduction of the resulting double bond by the 
ER. Differently, PKS modules can contain none, one or more of these enzymes, 
resulting in different grades of reduction. 
 
 
Figure 1-4: optional reduction steps during PK biosynthesis 
Catalytic reactions performed on the growing chain; ACP, acyl carrier protein; KR, 
ketoreductase; DH, dehydratase; ER, enoylreductase (from Cane & Walsh, 1999) 
 
The biosynthetic logic for non-iterative modular PKSs was unravelled through the 
identification of the 6-deoxyerythronolide B synthase (DEBS) gene cluster in 
Saccharopolyspora erythraea in the pioneer work by the groups of Peter Leadly 
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(Cortés et al., 1990) and Leonard Katz (Tuan et al., 1990). Consequently, DEBS 
became the archetype for this PKS class. The discoveries were facilitated by the fact 
that in microbes all genes for the biosynthesis and ancillary enzymes of a metabolite 
tend to cluster physically in the genome (Walsh, 2008). It was revealed that the 
number and order of the modules and their domains in a PKS system mirror the 
structure of the produced compound, thus allowing a prediction of the molecule 
structure. This relation is referred to as colinearity rule.  
 
 
Figure 1-5: 6-Deoxyerythronolide B (DEB) biosynthesis 
Organisation of a modular type I PKS system; formation of the erythromycin precursor  
(mod. after Staunton & Weissman, 2001) 
 
While in FAS a starter acetyl unit is usually elongated by malonyl-CoA, PKS loading 
modules employ a broader spectrum of incorporated building blocks (Moore & 
Hertweck, 2002), including acetyl-CoA, malonyl,CoA, propionyl-CoA and 
methylmalonyl-CoA, isobutyryl-CoA, ethylmalonyl-CoA, propylmalonyl-CoA and 
hydroxymalonyl-CoA (Pfeifer & Khosla, 2001). Further chain extension is performed 
by the use of either malonyl- or methylmalonyl-CoA. In this connection, the 
acyltransferases act as gatekeepers that confer the substrate specificity. In contrast 
to the generally fastidious ATs of the extender modules (Liou et al., 2003), the AT 
domain of the initiation module often shows a more relaxed specificity, giving rise to 
the possibility of incorporating alternate primer units to create derivatives of a natural 
product (Khosla et al., 1999).  
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This versatile use of building blocks and the varying degree of reduction both greatly 
contribute to the vast structural complexity of PKs. Gonzáles-Lergier and co-workers 
calculated that a PKS with six elongation modules could produce a theoretical 
number of 100,000 different structures (Gonzáles-Lergier et al., 2005). A further 
contribution to the diversity is made by so-called post-PKS tailoring enzymes. The 
bare PK backbone is often modified by hydroxylation, methylation, oxidation or the 
addition of deoxysugars (Rawlings, 2001) and thus turned into its bioactive form, e.g. 
as in the case of erythromycin. 
 
1.2.2 Classification of PKS types 
Polyketide synthases are generally classified according to their structural 
organisation into three types (Shen, 2003; Rawlings, 2001). As mentioned before, 
type I PKSs consist of multifunctional megaenzymes, in which each protein harbours 
a linear sequence of modules and their catalytic domains (Hertweck, 2009) and are 
therefore also termed modular PKS. From a structural point of view, this type 
resembles the animal FAS (Staunton & Weisman, 2001). A further subdivision can be 
made according to the non-iterative or iterative use of the single modules. In the first 
case, each module is only used once, so that the colinearity rule applies. This type is 
widely spread among eubacteria and has already been described before (1.2.1). The 
group of trans-AT type PKS will be described later.  
 
The iterative type I is typical for fungi and was found responsible for the production of 
compounds like 6-methylsalicyclic acid lovastatin. During biosynthesis, modules are 
used repeatedly for elongation. Even so, the degree of reduction and the substitution 
pattern can differ with each cycle, as KR, DH, ER and methylation domains (MT) are 
employed variably. The factors that regulate this alternating use are hitherto 
unknown. Further subdivision into non-reducing, partially-reducing or highly-reducing 
PKSs can be made depending on the presence of reductive domains. 
 
Type II PKS consist of discrete, monofunctional enzymes that work iteratively and 
thus resemble bacterial FAS. A minimal set comprises an ACP and two 
ketosynthases named KSα and KSβ. This type seems to be restricted to bacteria, 
where it is paradigmatic for the biosynthesis of aromatic compounds, a task that is 
taken over by iterative type I PKSs in fungi. Chain elongation in type II PKS is similar 
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to modular systems. The building blocks are transferred from the ACP to KSα, which 
catalyses the condensation to the next unit tethered to the ACP. In KSβ a catalytic 
histidine is replaced by a glutamine residue, which turns the condensing enzyme into 
a decarboxylase. This domain, also termed chain initiation factor (Bisang et al., 1999) 
or KSQ, provides the acetyl starter unit by decarboxylation of malonyl-CoA. KSQs 
can also be found in the loading module of some type I PKSs. Further modification 
steps are performed by accessory enzymes. The prototype for type II PKS was the 
actinorhodin synthase discovered by Hopwood and co-workers (Malpartida & 
Hopwood, 1984).  
 
Type III PKS are known as chalcone synthases and are distinct from the other two 
classes. They consist of homodimeric, iteratively acting condensing enzymes that 
select the starter units and perform the chain elongation in an ACP-independent 
manner by directly acting on the CoA-bound building blocks. Until the discovery of 
the RppA synthase in Streptomyces griseus (Funa et al., 1999) type III PKS were 
thought to be distinct for plants, but have meanwhile also been found in fungi 
(Seshime et al., 2005). 
 
      
Figure 1-6: structure and mechanism PKS types 
(a) iterative type II PKS; condensation reaction is catalysed by KSα; chain elongation factor KSβ 
acts as decarboxylase; (b) ACP independent, iterative type III PKS; KS acts directly on the CoA-
bound substrate (from Shen, 2003) 
 
1.2.3 Modular trans-AT PKS 
The analyses of PKS clusters from different bacterial phyla led to the discovery of a 
further family of modular polyketide synthases. In deviation from the textbook type I 
PKS, the modules are devoid of acyltransferases. Instead, the ACPs are loaded by 
one to three free standing ATs (Piel, 2010). In consequence, this class of PKSs was 
named trans-AT PKS to distinguish it from the conventional cis-type modular 
synthases. The first trans-AT cluster was the bacillaene PKS from Bacillus subtilis  
(a)                 (b) 
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(Scotti et al., 1993), although it could not be assigned to a product at that time. The 
first cluster attributed to a metabolite was the pederin synthase discovered by Piel 
and co-workers (Piel et al., 2002). The free standing ATs act iteratively and are 
responsible for the acylation of all PKS modules, as was first shown for the 
biosynthesis of leinamycin (Cheng et al., 2003). Trans-ATs are either encoded as 
single genes or are fused to an oxidoreductase (OR), which has the function of a 
trans-acting enoylreductase (Bumpus et al., 2008).  
 
Phylogenetic studies on the KS domains suggest a different evolutionary origin for 
cis- and trans-PKS enzymes (Piel et al., 2004). KS domains from cis-AT PKS usually 
mirror the phylogenetic group of their organisms, while the clade of trans-AT KS 
includes bacteria of different phyla. It was suggested that cis-AT PKS mainly evolved 
through repeated gene duplication (Jenke-Kodama et al., 2006) and fusion of 
module-encoding genes within evolving pathways. For trans-AT PKSs extensive 
horizontal gene transfer from various sources and recombination events seem to be 
responsible for a mosaic-like evolvement of these gene clusters. Furthermore, the 
analysis of numerous KS domains from trans-AT clusters revealed that the domain 
architecture allows conclusions about the substrate specificity of these domains 
(Nguyen et al, 2008). It was shown that the domains can be grouped corresponding 
to their substrate types, like e.g. saturated, α,β-unsaturated, α-methyl-branched or β-
hydroxylated, which assigns the role of a gatekeeper rather to the KS than the AT. 
 
          
Figure 1-7: Leinamycin biosynthetic pathway 
Example of a mixed NRPS-PKS system with a trans-AT type PKS part; AT LnmG is responsible 
for the loading of all ACPs during biosynthesis; A, adenylation; AT, acyltransferase; Cy, 
cyclisation;  ER, enoylreductase; KS, ketosynthase; DH, dehydratase KR, ketoreductase; TE, 
thioesterase (from Piel, 2010) 
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Trans-AT PKSs frequently show a number of peculiarities, which are uncommon in 
cis-type synthases (Hertweck, 2009). As many as 50 variants of module architecture 
are known so far in contrast to only eight different arrangements in cis-AT PKSs (Piel, 
2010). These include duplication of domains, unusual orders, division on different 
genes as well as obviously redundant domains or modules, which apparently do not 
correspond with the structure of the product. Especially the occurrence of multiple 
ACPs in one module is frequently observed. These modules are often involved in the 
introduction of β-branches (Calderone, 2008). Another peculiarity are KSs which lack 
a catalytic histidine residue (KS0) and are therefore unable to catalyse chain 
elongation, but merely pass on the polyketide intermediate. 
 
1.3 Non-ribosomal peptide synthetases 
Non-ribosomally derived peptides represent another class of natural products that is 
of equal structural diversity and pharmaceutical relevance as the already discussed 
polyketides. Among them are immunosuppressive agents as cyclosporin A, important 
antibiotics like gramicidin S and vancomycin as well as siderophores like myxochelin 
A or vibriobactin (Schwarzer et al., 2003). Similar to polyketides they are produced 
from simple monomers by modular multifunctional mega-enzymes, called non-
ribosomal peptide synthetases (NRPS). In general, they follow the same precepts as 
modular type I PKSs (Fischbach & Walsh, 2006), as was first exemplified at the 
tyrocidin biosynthetic cluster (Mootz & Marahiel, 1997). Analogous to PKSs, the 
minimal NRPS module comprises two catalytic domains and a carrier protein for the 
selection and activation of the substrate and the formation of the peptide bond. 
These are the adenylation (A) and condensation (C) domain and the peptidyl carrier 
protein (PCP), canonically arranged as C-A-PCP, whereas the initiation module 
usually lacks the C domain (Finking & Marahiel, 2004), though exceptions are known 
(see below).  
 
The A domain is responsible for the selection and activation of the substrate. Herein, 
it is not restricted to the 20 proteinogenic amino acids like in ribosomal peptide 
synthesis, but can choose from a diverse pool of building blocks, including a number 
of non-proteinogenic amino acids like ornithine, hydroxy- or dihydroxyphenylglycine 
as well as carboxylic acids like aryl acids. Today, more than 500 monomers have 
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been identified as parts of NRPs (Strieker et al., 2010). The carboxyl group of the 
cognate substrate is activated as aminoacyl-adenylate at the expense of ATP, which 
is then tethered to the 4’-phosphopantetheinyl arm of the PCP as thioester. Like in 
PKS, this requires the priming of the apo-PCP with its prosthetic group by the action 
PPTases to turn it into its active holo-form (Koglin & Walsh, 2009). The basis for the 
specificity of A domains was investigated by analysis of the substrate binding pocket 
in the crystal structure of the phenylalanine activating domain PheA from the first 
module of the gramicidin synthetase (Conti et al., 1997). Sequence comparison with 
other A domains led to the identification of a set of ten (Stachelhaus et al., 1999) or 
eight (Townsend et al., 2000) residues that confer substrate specificity. The discovery 
of this nonribosomal code gave rise to the possibility of altering the specificity by the 
introduction of point mutations (Eppelmann et al., 2002).  
 
The C domain mediates the chain elongation by catalysing the formation of a peptide 
bond between the upstream peptidyl-S-PCP and the downstream aminoacyl-S-PCP 
concomitantly with a translocation of the chain intermediate to the downstream PCP.  
 
              
 
Figure 1-8: Basic reactions in NRP biosynthesis 
(a) Substrate activation by the adenylation domain (A) ; (b) loading of the carrier protein (PCP); 
(c) amide bond formation between two building blocks by the condensation domain (C)  
(from Marahiel, 2009) 
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Like in PKS, the peptide chain is released from the synthetase by the action of a TE 
domain in the termination module. Intramolecular nucleophilic attack of the acyl-O-TE 
intermediate leads to the formation of a macrocyclic product, as observed e.g. in 
tyrocidin and surfactin biosynthesis, while simple hydrolysis results in the release of a 
linear peptide, as observed in the formation of pyochelin and yersiniabactin.  
Alternative mechanisms have been observed in some fungal PKs like saframycin and 
cyclosporine, in which chain release occurs through reduction or specialised C 
domains (Keating et al., 2001). 
 
1.3.1 Editing domains and domain subtypes in NRPS 
To the present date, a total of 10 different NRPS domains are known (Sieber & 
Marahiel, 2005). Besides the already described minimal set of domains, they include 
enzymes functionalities that introduce modifications to the peptide backbone. 
Furthermore, a number of functional subtypes of C domains have been identified 
(Rausch et al., 2007).  
 
Some clusters like the surfactin, lichenysin or fengycin encode a specialised starter C 
domain in their first module which acylates the following amino acid with a β-hydroxy-
carboxylic acid. The C domain of a module can be replaced by a specialised 
heterocyclisation (Cyc) domain, which not only catalyses peptide bond formation, but 
also cyclisation of threonine, serine or cysteine residues, resulting in the formation of 
thiazoline or oxazoline rings, respectively. In NRPs like bleomycin or myxothiazol 
additional oxidation (Ox) domains convert these heterocycles into more stable 
thiazole and oxazole rings. These heterocycles are important for the interaction with 
proteins or nucleic acids and the chelating of metal ions. Reduction (R) domains 
catalyse the opposite reaction and can also be involved in peptide release.  Further 
functional groups can be introduced by the action of formylation (F) and N-
methylation (Mt) domains.  
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Figure 1-9: Reactions performed by optional domains in NRP biosynthesis 
E, epimerisation; Cy, cyclisation; F, formylation; Ox, oxidation; R, racemisation; N-Mt, N-
methyltransferase (from Schwarzer et al., 2003) 
 
A distinct feature of NRPs is the frequent use of D-amino acids. One way of 
incorporation is the selection by specific A domains. More commonly, L-amino acids 
are racemised by epimerisation (E) domains. The selectivity for the correct 
enantiomer is conferred by the C domain that follows directly after the E domain. 
These DCL domains that catalyse the peptide formation of an upstream D-amino acid 
with a downstream L-amino acid can be differentiated by phylogeny and by sequence 
motifs from the subgroup of LCL domains, which connect two L-amino acids. A class 
of dual E/C domains is able to perform both the racemisation and the condensation 
reaction. Like in PKS systems, post-assembly tailoring enzymes can introduce further 
modifications to the non-ribosomal peptide backbone including oxidation, 
halogenation, methylation, hydroxylation or glycosylation (Koglin & Walsh, 2009). 
 
1.3.2 Classification of NRPS types 
By chance, all of the first NRPSs that were discovered and analysed belonged to the 
class of linear NRPS, which are analogous to the non-iterative type I PKS and whose 
biosynthetic logic follows the colinearity rule. The synthetases of tyrocidine, 
actinomycin, balhimycin and bacitracin belong to this group. What was first regarded 
as exceptions from this paradigm eventually emerged as new classes of NRPS. The 
three classes known today are denominated linear, iterative and nonlinear NRPS or 
types A, B and C (Mootz & Marahiel, 2002). 
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Figure 1-10: Tyrocidine biosynthetic pathway 
Example of a linear, non-iterative NRPS system (from Meier & Burkhart, 2009); A, adenylation; 
C, condensation; E, epimerization, PCP, peptidyl carrier protein 
 
In the iterative type, the modules are used more than once to produce multimeric 
compounds. The monomer produced by one round of synthesis is stalled on the C-
terminal TE domain, thus regenerating the NRPS for the next chain assembly. The 
monomers are oligomerised on the TE and finally released usually as cyclised 
product. This class of NRPS was found responsible for the biosynthesis of e.g. 
gramicidin S and enterobactin. 
 
The class of nonlinear NRPSs contains among others the biosynthetic pathways for 
vibriobactin, mycobactin and yersiniabactin. They are characterised by deviations 
from the canonical domain organisation in at least one module. The cysteine-specific 
A domain in yersiniabactin biosynthesis for example is responsible for the loading of 
three different PCPs (Suo et al., 2001). The vibriobactin cluster encodes an unusual 
tandem arrangement of Cyc domains, in which one is responsible for the cyclisation 
and the other for the peptide bond formation (Marshall & Walsh, 2002).  
 
1.3.3 Hybrid PKS-NRPS 
Apart from metabolites, which are exclusively the product of either a PKS or a NRPS, 
the existence of hybrid PKS/NRPS assembly lines has also been discovered (Cane & 
Walsh, 1999). Compounds like rapamycin, yersiniabactin, bleomycin and epothilone 
were found to be synthesised by hybrid systems. They seem to be especially 
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abundant in myxobacteria, from which e.g. compounds like myxothiazole and 
melithiazole originate, which are potent inhibitors of the respiratory chain (Weinig et 
al., 2003).  
 
The interaction of NRPS and PKS systems is enabled by their catalytic and structural 
similarities as well as their analogous modular architecture (Du et al., 2000). 
PKS/NRPS hybrids follow the same logic as the already described modular systems, 
so that the same domain prediction systems can be applied (Fischbach & Walsh, 
2006). The question how these assembly lines work at the PKS-NRPS interface has 
already been addressed by several groups (Koglin & Walsh, 2009). It was found that 
on the protein level PKSs and NRPSs recognise their correct partners through short 
recognition sequences at the protein termini, which were named communication-
mediating domains (COM) for NRPSs (Hahn & Stachelhaus, 2004) and 
interpolypeptide linkers or docking domains in the context of PKSs (Gokhale & 
Khosla, 2000; Broadhurst et al., 2003).  
 
The modular nature of PKS and NRPS assembly lines has inspired the development 
of “unnatural” natural products (Cane & Walsh, 1999), i.e. modification of product 
structures through combinatorial biosynthesis. By applying a strategy of “mix and 
match” (Richter et al., 2008) domains and modules can be modified, deleted or 
replaced by subunits from other biosynthetic clusters, as has been done intensively 
for the biosynthesis of epothilone (O’Connor et al., 2003) and erythromycin (McDaniel 
et al., 1999).  
 
1.4 The phylum Chloroflexi 
The phylum Chloroflexi is one of the deepest branching lineages of the bacteria and 
the first evolutionary branch with phototrophic members (Garrity & Holt, 2001). 
Organisms of this group are characterised by filamentous growth and gliding motility. 
They stain Gram-negatively, but lack a lipopolysaccharide-containing outer 
membrane and are therefore proposed to be typically monoderm (Sutcliff, 2010). The 
peptidoglycan of their cell wall contains L-ornithine instead of meso-diaminopimelic 
acid, a characteristic usually attributed to Gram-positive bacteria (Jürgens et al., 
1989). The phylum comprises the orders Chloroflexales and Herpetosiphonales.  
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Figure 1-11: Phylogenetic tree of the major prokaryotic groups (from Krieg & Garrity, 2001) 
 
1.4.1 Chloroflexales  
The order Chloroflexales contains a group of filamentous anoxygenic phototrophic 
bacteria. The family of Chloroflexaceae includes the genera Chloroflexus, 
Chloronema, Heliothrix and the genus Roseiflexus as the latest addition (Hanada et 
al., 2002). Recently, the Oscillochloridaceae were established as a second family 
(Keppen et al., 2000) and comprises the genus Oscillochloris. Species of this group 
are obligate or facultative phototrophs and capable of anoxygenic photosynthesis by 
the presence of bacteriochlorophylls (Stackebrand et al., 1996). The group was 
originally named green non-sulfur bacteria (Woese, 1987), but this term was 
challenged after comparison of 16S rDNA revealed that the Chloroflexi had no close 
relationship to any other phototrophic bacteria and after the addition of the genus 
Heliothrix, which is not even green. Recent genome studies, however, showed that 
the photosystem of Chloroflexus aurantiacus exhibits characteristics of green sulphur 
and purple phototrophic bacteria, which may be the result of horizontal gene transfer 
(Tang et al, 2011). While the type strain C. aurantiacus (Pierson & Castenholz, 1974) 
is a real thermophilic, other mesophilic species have been discovered as well. Some 
strains in this group are also capable of aerobic chemoheterotrophic growth. 
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1.4.2 Herpetosiphonales 
The order Herpetosiphonales is represented by the family of Herpetosiphonaceae 
with the two species H. aurantiacus and H. geysericola. Three marine species that 
were originally placed in this group were moved to the genus Lewinella in the phylum 
Bacteroides after analysis of 16S rDNA (Sly et al, 1998). Herpetosiphon species 
contain no bacteriochlorophyll and are supposed to have evolved from 
Chloroflexaceae by loss of the photosystem. They are aerobic chemoheterotrophs 
with O2 as terminal acceptor in respiration and a moderate G+C content of ~ 48-53%. 
Their colonies are of yellow to orange colour due to the presence of carotenoids  
(Kleinig & Reichenbach, 1977). Herpetosiphonaceae may be isolated from various 
environments like soil, freshwater, decaying organic matter and the activated sludge 
of sewage plants (Trick & Lingens, 1984), where they are suspected to be involved in 
bulking of the sludge (Björnsson et al, 2002). 
 
Holt & Lewin first described the type strain Herpetosiphon aurantiacus (Holt & Lewin, 
1968). The cells are rod-shaped with a diameter of 1.0-1.5 x 5-10 µm, which grow as 
flexible, unbranched filaments reaching lengths from 100 µm to more than 1200 µm. 
At the ends of these filaments the frequent occurrence of characteristic sleeves has 
been observed (Reichenbach & Golecki, 1975). There is a controversial discussion, 
whether these structures are part of a sheath surrounding the whole filament 
(Skerman et al., 1977) or if they are the remains of necridial cells. The fact that the 
filaments exhibit gliding motion as a whole and electron microscopy support the 
absence of a sheath-like structure (Lee & Reichenbach, 2006). Some Herpetosiphon 
strains were shown to exert bacteriolytic activity against some Gram-positive and 
negative bacteria (Quinn & Skerman, 1980). 
 
The 16S rDNA of Herpetosiphon exhibits idiosyncrasies in two highly conserved 
sequence regions (Oyaizu et al., 1987), which are regarded as an indication for a 
rapidly evolving line of bacteria (Woese et al., 1985). The complete genome was 
sequenced by the Joint Genome Institute (GenBank accession: NC_009972) and 
comprises 6.35 Mbp and is thus larger than the genome of Chloroflexus aurantiacus  
and other phototrophic Chloroflexaceae (Tang et al., 2011; GenBank accession: 
NC_010175). Genome mining discovered homologues to the lanM gene and 
suggests H. aurantiacus as a potential producer of lantibiotics (Begley et al, 2009).  
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1.4.3 Herpetosiphon sp. 060 
The siphonazole producing strain Herpetosiphon sp. 060 was isolated from a mud 
sample of the intertidal region (Nett, 2007). The strain shows the characteristic 
physiological features of the Herpetosiphonaceae including gliding motility and 
filamentous growth. On a dish culture, swarming filaments are clearly visible at the 
growing edge as translucent threads. Repeatedly, orange knob-like colonies are 
formed by the accumulation of intertwined filaments. Cultivation on VY/2 agar is 
concomitant with a clearing of the medium. The optimal growth temperature lies 
around 30°C with peptone as preferred carbon source. The strain exhibits salt 
tolerance only up to 1% NaCl, but strong bacteriolytic activity against E. coli. 
Sequencing of 16S rDNA revealed 99% identity to an uncultured Herpetosiphon 
species, which lead to the classification of strain 060 as a member of the genus 
Herpetosiphon. 
 
                          
Figure 1-12: Images of Herpetosiphon sp. 060 
(a) growth on VY/2 agar; orange protuberances and swarming streaks are clearly visible (from 
Nett, 2007); (b) phase-contrast micrograph (x1000) of Herpetosiphon sp. 060 filaments  
 
1.5 Siphonazole – a secondary metabolite from Herpetosiphon 
Siphonazole was discovered during a metabolite screening of ten different 
Herpetosiphon strains. The complete structure elucidation revealed an unusual 
composition of a styrene moiety, two oxazole rings connected by a C2-bridge and a 
hitherto unprecedented N-penta[2,4]dien side chain (Nett et al., 2006). Feeding 
studies with 13C-labeled precursors pointed at hydroxybenzoic acid derived from 
chorismic acid via the shikimate pathway as precursor. Further labelling studies 
proposed threonine as origin of the oxazole rings. The amide bond of the pentadien 
chain involves the incorporation of a glycine moiety, which is then elongated by two 
acetate units. It was deduced from the labelling pattern that the terminal acetate 
(a)                      (b) 
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moiety undergoes and unprecedented dehydrative decarboxylation. Besides the 
main compound, a derivative of siphonazole was isolated in small quantities, in which 
one of the hydroxyl groups of the styrene ring is also methylated.  
 
Due to lack of phenylalanine ammonia lyase in prokaryotes (Bode & Müller, 2003), 
only few metabolites are described that contain derivatives of cinnamic acid together 
with polyketide structures and incorporated amino acids. Other examples were 
isolated from myxobacteria and include crocacins and phenoxan (Jansen et al., 
1999; Jansen et al., 1991), of which only the latter exhibits some similarity to 
siphonazole from a biosynthetic point of view. Though the presence of two oxazole 
rings is common in natural products, most of them are either linked directly or 
separated by at least three carbon atoms (Lindner et al, 2008), while the occurrence 
of a bridge with only one or two carbons is rare.  
 
 
Figure 1-13: Molecular structure of siphonazole and phenoxan 
Origin of building blocks are marked according to feeding experiments; amino acid derived 
parts are coloured red; acetate moieties are shown as purple arrows (from Nett, 2007); 
phenoxan produced by Polyangium sp. 
 
Siphonazole was tested for antibiotic properties, but showed no activity against 
selected baceria, fungi and viruses. Also, the cytotoxic effect against 36 cancer cell 
lines was too weak for a use as anticancer agent. Siphonazole was only shown to 
have a moderate activity (IC50: 0.59 µg/ml; 1.27 µM) against the Plasmodium 
falciparum. A total synthesis of siphonazole and methoxysiphonazole was achieved 
by the groups of Moody (Lindner et al., 2008) and Ciufolini (Zhang et al., 2009).  
siphonazole 
phenoxan 
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2 Scope of the Study 
The Herpetosiphonales are an ancient eubacterial group, whose metabolic potential 
has not been probed so far. To the present date, the compound siphonazole, isolated 
from Herpetosiphon sp. 060, is the only secondary metabolite from this group that 
has been characterised. The molecule shows several interesting structural features, 
including a styrene ring, two oxazole rings and an unusual diene terminus. Although 
the structure hinted at a mixed PKS/NRPS pathway, the biosynthetic enzymes for 
siphonazole were unknown to the date of the study.  
 
Therefore, the primary intend of this study was the elucidation of the siphonazole 
biosynthetic gene cluster. In previous works a fosmid library of Herpetosiphon sp. 
060 has already been established and screened for PKS and NRPS genes. Thereby, 
several fosmids carrying putative parts of a siphonazole gene cluster have been 
identified. The obtained sequences were taken as a base for gene knock-out 
experiments, which aimed at the disruption of the putative cluster. Together with an 
observation of siphonazole production by LC-MS, a knock-out would allow the 
unambiguous identification of the biosynthetic enzymes, which can then be subjected 
to a detailed sequence analysis. This approach necessitated the development of 
suitable methods for the gene inactivation in Herpetosiphon sp. 060 comprising the 
construction of an integrative vector and first and foremost the establishment of a 
protocol for the transformation of Herpetosiphon cells. 
 
As an alternative approach the genome of Herpetosiphon sp. 060 was sequenced to 
allow the localisation of the identified fosmid inserts and characterisation of the 
encoded enzymes. Hence, an analysis by bioinformatic methods was included in this 
study to bring further insights about the encoded enzymes and allow the identification 
of putative parts of the siphonazole biosynthesis. The obtained data were to be used 
as a basis for a PCR-guided completion and elucidation of the cluster. Furthermore, 
the sequences were utilised to probe the genome for further secondary metabolite 
gene clusters.   
 
After identification of the siphonazole gene cluster, an ensuing part of this study 
targeted the reconstitution of the complete cluster from fragments identified in the 
fosmid library. This part comprised the attainment of fosmids covering the complete 
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cluster range and the application of suitable methods for the recombination of large 
DNA fragments to a vector carrying the complete functional gene cluster. These 
working steps aimed at the construction of a vector that can be further modified for an 
expression in a heterologous host and for ensuing experiments on single domain 
functions. 
 
The last part of the study addressed a first characterisation of the cluster and 
individual biosynthetic enzymes. The temporal expression of siphonazole was 
investigated by analysis of the mRNA expression of the putative genes, while the 
spatial localisation of the compound was observed by imaging mass spectrometry. 
Single proteins and domains of the putative biosynthetic enzymes were selected for a 
heterologous expression in E. coli. Purified proteins should be subjected to in vitro 
assays for an investigation of their specific functions. For this purpose, suitable 
expression vectors, as well as cultivation and purification conditions had to be found.  
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3 Materials & Methods 
3.1 Materials 
All chemicals were purchased in research grade or pro analysi quality. Ultra pure 
water was taken from a Milli-Q® Water System and heat sterilised. For media 
composition deionised water was used. 
 
3.1.1 Chemicals 
Reagent Manufacturer 
Acetic acid KMF Laborchemie Handels GmbH (Darmstadt, Germany)  
Aceton-d 99.8% D Deutero GmbH (Kastellaun, Germany)  
Acetonitrile VWR International GmbH (Darmstadt, Germany) 
Adenine hemisulphate Sigma-Aldrich Co. LLC (St. Louis, MO, USA) 
Agar Fluka Chemie GmbH (Buchs, Switzerland) 
Amberlite® XAD16 Sigma-Aldrich Co. LLC (St. Louis, MO, USA) 
Ammonium acetate Roth Chemie GmbH (Karlsruhe, Germany)  
Bacto™ Casitone Becton, Dickinson and Company (Franklin Lakes, NJ, USA) 
Bis-acrylamide Roth Chemie GmbH (Karlsruhe, Germany) 
Boric acid Roth Chemie GmbH (Karlsruhe, Germany) 
CaCl2 × 2 H2O  Merck KGaA (Darmstadt, Germany)  
Chloroform  Roth Chemie GmbH (Karlsruhe, Germany) 
Brilliant Blau R 250 Roth Chemie GmbH (Karlsruhe, Germany) 
CopyControlTM 
Induction solution  
Epicentre (Madison, USA)  
dNTPs Promega GmbH (Mannheim, Germany)  
Drop-out Mix Synthetic 
Minus Uracil w/o 
Yeast Nitrogen Base 
Biomol GmbH (Hamburg, Germany) 
Ethanol 99,8% p.a.  Roth Chemie GmbH (Karlsruhe, Germany)  
Ethidium bromide Roth Chemie GmbH (Karlsruhe, Germany)  
Ethyl acetate Julius Hoesch GmbH & Co. KG (Düren, Germany) 
Glycerol Roth Chemie GmbH (Karlsruhe, Germany)  
Gel loading dye (6x) Fermentas GmbH (St. Leon Rot, Germany)  
22  Materials & Methods 
Imidazole Roth Chemie GmbH (Karlsruhe, Germany) 
Isopropanol Roth Chemie GmbH (Karlsruhe, Germany) 
Isovanillic acid Alfa Aesar (Ward Hill, MA, USA) 
Ni-NTA agarose Qiagen GmbH (Hilden, Germany)  
Methanol Merck KGaA (Darmstadt, Germany)  
MgCl2 × 6 H2O Merck KGaA (Darmstadt, Germany)  
MgSO4 x 7 H2O Merck KGaA (Darmstadt, Germany)  
Na-acetate Merck KGaA (Darmstadt, Germany)  
NaCl Merck KGaA (Darmstadt, Germany)  
Na2-EDTA  Roth Chemie GmbH (Karlsruhe, Germany)  
NaOH Merck KGaA (Darmstadt, Germany)  
peqGOLD Agarose PEQLAB Biotechnologie GMBH (Erlangen, Germany)  
Phenol  Merck KGaA (Darmstadt, Germany)  
Protocatechuic acid Roth Chemie GmbH (Karlsruhe, Germany) 
SDS Roth Chemie GmbH (Karlsruhe, Germany)  
Sorbitol Roth Chemie GmbH (Karlsruhe, Germany)  
Trifluoracetic acid Roth Chemie GmbH (Karlsruhe, Germany)  
Tris Roth Chemie GmbH (Karlsruhe, Germany)  
Tris-HCl Roth Chemie GmbH (Karlsruhe, Germany)  
Tryptone  Roth Chemie GmbH (Karlsruhe, Germany)  
Yeast extract  Fluka Chemie GmbH (Buchs, Switzerland)  
Yeast Nitrogen Base 
w/o amino acids, 
carbohydrate & w/AS 
Biomol GmbH (Hamburg, Germany) 
 
3.1.2 Devices 
Article Manufacturer 
Autoclave  Varioklav®, H+P Labortechnik AG 
(Oberschleißheim, Germany)  
Bandelin Sonorex RK 31 Bandelin electronic GmbH & Co. KG  
(Berlin, Germany)  
Biometra T3000 Thermocycler Biometra GmbH (Goettingen, Germany) 
Bio-Rad Micropulser™ Bio-Rad Laboratories GmbH (Hercules, USA) 
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BioRad PowerPacTM Basic Bio-Rad Laboratories GmbH (Hercules, USA)  
Branson Sonifier 250 G. Heinemann Ultraschall- und Labortechnik 
(Schwäbisch Gmünd, Germany) 
Centrifuge Heraeus Biofuge 
fresco 
Thermo Fisher Scientific (Waltham, USA)  
Centrifuge Heraeus Contifuge 
Stratos 
Thermo Fisher Scientific (Waltham, USA)  
Centrifuge Heraeus Fresco 17 Thermo Fisher Scientific (Waltham, USA)  
Gel chamber Horizon 58 Life technologies (Karlsruhe, Germany) 
Gel chamber Horizon 11.14 Life technologies (Karlsruhe, Germany) 
Incubator  Memmert GmbH + Co. KG (Schwalbach, 
Germany)  
Inolab pH meter WTW GmbH (Weilheim, Germany)  
Intas iX Imager Intas Science Imaging Instruments GmbH 
(Göttingen, Germany) 
Laminar Airflow Clean Bench 
BSB 4A (Hera Safe, Class II) 
Heraeus (Hanau, Germany) 
Magnetic stirrer (IKA® RH basic) IKA® Werke GmbH & Co. KG (Staufen, Germany) 
Milli-Q® Water System  Millipore (Eschborn, Germany)  
Multitron incubation shaker Infors AG (Bottmingen, Switzerland)  
Olympus BX 51  Olympus America Inc. (Center Valley, USA)  
Scale (Sartorius BL 3100)  Sartorius AG (Göttingen, Germany)  
Scale (Sartorius BP 221S)  Sartorius AG (Göttingen, Germany)  
Thermomixer Eppendorf  Eppendorf (Hamburg, Germany)  
UV mini 1240 UV/Vis spectro-
photometer  
Shimadzu (Kyoto, Japan)  
UV cuvettes  Ratiolab GmbH (Dreieich, Germany)  
Water bath (Haake DC 10)  Thermo Haake GmbH (Karlsruhe, Germany)  
 
 
 
 
 
24  Materials & Methods 
3.1.3 Antibiotics 
Reagent Manufacturer 
Ampicillin Roth Chemie GmbH (Karlsruhe, Germany)  
Apramycin Sigma-Aldrich Co. LLC (St. Louis, MO, USA) 
Carbenicillin Roth Chemie GmbH (Karlsruhe, Germany) 
Chloramphenicol Fluka Chemie GmbH (Buchs, Switzerland)  
Gentamycin Fluka Chemie GmbH (Buchs, Switzerland) 
Kanamycin Sigma-Aldrich Co. LLC (St. Louis, MO, USA) 
Nalidixinic acid Roth Chemie GmbH (Karlsruhe, Germany) 
Streptomycin Sigma-Aldrich Co. LLC (St. Louis, MO, USA) 
Tetracyclin Fluka Chemie GmbH (Buchs, Switzerland) 
Zeocin Invitrogen Life Technologies Co. (Karlsruhe, Germany) 
 
3.1.4 Disposable material 
Article Manufacturer 
Amicon Ultra Centrifugal Filters Millipore GmbH (Schwalbach, Germany) 
Centrifuge tubes (15/50 ml)  TPP AG (Trasadingen, Germany)  
Eppendorf tubes (0.5, 1.5, 2 ml)  Eppendorf (Hamburg, Germany)  
PD-10 Desalting Columns GE Healthcare (München, Germany) 
Polypropylene columns (1ml) Qiagen GmbH (Hilden, Germany)  
Parafilm® Pechiney Plastic Packaging Company  
(Chicago, USA)  
Sterile filter (0.2 μm)  Renner GmbH (Dannstadt, Germany)  
 
3.1.5 Buffers and stock solutions 
Buffer Composition 
Buffer P1 50 mM Tris-HCl (pH 8), 10 mM EDTA,  
100 μg/mL RNase A 
Buffer P2 200 mM NaOH, 1% SDS  
Buffer P3 3M potassium acetate (pH 5.5)  
TE-buffer 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
10x TBE-buffer 0.89 M Tris base, 0.02 M EDTA, 0.87 M H3BO3, H2O ad 1 l  
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10x glycine SDS 
electrophoresis buffer 
250 mM Tris, 2M glycine, 1% SDS,  
pH 8.9 
A Domain buffer (Phelan 
et al., 2009) 
20 mM Tris-HCl (pH 7.5), 5% glycerol, 1mM DTT 
Trace element solution 20 mg ZnCl2, 100 mg MnCl2 x 4 H2O, 10 mg H3BO3, 10 
mg CuSO4, 20 mg CoCl2, 5 mg SnCl2 x 2 H2O, 5 mg 
LiCl, 20 mg KBr, 20 mg KI, 10 mg Na2MoO4 x 2 H2O, 
5.2 g Na2-EDTA x 2 H2O, H2O ad 1 l; filter sterilise 
P-buffer (mod. after 
Okanishi et al., 1974; 
Hopwood & Wright, 1978) 
0.3M sorbitol, 1mM MgCl2 x 6H2O, 2 ml trace element 
solution, H2O ad 800 ml; after autoclaving add the 
following sterile solutions: 10 ml KH2PO4 (0.5%), 100 ml 
CaCl2 x 2 H2O (3.68%), 100 ml TE-buffer (pH 7.2) 
T-buffer (mod. after 
Thompson et al., 1982) 
25% PEG 1000, 50 mM Tris (pH 8), 75 mM sorbitol, 100 
mM CaCl2 x 2 H2O; filter sterilise, do not autoclave 
Protein lysis buffer 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole,  
pH 8.0 
Protein wash buffer 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole,  
pH 8.0; for more stringent washing 40 mM imidazole 
were applied  
Protein elution buffer 50 mM NaH2PO4, 300 mM NaCl, pH 8.0; for gradual 
elution buffers with 100, 150, 200 and 300 mM 
imidazole were used 
 
3.1.6 Media 
Medium Composition 
LB medium 10 g tryptone, 5 g yeast extract, 10 g NaCl, H2O ad 
1 l, pH 7.5  
LB agar 10 g tryptone, 5 g yeast extract, 5 g NaCl, 15 g 
Agar, H2O ad 1 l, pH 7.5  
CY medium 3.0 g casiton, 1.36 g CaCl2 x 2 H2O; 1.0 g yeast 
extract, H2O ad 1 l, pH 7.2; after autoclaving add 
1 ml filter sterilised trace element solution and  
1 ml vitamin B12 solution (0.5 mg/ml) 
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VY/2 agar 50 ml sterilised baker’s yeast suspension (10%), 
1.36 g CaCl2 x 2 H2O, 15 g agar, H2O ad 1 l,  
pH 7.2; after autoclaving add 1 ml filter sterilised 
vitamin B12 solution (0.5 mg/ml) 
Synthetic drop-out medium 6.7 g Yeast Nitrogen Base without amino acids, 
carbohydrate & with ammonium sulphate; 2 g 
Drop-out Mix Synthetic Minus Uracil without 
Yeast Nitrogen Base; 20 g agar; H2O ad 900 ml; 
pH 5.6 – 5.8; after autoclaving add 100 ml 20% 
sterile glucose solution 
SOB 20 g tryptone, 5g yeast extract; 0.5 g NaCl, 0.186 
g KCl, H2O ad 1 l, pH 7.5 
SOC 20 g tryptone, 5g yeast extract; 0.5 g NaCl, 0.186 
g KCl, H2O ad 1 l, pH 7.5; after autoclaving add 
20 ml 1M filter sterilised glucose solution  
YPAD medium 10 g yeast extract, 20 g peptone, 20 g glucose, 
40 mg adenine hemisulphate; H2O ad 900 ml; 
after autoclaving add 100 ml 20% sterile glucose 
solution 
 
3.1.7 Enzymes 
Enzyme Manufacturer 
GoTaq® Flexi DNA Polymerase  Promega (Mannheim, Germany)  
Lysozyme  Roth (Karlsruhe, Germany)  
Proteinase K  Roth (Karlsruhe, Germany)  
Restriction enzymes  Fermentas GmbH (St. Leon-Rot, Germany)  
RNase (DNase free)  Roth Promega (Mannheim, Germany)  
Fast-Link™ DNA Ligase Epicentre (Madison, USA)  
T4 DNA-ligase  Fermentas GmbH (St. Leon-Rot, Germany)  
CIAP Fermentas GmbH (St. Leon-Rot, Germany)  
SAP Fermentas GmbH (St. Leon-Rot, Germany)  
 
Materials & Methods  27 
 
3.1.8 Kits and standards 
Article Manufacturer 
Gene RulerTM DNA Ladder Mix  Fermentas GmbH (St. Leon-Rot, Germany)  
Gene RulerTM 1kb plus DNA ladder Fermentas GmbH (St. Leon-Rot, Germany)  
Gene RulerTM 50bp DNA ladder Fermentas GmbH (St. Leon-Rot, Germany)  
Gene RulerTM high range DNA ladder Fermentas GmbH (St. Leon-Rot, Germany)  
QIAquick PCR Purification Kit  Qiagen GmbH (Hilden, Germany)  
QIAquick Gel Extraction Kit  Qiagen GmbH (Hilden, Germany)  
QIAGEN Plasmid Midi Kit Qiagen GmbH (Hilden, Germany)  
QIAGEN Plasmid Maxi Kit  Qiagen GmbH (Hilden, Germany)  
QIAprep®Spin Miniprep Kit Qiagen GmbH (Hilden, Germany)  
RevertAid™ H Minus First Strand 
cDNA Synthesis Kit 
Fermentas GmbH (St. Leon-Rot, Germany) 
Wizard® SV Gel and PCR Clean-Up 
System 
Promega (Mannheim, Germany)  
Wizard® Genomic DNA Purification Kit Promega (Mannheim, Germany)  
PureYieldTM Plasmid Miniprep System Promega (Mannheim, Germany)  
DNA Clean & ConcentratorTM Zymo Research Corporation (Irvine, USA) 
Zymoclean™ Large Fragment DNA 
Recovery Kit 
Zymo Research Corporation (Irvine, USA) 
Zymoprep™ Yeast Plasmid Miniprep I 
Kit 
Zymo Research Corporation (Irvine, USA) 
 
3.1.9 Organisms 
Organism Genotype Provider 
Herpetosiphon sp. 060 wild type own strain collection 
XL1-Blue E. coli cells  recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZΔM15 Tn10 (Tetr)] 
Stratagene (La Jolla, CA, 
USA) 
BL21 (DE3) E. coli 
cells 
F– ompT gal dcm lon hsdSB(rB
- 
mB
-) λ(DE3 [lacI lacUV5-T7 
gene 1 ind1 sam7 nin5]) 
Invitrogen Life 
Technologies Corporation 
(Karlsruhe, Germany) 
BAP1 E. coli cells n.a.; sfp from B. subtilis Pfeifer et al., 2001 
ET12567 E. coli cells Dam-, dcm-, hsdM- MacNeil et al., 1992 
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Phage T1-Resistant 
TransforMax™ EPI-  
300™-T1R chemically 
competent E.coli cells 
F- mcrA D(mrr-hsdRMS-
mcrBC) f80dlacZDM15  
DlacX74 recA1 endA1 
araD139 D(ara, leu)7697  
galU galK λ- rpsL nupG trfA 
tonA dhfr  
Epicentre Biotechnologies 
(Madison, USA)  
 
BW25113 E. coli cells F-, Δ(araD-araB)567, 
ΔlacZ4787(::rrnB-3), λ-, rph-1, 
Δ(rhaD-rhaB)568, hsdR514 
Gust et al., 2003 
BL21 star E. coli cells F- ompT hsdSB (rB
-mB-) gal 
dcm rne131 (DE3) 
Invitrogen Life 
Technologies Corporation 
(Karlsruhe, Germany) 
TOP10 E. coli cells F- mcrA Δ(mrr-hsdRMS-
mcrBC) Φ80lacZΔM15 
ΔlacΧ74 recA1 araD139 
Δ(ara-leu)7697 galU galK rpsL 
(StrR) endA1 nupG 
Invitrogen Life 
Technologies Corporation 
(Karlsruhe, Germany) 
ArcticExpress (DE3) 
competent E. coli cells 
E. coli B F– ompT hsdS (rB– 
mB–) dcm+ Tetr gal λ(DE3) 
endA Hte [cpn10 cpn60 Gentr] 
[argU proL Strr] 
Agilent Technologies 
(Santa Clara, CA, USA) 
Saccharomyces 
cerevisiae 
n.a.; ura3P deficient C. Gurgui (Piel group, 
University  of Bonn) 
 
3.1.10 Vectors 
Vector Resistance Manufacturer 
pET28a(+) kanamycin Merck KGaA (Darmstadt, Germany)  
pIJ773 apramycin Gust et al., 2003 
pIJ778 streptomycin Gust et al., 2003 
pKD46 ampicillin Datsenko et al., 2000 
pCC1FOSTM chloramphenicol Epicentre Biotechnologies (Madison, USA)  
pET151/D-
TOPO® 
ampicillin Invitrogen Life Technologies Corporation 
(Karlsruhe, Germany) 
pENTRC1FOS chloramphenicol C. Gurgui (Piel group, University  of Bonn) 
pGEM-T ampicillin Promega (Mannheim, Germany) 
pUC19 ampicillin own collection 
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3.1.11 Clones & DNA-constructs 
The following table lists all vectors and DNA-constructs used or created in this study. 
 
Construct Vector Insert 
EC9 pCC1FOS Genomic DNA from Herpetosiphon sp. 060 with 
parts of the putative siphonazole gene cluster 
EC10 pCC1FOS Genomic DNA from Herpetosiphon sp. 060 with 
parts of the putative siphonazole gene cluster 
CF4 pCC1FOS Genomic DNA from Herpetosiphon sp. 060 with 
parts of the putative siphonazole gene cluster 
IC2 pCC1FOS Genomic DNA from Herpetosiphon sp. 060 with 
parts of the putative siphonazole gene cluster 
EC9-2, -5, -7 pGEM-T Subclones with fragments from fosmid EC9 
EC10-1, -3, -5, -6,  
-7, -8, -9, -10 
pGEM-T Subclones with fragments from fosmid EC10 
CF4-2, -4, -5, -6,  
-7, -8, -9, -10 
pGEM-T Subclones with fragments from fosmid CF4 
SphB pET28a(+) O-MT SphB from Herpetosiphon sp. 060 
SphI pET151 DAHP synthase SphI from Herpetosiphon sp. 060 
SphC-A1 pET151 A domain from Herpetosiphon sp. 060 
EC10-aadA pCC1FOS Fosmid EC10 with aadA resistance gene 
IC2-apra pCC1FOS Fosmid IC2 with aac(3)IV resistance gene 
EC9+IC2 pCC1FOS Fosmid with inserts from EC9 and IC2-apra 
Siphonazole pCC1FOS Fosmid with complete putative siphonazole cluster, 
recombined from EC9+IC2 and EC10-aadA 
 
3.1.12 Primers 
PCR-primers were purchased from Eurofins MWG Operon (Ebersberg, Germany) as 
desalted, lyophylised powder. The oligonucleotides were reconstituted in sterile water 
and adjusted to a concentration of 100 pmol/µl. Reconstituted primers were either short-
term stored at 4°C or at -20°C for longer periods. A compilation of the nucleotides 
sequences is given in the appendix (8.3).  
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3.1.13 Software and Databases 
Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov/) 
provided by the National Center for Biotechnology Information (NCBI) was used for 
multiple sequence alignments of protein primary sequences and alignments of 
nucleotide sequences. Protein homologies and conserved domains were analysed by 
application of BLASTp and the Conserved Domain Database (CDD; Marchler-Bauer, 
2011). 
 
The Cluster Sequence Analyzer (CLUSEAN) pipeline combines database research 
and specific tools for the identification of PKS and NRPS domains and conserved 
motifs (Weber et al., 2009). This pipeline was used for the analysis of draft genomic 
data and the annotation of the putative siphonazole biosynthetic gene cluster. 
 
The NRPSPredictor and NRPSPredictor2 (Rausch et al., 2005; Röttig et al., 2011) 
software provided by the University of Tübingen (http://ab.inf.uni-
tuebingen.de/software/NRPSpredictor/) predict the substrate specificity of A domains 
by analysis of amino acid signature sequences (Stachelhaus et al., 1999). The 
software was used for the specificity prediction of identified adenylation domains. 
 
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) of the European 
Bioinformatics Institute (EBI) was applied to generate multiple alignments of amino 
acid or nucleotide sequences (Larkin et al., 2007; Goujon et al., 2010). Reference 
protein sequences were derived from NCBI databases (http://www.ncbi.nlm.nih.gov/). 
 
DNASTAR Lasergene® from DNASTAR Inc. (Madison, WI, USA) comprises number 
of sequence assembly and analysis tools. The SeqMan tool was used for the 
assembly of data obtained by 454 sequencing.  
 
The Protparam tool (http://web.expasy.org/protparam/) on the ExPASy server of the 
Swiss Institute for Bioinformatics (SIB) was employed to calculate the physic-
chemical parameters of recombinant proteins like pI, molecular weight and predicted 
stability and solubility (Gasteiger et al., 2005).  
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The Artemis Genome Browser and Annotation Tool (Rutherford et al., 2000; 
Carver et al., 2011) by the Sanger Institute was utilised for the annotation of open 
reading frames, analysis of GC-content and visualisation of bioinformatic data 
obtained by CLUSEAN. Analysis of codon bias and calculation of the Codon 
Adaptation Index (CAI) was carried out by application of the Jcat tool (Grote et al., 
2005; http://www.jcat.de/). 
 
Design of PCR-primers and planning of cloning experiments were performed with the 
CloneManager 9 software by Sci-Ed Software. Restriction site analysis was 
accomplished with the NEBcutter V2.0 (http://tools.neb.com/NEBcutter2/) by New 
England Biolabs (Vincze et al., 2003). 
  
The NaPDos tool (http://napdos.ucsd.edu/) detects and extracts A and KS domains 
from nucleotide sequence data. Candidate genes are processed and subjected to 
database comparisons with known secondary metabolite gene clusters. This tool was 
utilised to search the draft genome of Herpetosiphon sp. 060 for parts of PKS and 
NRPS gene clusters (Ziemert et al., 2011).  
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3.2 General methods concerning micro-organisms 
3.2.1 Sterilisation 
Materials and solutions used for microbiological work were sterilised by autoclaving 
for 20 min at 121°C and 2 bars pressure in a Varioklav steam steriliser. Heat 
sensitive solutions were sterilised by filtration through a 0.22 µm disposable filter cap 
instead.  
 
3.2.2 Storage of organisms 
For long term preservation of micro-organisms cryogenic cultures were prepared. 
0.75 ml of a fully grown liquid culture was mixed with the same amount of sterile 
glycerol in a cryogenic vial. The culture was thoroughly mixed by inverting the tube 
and stored at -80°C. 
 
3.2.3 Cultivation of bacterial organisms 
All working steps with bacteria were performed on a laminar air flow clean bench 
under sterile conditions. All working materials, solutions and tools were either 
autoclaved, sterile-filtered or heat sterilised in a Bunsen burner flame. For cultivation, 
always autoclaved media were used. 
 
Small E. coli cultures were incubated in a either 10 ml glass tubes or 2 ml Eppendorf 
tubes. Larger cultivation was performed in Erlenmeyer flasks. For the cultivation on 
agar plates, 100 – 250 µl of a liquid culture were spread on the agar and left under 
the sterile bench with the lid open, until the liquid was absorbed by the medium. E. 
coli cultures were incubated at 37°C, if not stated otherwise. Liquid cultures of 
Herpetosiphon were always incubated in Erlenmeyer flasks on a horizontal shaker at 
30°C and 140 rpm. For cultivation, VY/2 medium supplemented with Vitamin B12 and 
trace elements was inoculated with blocks from a Petri dish culture of Herpetosiphon. 
Solid cultures were grown on CY-agar at 30°C. 
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3.2.4 Preparation of a crude extract from Herpetosiphon sp. 060 
The production of siphonazole was observed by detecting its mass in a crude extract 
by HPLC-LCMS (3.6.9). Therefore, 1.5L VY/2 medium with 2% (m/v) Amberlite 
XAD16 adsorber resin were prepared in a 5L flask and inoculated with 100 ml of a 
pre-culture. The main culture was incubated for seven days to allow extensive 
production of siphonazole and adsorption of metabolites by the Amberlite. Following, 
cells and resin were pelleted by centrifugation at 4,000 rpm for 15 min. The liquid was 
decanted the residue transferred to a suction strainer. Compounds absorbed by the 
resin and from adherent cells were eluted by extracting three times with 100 ml 
acetone. The extract was dried at 40°C in a vacuum rotary evaporator and resolved 
in 250 ml 60% aqueous methanol. Following three times extraction with 100 ml 
dichloromethane the extract was concentrated and finally solved in 25 ml ethyl 
acetate. This fraction was dried again and stored until measurement at -20°C. 
 
3.2.5 Test for antibiotic resistance of Herpetosiphon sp. 060 
Herpetosiphon strain 060 was tested for natural resistance against different 
antibiotics. VY/2 agar plates each containing one antibiotic agent were inoculated 
with 50 and 100 µl of a liquid culture and incubated for three days at 30°C. Growth on 
the plates was observed and the grade of inhibition qualitatively classified.  
 
3.2.6 Imaging mass spectrometry (IMS) 
All experiments on IMS with Herpetosiphon sp. 060 were conducted by Dr. Till 
Schäberle in the Dorrestein Lab at the University of San Diego (UCSD, California, 
USA).  
 
This MALDI-TOF (Matrix Assisted Laser Desorption/Ionisation – Time Of Flight) 
based mass spectrometry method developed by Esquenazi and co-workers 
(Esquenazi et al., 2008) allows the detection of secondary metabolites and the 
visualisation of their spatial distribution. For this purpose, cultures are directly grown 
on MALDI target plates and sprayed with a matrix, which allows immediate MALDI 
imaging. The detected masses can then be evaluated with suitable software, where 
they can be displayed in individual colours and are available for analysis and 
comparison with known compounds. 
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3.3 Transformation of bacterial cells 
Transformation of bacterial cells describes the introduction of foreign DNA into the 
cells. Available methods include transformation by heat shock, electroporation and 
sonication (Yoshida & Sato, 2009). In most cases, the preparation of competent cells 
is necessary prior to the actual transformation, as most bacteria do not naturally take 
up foreign DNA. The DNA transfer by conjugation exploits a naturally occurring 
mechanism of horizontal gene transfer. 
 
3.3.1 Preparation of chemically competent cells 
Chemically competent E. coli cells were always prepared in the same way 
independent of the used strain. A 3 ml LB culture was inoculated with a single colony 
and incubated overnight at 180°C and 180 rpm. With this pre-culture 70 ml of 2xYT-
medium were inoculated. The culture was grown to an OD600 of 0.3 – 0.4 and the 
cells harvested by centrifugation for 10 min at 8,000 rpm and 4°C. To confer 
competence, the cells were resuspended in 10 ml ice cold CaCl2/MgSO4-solution (70 
mM CaCl2/20 mM MgSO4) and incubated on ice for 30 min. The cells were harvested 
and incubated again in 3.5 ml of the CaCl2/MgSO4-solution. After the addition of 875 
µl sterilised glycerol, the cells were stored as 100 µl aliquots at -80°C until usage. 
 
3.3.2 Preparation of electro-competent cells 
Electro-competent E.coli cells were always freshly prepared and used on the same 
day. The method follows a modified protocol after Gust et al. (2003). All centrifugation 
steps were carried out at 4°C. The cells were strictly kept on ice all the time. 
 
100 ml SOB medium were inoculated with 1 ml of a 3 ml-overnight culture and grown 
to an OD600 of about 0.5. The culture was divided into two sterile 50 ml falcon-tubes 
and the cells harvested by 5 min centrifugation at 6,000 rpm. The supernatant was 
discarded and the cells washed once with 10 ml and twice with 5 ml sterile ice cold 
10% glycerol. Each washing step was followed by 5 min centrifugation at 6,000 rpm. 
After the last step the supernatant was removed and the cells suspended in 200 µl 
ice cold 10% glycerol. The suspension was aliquotted à 100 µl and kept on ice until 
use. 
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3.3.3 Transformation of chemically competent cells 
For protein expression and in vivo amplification of plasmids, DNA was transformed 
into chemically competent cells (3.3.1) by heat shock. An aliquot of competent cells 
was thawed on ice and mixed with 5 µl of purified plasmid or a ligation reaction 
(3.4.8). After incubation on ice for 30 min, the sample was subjected to heat-shock at 
42°C for 90 s and immediately replaced on ice for 2 min. To allow recovery of the 
cells they were incubated with 1 ml LB-medium for 1h at constant mixing at 850 rpm 
in a thermo mixer. 250 µl of the culture were spread onto an agar plate containing 
suitable antibiotics for the selection of transformants and incubated overnight at 
37°C. Clones were screened for the correct insert by whole cell PCR (3.4.1.1). 
 
3.3.4 Transformation of electro-competent E. coli cells 
Freshly prepared electro-competent cells (3.3.2) were mixed on ice with 3-15 µl of 
the DNA to be transformed. The cell suspension was filled into a pre-chilled 
electroporation cuvette with 0.2 mm diameter and electroporated at 2.5 kV using a 
Biorad MicroPulser™ electroporator. The cells were recovered immediately with 1 ml 
ice cold SOC medium and incubated in 2ml eppendorf tubes at 30°C for 1h. 
Afterwards, the cells were harvested by 2 min centrifugation at 6,000 rpm and most 
of the supernatant discarded. The pellet was resuspended in the remaining liquid and 
spread onto an LB agar plate containing appropriate antibiotics. The plate was 
incubated over night at 30°C. 
 
As large constructs such as fosmids have a very low transformation rate, high 
amounts of DNA are needed for successful transformation. In this study amounts 
>1µg DNA were used frequently for electroporation. 
 
3.3.5 Generation of protoplasts from Herpetosiphon 
Protoplasts of Herpetosiphon sp. 060 were generated for transformation experiments 
following a modified protocol after Thompson et al. (1982). 100 ml CY-medium were 
inoculated with agar blocks from a Herpetosiphon dish culture and grown for 24h. 
The culture was divided into two 50 ml falcon tubes and the cells harvested by 10 min 
centrifugation at 4,000 rpm. The pellets were washed in 7.5 ml buffer P and 
resuspended in 10 ml buffer containing 10 mg/ml lysozyme. The cells were incubated 
36  Materials & Methods 
at 30°C and constant shaking with 180 rpm to allow digestion of the cell wall. 
Samples were taken after 2, 3 and 4h and progress examined microscopically. At a 
protoplastation level of approx. 90%, 5 ml buffer P was added and the suspension 
carefully pipetted up and down with a 5 ml pipette tip to dissolve clumps of cells. To 
separate the protoplasts from remaining filaments, the suspension was filtered 
through a syringe with sterile cotton cloth applying gentle pressure only. The filtered 
cells were pelleted at 3,000 rpm for 10 min, washed with 10 ml buffer P to remove 
lysozyme and finally resuspended in 1 ml buffer P. The cell suspension was either 
used directly or stored at -80°C as 100 µl aliquots.  
 
3.3.6 PEG-mediated transformation of Herpetosiphon protoplasts 
Transformation of protoplasts (3.3.5) was carried out after modified protocols 
following the procedures as described elsewhere (Bibb et al., 1978; Thompson et al., 
1982). 100 µl protoplasts were mixed with 1 µg of the DNA construct to be 
transformed. Immediately 400 µl of buffer T or buffer P containing 25% – 50% PEG 
were added and carefully mixed. The mixture was spread on VY/2-agar containing 
0.3 M Sorbitol as a protective agent against osmotic stress and incubated at 30°C. 
The cells were either directly plated on selective medium containing suitable 
antibiotics or first regenerated for 1-3 days without selection before covering the plate 
with selective soft agar or a solution of the selective agent. The amount of the used 
antibiotics was calculated for an agar culture with 25 ml medium. 
 
3.3.7 Glycine treatment of Herpetosiphon cultures 
Glycine is described as a cell wall-weakening agent (Hammes et al., 1977), which is 
commonly used prior to the electro-transformation of bacterial cells (Buckley et al., 
1999). 100 ml CY-medium were inoculated with agar blocks from a Herpetosiphon 
dish culture and grown for 24h. Glycine was added to the medium at a final 
concentration of 2% – 5% (w/v) and the culture grown for another 24h. The following 
steps were all carried out under constant cooling. 2 ml aliquots were pelleted at 5,000 
rpm for 10 min and the cells washed two times with 1 ml electroporation buffer. After 
the second washing step, the pellet was resuspended in 50 µl electroporation buffer 
and placed on ice until usage (3.3.8.2).   
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3.3.8 Electroporation of Herpetosiphon sp. 060 cells 
2 ml from a liquid culture of Herpetosiphon were pelleted for 4 min at 13,000 rpm and 
washed two times with 1 ml electroporation buffer. The pellet was resuspended in 50 
µl electroporation buffer, mixed with 5 µl of the DNA to be transformed and incubated 
for 5 min on ice. Electroporation was performed in 0.1 cm cuvettes at 1.25 and 2.0 
kV. The cells were recovered in 1 ml CY-medium and incubated at 30°C for 2h 
before spreading on selective VY/2 agar plates. 
 
3.3.8.1 Electroporation of Herpetosiphon protoplasts 
A 100 µl aliquot of Herpetosiphon protoplasts was sedimented for 10 min at 3,000 
rpm. The supernatant was discarded and the pellet resuspended in 50 µl 
electroporation buffer. After the addition of 1 µg of the DNA to be transformed, the 
sample was incubated on ice for 5 min. Electroporation was performed in 0.1 cm 
cuvettes at 0.35 kV. The cells were recovered in 1 ml CY-medium containing 0.3M 
sorbitol. One half of the suspension was directly plated on selective VY/2 agar plates 
containing 0.3M sorbitol. The other half was incubated at 30°C and 500 rpm in a 2 
ml-eppendorf cap for 24h before plating.  
 
3.3.8.2 Electroporation of Herpetosiphon cells after glycine treatment 
A 50 µl aliquot of glycine treated cells (3.3.7) was mixed with 1 µg of the DNA to be 
transformed and incubated on ice for 10 min. Electroporation was performed in 0.1 
cm cuvettes at 1.8 kV. The cells were either treated in the same way as protoplasts 
(3.3.8.1) or alternatively recovered in 5 ml CY-medium containing 0.3M sorbitol and 
regenerated for 5 days at 30°C and 140 rpm in a 15ml falcon-tube. The cells were 
harvested by centrifugation for 10 min at 5,000 rpm and resuspended in 1 ml CY 
medium and spread on selective VY/2 agar plates containing 0.3M sorbitol 
 
3.3.9 Sonication 
The use of ultrasound has been described as a method for the delivery of DNA into 
bacterial cells (Song et al., 2007). A 100 ml CY culture of Herpetosiphon sp. 060 was 
grown for 48h, including the optional addition of 1% glycine after the first 24h. 2 ml of 
the culture were pelleted by centrifugation, washed two times with electroporation 
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buffer and finally resuspended in 50 µl electroporation buffer. The cells were mixed 
with 500 ng of the DNA to be transformed and incubated on ice for 5 min. 
Sonoporation was performed in a Bandelin Sonorex RK 31 ultrasound-bath. The cells 
were exposed to a constant ultrasound output for 10s, 30s and 60s. Immediately 
following the treatment, 1 ml CY medium was added and the cells incubated for 2h at 
30°C, before spreading 500 µl on selective VY/2 agar plates.  
 
3.3.10 Bacterial conjugation 
Bacterial plasmids can be mobilised and transferred to other cells by horizontal gene 
transfer (Smillie et al., 2010). During bacterial conjugation plasmids that carry a 
special origin of replication (origin of transfer, oriT) are targeted by a set of proteins, 
which initiate a rolling circle replication. Through the formation of a pilus, which 
connects two conjugating cells, the newly synthesised plasmid is transferred to the 
receptor cell. This process can be exploited for the transformation of bacterial cells. 
In this study the E. coli strain ET12567 was used for this purpose, which harbours the 
helper plasmid pUZ8002. This plasmid can mediate the mobilisation of other vectors 
that contain an oriT, but is not self-transmissible due to a mutation (Kieser et al., 
2000).  
 
A DNA fragment of approx. 1kb was inserted into the oriT containing vector pIJ773 
and transformed into ET12567 cells. The E. coli cells were grown at 37°C in 30 ml LB 
medium to an OD600 of 0.4. 30 ml CY-medium were inoculated with agar blocks from 
a Herpetosiphon sp. 060 dish culture and grown for 48h @ 30°C. The cells of both 
cultures were harvested by centrifugation and washed with LB medium and finally 
resuspended in 1.5 ml LB medium. 500 µl of each cell suspension were mixed and 
pelleted by centrifugation. The supernatant was decanted and the cells resuspended 
in the remaining liquid, before spreading them on VY/2 agar plates. After incubation 
at 30°C for 24h, the cultures were covered with 1 ml of an antibiotic solution, which 
always contained apramycin as selective agent and either nalidixinic acid, 
carbenicillin or gentamycin to eliminate the E. coli cells, but not Herpetosiphon (see 
also 4.1.1). The amounts of antibiotic agents were calculated for an agar plate with 
25 ml solid medium. The plates were incubated again at 30°C and observed for 
several days. 
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3.4 Molecular biological methods concerning nucleic acids 
3.4.1 PCR 
The polymerase chain reaction (PCR) allows the rapid amplification of a DNA region 
of interest between two defined primer regions. First, the DNA is denatured by 
heating, so that the oligonucleotide primers can anneal to their complement 
sequences. These primers act as a template for a DNA-polymerase, which elongates 
the DNA strands. Repetitive cycles of this procedure allow the exponential 
amplification of the target region. While dNTPs for the elongation are added in high 
surplus, the amount of primers is usually the limiting factor of the product yield.  
 
Most commonly, the thermostable polymerase from Thermus aquaticus (Taq) is used 
for PCR. The amplification of an open reading frame used for heterologous protein 
expression was performed with DNA-polymerase from Pyrococcus furiosus (Pfu), 
which is capable of proofreading activity. PCR-reactions were composed as follows: 
 
10x PCR-Buffer   2 µl 
MgCl2 (25mM)   1 µl 
dNTPs (10 mM)   0.4 µl 
Forward-Primer (100 µM)  0.5 µl 
Reverse-Primer (100 µM)  0.5 µl 
DNA-polymerase (5 U/µl)  0.16 µl 
Template    1 µl 
Water     ad 20 µl 
 
The following thermocycler programme was used for PCR reactions. Elongation 
times were chosen according to the expected product length, assuming an 
elongation speed of 1kb/min for the Taq-polymerase. Annealing temperatures were 
chosen according to the primers used in the reaction and usually were 2-5°C below 
the melting temperature as calculated by the CloneManager software. As a control 
reaction for unspecific amplification or contamination with foreign DNA, a reaction 
without template was used. 
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1. Initial denaturation 95°C  5 min 
2. Denaturation  95°C  30 s 
3. Annealing   53-65°C 30 s 
4. Elongation  72°C  30-120 s 
5. final elongation  72°C  5 min 
6. cooling   4°C  hold 
 
Steps 2-4 were repeated 25-30 times. 
 
3.4.1.1 Whole cell PCR 
For the rapid screening of bacterial clones, cells were picked from an agar plate with 
a sterile tooth-pick and stirred directly into the PCR reaction mix. If a clone was to be 
tested in more than one PCR, 2 µl of a liquid culture were used as template in the 
reaction. The first step was prolonged to 10 min to ensure complete denaturation of 
the cells and DNA. 
 
3.4.2 Agarose gel electrophoresis 
Non-denaturing agarose gel electrophoresis was employed for the separation of DNA 
samples for purposes of analysis and preparations like gel extraction (3.4.3). Gels 
with a concentration of 0.7% – 3% in 1x TBE-buffer were used. Samples were mixed 
with 6x loading buffer before they were loaded onto the gel. PCR-reactions were 
directly loaded, as the loading buffer was already included in the reaction mix. An 
appropriate size marker was filled into one well to enable the estimation of the 
molecular weight of the samples. Gels were run at 120V and stained afterwards in an 
ethidium bromide bath for approximately 2 min on a horizontal shaker. Background 
staining was removed by washing the gel for several minutes in a water bath. Nucleic 
acids were visualized with the help of an illuminator employing UV-light at a 
wavelength of 336 nm. Ethidium bromide intercalates in the DNA, which enhances 
the fluorescence of the dye compared with the unbound reagent. Thus, areas 
containing nucleic acids can be identified as coloured areas. Gels were documented 
with the Intas Gel iX Imager. 
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3.4.3 Isolation of DNA from agarose gels 
DNA fragments and PCR products which were to be used in cloning experiments 
were extracted from agarose gels after separation by electrophoresis. The areas of 
interest were excised with a clean scalpel and subsequently eluted from the gel with 
the help of the Qiagen gel extraction kit following manufacturer’s instructions. The 
purified DNA was solved in sterile ultrapure water. 
 
3.4.4 Isolation of plasmid and fosmid DNA 
Vectors required in this study as well as recombinant plasmids and fosmids 
generated in cloning experiments were isolated from the corresponding host strain 
harbouring the construct of interest. Usually 3 ml LB medium were inoculated with a 
single colony and cultivated overnight. 
 
Plasmids were purified from this culture using either the Promega PureYield Miniprep 
System or the Qiagen Plasmid Mini Kit following the manufacturer’s instructions.  
 
Alternatively, the cells were pelleted by centrifugation at 13,000 rpm for 2 minutes 
and resuspended in 350 µl buffer P1. Cells were lysed by addition of 350 µl buffer P2 
and the mixture neutralised by mixing it with 350 µl buffer P3. Cell debris and 
proteins were pelleted by 5 minutes centrifugation.  
 
The supernatant containing the DNA was mixed with one volume phenol to remove 
proteins from the solution. The mixture was centrifuged for 5 min and the aqueous 
phase recovered. Remaining phenol was removed by the addition of one volume 
chloroform and a further centrifugation step. Subsequently, plasmid DNA was 
recovered from the aqueous phase by ethanol precipitation (3.4.6). 
 
Large scale preparations from up to 100 ml culture were either performed as 
described above or by application of the Qiagen Plasmid Maxi Kit. Fosmids from 
EPI300 cells were always isolated from 100 ml cultures, which were induced to high 
copy plasmid production with the CopyControl™ Induction Solution.  
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3.4.5 Isolation of genomic DNA 
Chromosomal DNA of Herpetosiphon 060 was isolated using the Promega Genomic 
Wizard Kit according to the manufacturer’s instructions. Genomic DNA was readily 
extracted from either 2 ml liquid culture or bits of frozen cell pellets from 100 ml liquid 
cultures. Genomic DNA for the 454 sequencing was isolated with the Qiagen DNeasy 
Blood & Tissue Kit according to the manufacturer’s protocol. 
 
3.4.6 DNA precipitation 
For the recovery of DNA from aqueous solutions 0.1 volumes of 3M NaOAc (pH 5.5) 
were added to acidify the solution and facilitate precipitation of nucleic acids. Three 
volumes of ice cold ethanol (99.8%) were added and the sample centrifuged at 
13,000 and 4°C for at least 30 min. The supernatant was discarded and the pellet 
washed with 70% ethanol to remove precipitated salts from the pellet. After 
centrifuging again for 5 min the liquid was removed and the pellet air dried before 
being solved in an appropriate amount of sterile ultrapure water. 
 
If especially high concentrations of DNA were needed, precipitation was further 
enhanced by incubating the sample at -20°C for up to 30 min prior to centrifugation.  
 
3.4.7 Restriction digestion 
DNA restriction endonucleases catalyse the cleavage of phosphodiester bonds in 
double stranded DNA in a sequence specific manner. Recognition sites of restriction 
enzymes are often palindromic sequences with 4 – 8 bp length. While some enzymes 
produce DNA fragments with blunt ends, most endonucleases generate so called 
cohesive or sticky ends with short single strand overhangs. Due to the palindromic 
nature of restriction sites, these fragments can be ligated to DNA cut with either the 
same enzyme or another that produces compatible ends. Restriction endonucleases 
originate from the defence mechanism of bacteria against foreign DNA. As in this 
context the methylation pattern is also important for the discrimination of own and 
foreign DNA, certain methylations can impair the activity of some enzymes. 
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Restriction digestion was used to prepare DNA fragments and PCR-products for the 
ligation into vectors treated in the same way. To ensure the later orientation of the 
insert in the plasmid, usually two different restriction enzymes were used in cloning 
experiments. If this was not possible, vectors linearised with only one enzyme were 
dephosphorylated (3.4.9) to prevent religation. 
 
Reaction buffers for single and double digestions were chosen following the 
manufacturer’s recommendations. 
 
3.4.8 Ligation of DNA fragments 
Linear DNA fragments produced by restriction digestion (3.4.7) of PCR-products or 
vectors were ligated using T4 DNA-ligase. The enzyme catalyses the formation of a 
phosphodiester bond between the 5'-phosphate and 3'-hydroxyl termini in double-
stranded nucleic acids. Thus, DNA fragments with compatible cohesive ends or blunt 
ends can be linked together, e.g. to form a circular plasmid. This was used to clone 
PCR-products into suitable vectors. A standard reaction scheme is given below. 
 
10x T4-ligase buffer 2 µl 
T4 DNA ligase  1 µl 
Vector   5 µl 
Insert    8 µl 
Water    ad 20 µl 
 
The reaction was incubated at 22°C for 2 – 16h, where prolonged incubation 
increased efficiency. As the enzyme can interfere with downstream processes, it was 
inactivated at 70°C for 10 min. 
 
The pGEM-T vector system comprises a linearised plasmid with T-overhangs, which 
are compatible to the A-overhangs produced by the Taq polymerase at the ends of 
PCR-products. Cloning into pGEM-T was performed according to manufacturer’s 
instructions. 
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3.4.9 Dephosphorylation of linear DNA 
Vectors that are cut with only one restriction enzyme or with endonucleases which 
produce compatible or blunt ends are able to religate again to circular DNA. This 
process is unwanted in cloning experiments, where linear DNA shall be inserted into 
the vector. To avoid self-ligation, the ends of linearised vectors are dephosphorylated 
using either calf intestine alkaline phosphatase (CIAP) or shrimp alkaline 
phosphatase (SAP) according to the manufacturer’s instructions. Subsequently, the 
DNA was purified with a Qiagen Miniprep Kit to remove the enzyme, which otherwise 
could impair following ligation reactions.  
 
3.4.10 Determination of nucleic acid concentration and purity 
The concentration of aqueous solutions of nucleic acids was quantified by 
measurement of the absorption at a wavelength of 260 nm in an UV/VIS 
spectrometer. Employing the Lambert-Beer law, the concentration can be calculated 
according to the following formula. The used coefficients describe an average for 
nucleic acids of unknown sequence or mixtures. As a linear correlation of 
concentration and absorption is given only for an extinction of approximately 0.1 – 
1.0, the samples were diluted accordingly prior to measurement.  
 
Formula 1:  𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛  
𝑚𝑚𝑜𝑙
𝐿
 =
𝑂𝐷×𝑘×𝑑
 𝑛𝑡×𝑀𝑊
 
OD260 = optical density at 260 nm 
d = dilution factor 
k = coefficient with OD260 1.0 = 50 µg/ml dsDNA 
   OD260 1.0 = 35 µg/ml ssDNA 
   OD260 1.0 = 40 µg/ml ssRNA 
∑nt = number of nucleotides 
MW = molecular weight with  DNA = 330 g/mol 
     RNA = 345 g/mol 
  
Aromatic amino acids show high absorption at 280 nm. Therefore, the contamination 
of DNA by proteins can be determined by the calculation of the A260/A280 ratio. Highly 
pure DNA has a ratio between 1.8 and 2.0. 
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3.4.11 Sequencing of vector constructs and PCR-products 
To determine the sequence of a PCR-product and to exclude mutations in plasmid 
inserts, their nucleic acid sequence had to be analyzed. Sequencing was performed 
by GATC Biotech AG (Konstanz, Germany) on an ABI3730xl after the Sanger 
dideoxy method (Sanger et al., 1977). In the course of this procedure single-stranded 
DNA is amplified with one primer by PCR in four individual reactions. Each contains, 
next to dNTPs, also an amount of one of four fluorescently labelled didexoy 
nucleotide triphosphates (ddATP, ddTPP, ddCTP, ddGTP), which are statistically 
incorporated into the growing DNA chain. The lack of the 3’-OH group leads to chain 
termination, so that fragments of varying sizes are generated. These can be 
separated by gel electrophoresis. The visualisation of the different fluorescence tags 
allows elucidation of the exact sequence. 
 
For sequencing reactions, either PCR-specific primers or general primers (T7 or SP6) 
for the corresponding plasmid were used. End sequencing of fosmid inserts were 
performed with either T7 or Epi-RP primers. For the analysis of 16S rDNA, general 
primers (16S rDNA fwd & rev) were applied. 
 
3.4.12 454 Genome sequencing 
A draft genome of Herpetosiphon sp. 060 was generated by sequencing of genomic 
DNA with the next generation Roche 454 technology, which was carried out by GATC 
Biotech AG (Konstanz, Germany). In this approach, the template is prepared by 
random fragmentation of the genomic DNA into small sizes and subsequent 
immobilisation on beads by common adaptors. These beads are encapsuled 
individually in droplets on a picotiterplate, where amplification is performed by 
emulsion-PCR on single molecules (Metzker, 2010). The incorporation of specific 
nucleotides is visualised by a bioluminescence method named pyrosequencing. The 
produced fluorescence signal allows determination of the assembled DNA sequence. 
The DNA reads, obtained by these reactions are then assembled into larger 
fragments called contigs, which represent altogether the draft genomic data. The size 
of the gaps between the contigs is dependent on the achieved genome coverage by 
the produced reads. 
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3.4.13 Screening of a genomic library 
The fosmid library of Herpetosiphon 060 created by Ö. Erol was screened in a PCR-
based approach the final part of the siphonazole cluster. Therefore, specific primers 
were derived from the DNA sequences obtained by genome sequencing. For rapid 
screening, always 12 clones from a row of a 96-well plate were pooled and subjected 
to whole cell PCR (3.4.1.1). PCR-reactions were analysed by gel electrophoresis 
(3.4.2) to identify the pools yielding a product. The clones of these pools were then 
analysed individually and the corresponding clone identified. 
 
3.4.14 RNA-isolation and expression analysis 
All experiments on RNA and derived cDNA were conducted by G. Rashid. Total RNA 
was isolated from cultures of Herpetosiphon sp. 060 with the help of the 
NucleoSpin® RNA II kit (Macherey-Nagel) following the manufacturer’s protocol. The 
isolated RNA was used for the synthesis of cDNA from mRNA using oligo (dT)18 
primers and the RevertAid™ H Minus First Strand cDNA Synthesis Kit (Fermentas) 
according to the manufacturer’s instructions.  
 
The expression of open reading frames was probed by PCR-reactions (3.4.1) with 
standardised amounts of cDNA as template. Specific primer pairs aiming at the 
intergenic regions and the adjacent regions were derived from the DNA sequences of 
the targeted gene cluster. Evaluation of the PCR-results was carried out by agarose 
gel electrophoresis (3.4.2).  
 
3.5 Recombination and cloning methods 
3.5.1 Λ-Red recombination 
Recombination-mediated genetic engineering is a powerful tool for the site-specific 
introduction of linear DNA into fosmid or chromosomal DNA. Generally, most bacteria 
cannot be readily transformed with linear DNA due to intracellular exonucleases, 
which degrade linear DNA as part of the bacterial defence mechanism. This problem 
can be alleviated by use of recombination genes from bacteriophage λ, which greatly 
enhance the recombination rate (Gust et al., 2004). This method allows the 
replacement of a DNA sequence with a construct of linear DNA containing a 
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selectable marker and homology arms at both ends. As these homology extensions 
only need to be as short as 39 bp for successful recombination, they can easily be 
added by PCR primers.  
 
In order to allow λ-Red recombination steps on fosmids, they had to be transformed 
into cells of E. coli BW25113 harbouring the helper plasmid pKD46, which carries the 
necessary λ RED (gam, bet, exo) recombination functions.  
 
A single colony of BW25113 was used to inoculate 3 ml LB medium containing 
ampicillin (100 µg/ml), which was incubated overnight at 37°C at constant shaking. 
100 ml LB medium containing ampicillin were inoculated with 1 ml pre-culture and 
grown to an OD600 of ~0.5. Cells were then prepared for electroporation according to 
protocol (3.3.2) and transformed with fosmid DNA (3.3.4). The cultures were grown at 
30°C and selected on LB-agar containing ampicillin (for pKD46) and chloramphenicol 
(34 µg/ml; for pCC1FOS). 
 
Clones containing both pKD46 and the fosmid to be modified were used for λ-Red 
recombination. Therefore, 100 ml SOB-medium containing ampicillin and 
chloramphenicol in 500 ml flasks were inoculated with 1 ml of an overnight pre-
culture. To induce the expression of recombination genes, 1 ml of a 1M L-arabinose 
solution was added to the culture, before it was grown at 30°C to an OD600 of ~0.5. 
The cells were prepared for electroporation and transformed with 3 – 15 µl linear 
DNA. After incubating the sample in 1 ml SOC-medium at 30°C for 1h, transformants 
were selected on LB-agar containing ampicillin and appropriate antibiotics.  
 
3.5.1.1 Generation of linear DNA for λ-Red recombination 
Streptomycin and apramycin resistance cassettes were amplified from plasmids 
pIJ778 and pIJ773 respectively by PCR using primers with 40bp homology 
extensions. PCR products were purified by gel electrophoresis (3.4.2) and extracted 
according to protocols (3.4.3).  
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For the recombination of cluster parts already containing selection markers, linear 
DNA was generated by subjecting the fosmids to restriction digestion (3.4.7) with 
suitable enzymes. The fragments of interest were obtained by extraction from an 
agarose gel (3.4.3). 
  
3.5.2 Cloning of PCR-products 
The DNA of interest was amplified by PCR (3.4.1) with primers containing suitable 
restriction sites for insertion into the target vector and was purified by electrophoresis 
and gel extraction (3.4.2 and 3.4.3). Insert and vector were digested (3.4.7) with the 
chosen restriction enzymes and ligated (3.4.8), before transforming the generated 
construct into competent E. coli cells (3.3.3). Clones could then be used for further 
experiments.  
 
For insertion of DNA fragments into the pET151 vector, the Champion Directional 
TOPO Expression Kit (Invitrogen) was used. Amplification of the insert was 
performed with Pfu DNA-polymerase to generate blunt end products. The forward 
primer contained a CACC 5’-extension for directional integration into the 
topoisomerase-activated linearised vector. 
 
3.5.3 Yeast recombinational cloning 
This cloning method exploits the ability of yeast cells to recombine DNA elements 
with homologous regions. This can be used for the constitution of multiple DNA 
fragments to one single plasmid construct. This protocol is derived from the LiOAc / 
ssDNA / PEG mediated transformation method described by Gietz and co-workers 
(Gietz et al., 2007).  
 
50 ml YPAD medium was inoculated with a 10 ml YPAD overnight culture of S. 
cerevisiae and grown at 28°C and 200 rpm for five hours. Thereafter, the cells were 
harvested by 5 min centrifugation at 3,000 g and the supernatant discarded. The 
pellet was resuspended in 1 ml 0.1M LiOAc and transferred to a 1.5 ml tube. The 
cells were pelleted again for 1 s at top speed and resuspended again in 400 µl 0.1M 
LiOAc. For the transformation, 50 µl aliquots were prepared.  
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High molecular single-stranded DNA from salmon testes was used as carrier DNA, 
which facilitates the delivery of DNA fragments into the cells. 20 mg ssDNA were 
thoroughly dissolved in 10 ml TE buffer (10 mM Tris/HCl, pH 8.0, 1 mM EDTA) and 
frozen at -20°C in 250 µl aliquots. Immediately before use, an aliquot was boiled for 5 
min and then placed on ice.  
 
The prepared cell aliquots were centrifuged for 15 s at top speed and the supernatant 
was removed. The cells were mixed with 240 µl 50% PEG (3350) solution, 50 µl 1M 
LiOAc and 50 µl ssDNA and then vortexed. Equal amounts of the DNA fragments to 
be transformed were mixed separately and then added to the cell suspension. The 
samples were first incubated at 30°C for 30 min and then at 42°C for 30 min. The 
cells were recovered by 15 s centrifugation at 6,000 rpm and resuspended in 1 ml 
sterile water. A 200 µl aliquot was spread on synthetic drop-out medium (minus 
uracil) and incubated at 28°C for two days. 
 
3.5.3.1 Isolation of plasmid DNA from yeast cells 
Plasmid DNA was purified from yeast cells in small scale using the Zymoprep™ 
Yeast Plasmid Miniprep I Kit (Zymo Research) according to the manufacturer’s 
instructions. Plasmids from 50 ml cultures were isolated by the following method.  
 
The cells were harvested by centrifugation and resuspended in 4 ml buffer P1. 5 g 
glass beads were added and the sample thoroughly vortexed for 3 – 5 min. The 
culture was frozen at -80°C for 10 minutes and thawed in a 60°C water bath before 
vortexing again. 4 ml buffer P2 and 4 ml buffer P3 were added and mixed by 
inversion. The sample was pelleted at 10,000 xg and 4°C for 5 min. 15 ml phenol 
were added and the sample spinned again for 5 min. The upper phase was removed, 
mixed with 10 ml ice-cold ethanol (99.8%) and placed at -20°C for 30 – 60 min. The 
sample was centrifuged for 25 min at 10,000 xg and the supernatant removed. The 
pellet was washed with 70% ethanol and spinned again for 5 min. Liquid was 
removed and the pellet air-dried under a clean bench. DNA was allowed to dissolve 
in 50 µl H2O at room temperature for 15 min and by tapping. 
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3.6 Molecular biological methods concerning proteins 
3.6.1 Heterologous expression of proteins 
The in vitro investigation of protein functions requires the purification of the target 
protein from the cell. As in most cases the natural protein is only expressed in small 
amounts, the overexpression in a heterologous host is necessary. Therefore, the 
DNA sequence of the protein is inserted into an expression vector that usually 
contains an inducible promoter as well as an affinity tag such as 6x-his (consisting of 
6 successive histidines). These tags are expressed at the N- or C-terminus of the 
protein, depending on the vector, and greatly facilitate the purification via affinity 
chromatography (3.6.3).  
 
The DNA sequence of the protein of interest was amplified by PCR (3.4.1) and 
cloned (3.5.2) into the multiple cloning site of the expression vector, so that the start 
codon of the protein was in-frame with the 6x-his tag on the plasmid. The generated 
plasmid was first transformed into competent XL1-blue E. coli cells (3.3.3), where 
colonies were screened for correct transformants by whole-cell PCR. To exclude the 
possibility of mutations in the reading frame, the chosen clones were submitted for 
sequencing (3.4.11). Plasmid DNA was isolated from confirmed clones and 
transformed into an E. coli expression strain.  
 
3 ml pre-cultures were used to inoculate LB medium containing appropriate 
antibiotics. Culture sizes ranged from 100 to 600 ml depending on the purpose and 
expected expression levels. After inoculation, the main culture was grown to an 
OD600 of ~0.4 – 0.6. Protein expression was induced by adding IPTG to a final 
concentration of 0.1 – 1.0 mM. Again, culture conditions were chosen according to 
the expression level and solubility of the expressed proteins. Generally, cultivation 
was carried out for 3h at 30 - 37°C, 4h at 20°C or overnight at 16°C. 
 
3.6.2 Cell lysis by sonication 
Cells from protein expression were harvested by centrifugation at 8,500 rpm for 5 min 
using 50 ml Falcon tubes. The cell pellet was resuspended in lysis buffer in 1/50 
volume of the original culture and placed on ice. Cells were lysed with the help of a 
Branson Sonifier 250, set to output level 4, 50% duty cycle. The samples were 
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sonified 5 times with ten pulses each. Between the pulses the cells were placed back 
on ice to avoid overheating of the sample. Cell debris and insoluble parts were 
pelleted by centrifugation for 15 min at 8,500 rpm and 4°C. The supernatant 
containing the soluble proteins and the pellet were collected. 
 
3.6.3 Purification of recombinant proteins by Ni-NTA-columns 
Proteins harbouring a his-tag can easily be purified by affinity chromatography on a 
Ni-NTA matrix. The histidine residues are bound by the matrix, while other proteins 
elute. Unspecifically bound proteins can be eluted by increasing concentrations of 
imidazole, which competes with the histidines for the binding. The six histidines of the 
tag ensure that the target protein only elutes at high concentrations. 
 
For the affinity chromatography a gravity-flow column with 1 ml Ni-NTA-agarose was 
prepared and equilibrated in lysis buffer. The sample was added to the column and 
allowed to pass the matrix. The column was washed two times with 4 ml washing 
buffer. Elution was carried out in four steps by adding 0.5 ml of elution buffer with 
100, 150, 200, 300 and 300 mM imidazole. All fractions were collected and kept on 
ice to prevent protein degradation. 
 
3.6.4 Denaturing SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
This method allows the analytical separation of proteins according to their size. In a 
denaturing approach the proteins are boiled and treated with mercapto-ethanol to 
remove any disulfide-bonds. During electrophoresis the unfolded proteins are 
covered with the negatively charged sodium dodecyl sulfate (SDS), which masks the 
inherent charge of the protein, thus allowing a strict separation by molecular weight. 
 
The separating gel is formed by radical polymerisation of bis-acrylamide to 
polyacrylamide, which forms a molecular sieve. The concentration of polyacrylamide 
can be chosen in dependence of the analysed protein size. For a better focussing of 
protein bands discontinuous gels were used, where the separating gel is covered 
with a low concentrated stacking gel. 
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The reaction mix is given below. After polymerisation was initiated by the addition of 
ammoniumperoxosulfate (APS) and N,N,N’,N’-tetraethylendiamin (TEMED), the gel 
was pipetted between two plates with a spacer distance of 1.0 or 1.5 mm. During 
polymerisation, the separating gel was covered with isopropanole to ensure a smooth 
surface. Isopropanole was removed before the addition of the stacking gel. 
 
Glycin SDS-stacking gel (4%) 
Tris/HCL pH 6.8 (1M)  1,250 µl 
 SDS (10%)    25 µl 
 Bis-acrylamide (30%)  675 µl 
 Water     3,050 µl 
 APS (10%)    25 µl 
 TEMED    2.5 µl 
 
Glycin SDS-separating gel (12%) 
Tris/HCL pH 6.8 (1M)  2,500 µl 
 SDS (10%)    100 µl 
 Bis-acrylamide (30%)  675 µl 
 Water     3,050 µl 
 APS (10%)    50 µl 
 TEMED    2.5 µl 
 
For each gel run, the reservoirs of the electrophoresis assembly were filled with fresh 
1x glycine-running buffer. Protein samples were mixed with 4x denaturing loading 
buffer and boiled at 99°C for 5 min, before loaded onto the gel. Electrophoresis was 
performed at 120V until the samples reached the separating gel and voltage 
increased to 160V afterwards. As a reference, a molecular size marker was loaded in 
one well. After electrophoresis the gels were analysed by coomassie-staining. 
 
3.6.5 Coomassie-staining 
A staining with coomassie brilliant blue was used to analyse the proteins on a 
polyacrylamide gel. Gels were immerged in the staining solution and shortly heated in 
a microwave oven for quicker staining and then incubated several minutes on a 
horizontal shaker. Destaining of the background colour was performed by shaking 
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with destaining solution for several hours or overnight in the fridge. The gels were 
documented with the INTAS illuminator. 
 
3.6.6 Concentration of purified proteins and buffer exchange 
Samples containing purified protein from heterologous expression (3.6.1) were 
concentrated with the help of Amicon Ultra centrifugal filters according to the 
manufacturer’s instructions. This method was also used to remove imidazole from the 
buffer, which could interfere with following assays. Following the manufacturer’s 
manual, the buffer was replaced in several centrifugation steps with 50 mM Tris/HCl, 
pH8.  
 
In cases, where concentration of a sample led to precipitation of proteins, buffer 
exchange was carried out with gravity-flow PD-10 desalting columns by GE 
Healthcare following the manufacturer’s protocol. 
 
3.6.7 Determination of protein concentrations after Lambert-Beer 
This method allows the determination of a homogenic protein solution based on the 
absorption at a wavelength of 280 nm. It requires the knowledge of the molar 
extinction coefficient ε, which can be calculated in good approximation for a given 
amino acid sequence. In this study the program ProtParam provided by the Swiss 
Institute for Bioinformatics (3.1.13) was used for the calculation of ε. The protein 
concentration can be determined by the following equation. 
 
Formula 2:  𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛  
𝑚𝑜𝑙
𝐿
 =
𝑂𝐷×𝑑
𝜀
  
Division by molecular weight gives concentration in g / l. 
OD280 = optical density at λ = 280 nm 
d = dilution factor 
ε = molar extinction coefficient [M-1 cm-1] 
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3.6.8 O-methyltansferase activity assay 
The activity of a heterologously expressed O-methyltransferase was observed by an 
in-vitro methylation assay similar to the method described by Sherman and co-
workers (Shengying et al., 2009). The reaction was performed in 50 mM Tris-HCl 
buffer with pH 7.5. Reagents and protein solution were always prepared freshly and 
directly used for the assay. The reaction mixture is given below. 
 
O-methyltransferase (sphB) 25 µM 
protocatechuic acid  (susbtrate) 1 mM 
S-adenosylmethionine  500 µM 
MgCl2     10 mM 
50 mM Tris/HCl (pH 7.5)  ad 100 µl 
 
The reaction was incubated at 30°C for 2h.  
 
3.6.8.1 High performance liquid chromatrography (HPLC) 
HPLC analysis of the methylation assay was carried out on a Merck-Hitachi system 
consisting of a D-6000A interface with an L-6200A Intelligent Pump, a Rheodyne 
7725i injection system and a L-4500A diode array detector. Column was a Waters 
XTerra™ C18 (5 µm, 4.6 x 250 mm). The complete reaction mix was injected without 
further preparation and separated using a gradient of 0.1% TFA and acetonitrile as 
liquid phase. The complete setup is given below. 
 
Solvent A H20 with 0.1% TFA 
Solvent B acetonitrile 
Gradient 0 min:  90% A, 10% B 
  20 min: 40% A, 60% B 
Flow  1 ml / min 
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3.6.9 Mass spectrometry 
For LC-ESI MS measurements samples were dissolved in methanol at a 
concentration of 1 mg/ml. All measurements were conducted by E. Eguereva at the 
institute for pharmaceutical chemistry (University of Bonn, Germany). Experiments 
were recorded in positive (+Q1) and negative (-Q1) mode and analysed by Applied 
Biosystems/ MDS Sciex Analyst software. 
 
MALDI-TOF-MS measurements were conducted by M. Josten at the Institut für 
medizinische Mikrobiologie, Immunologie und Parasitologie (Universitätsklinikum 
Bonn) 
 
3.6.10 ATP - PPi exchange assay 
Adenylation domains activate their substrates at the expense of ATP. The assay 
described by Phelan and co-workers (Phelan et al., 2009) measures the consumption 
of γ-18O4-labelled ATP and the formation of 
16O4-ATP by an excess of unlabelled PPi. 
The resulting mass shifts are detected by MALDI-TOF-MS. Thus, the activity of the A 
domain can be measured. Incubation with different substrates and comparison of the 
ATP-PPi exchange rate allows determination of the substrate specificity of the 
studied domain. The assays were performed by Dr. T. Schäberle in the laboratory of 
the Piel group at the Kekulé-Institut for organic chemistry and biochemistry 
(University of Bonn, Germany) according to the described method. In short, 200 nM 
purified A domain (in A domain buffer, 3.1.5) was incubated with 1 mM γ-18O4-ATP, 
1mM substrate, 5 mM MgCl2 and 5 mM PPi  in a reaction volume of 6 µl for 30 min at 
RT. Exchange rate by MALDI-TOF-MS was determined by comparison of the ratio of 
γ-16O4-ATP (m/z 506) to the sum of all ATP species, including unlabelled, partially 
labelled, fully labelled (m/z 514), and monosodium-coordinated ions (m/z 506, 508, 
510, 512, 514, 528, 530, 532, 534, 536). Determination of percent exchange was 
normalised with the following modifier: % exchange = (100/0.833) x 16O/(18O + 16O) 
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4 Results 
4.1 Knock-out experiments with Herpetosiphon sp. 060 
In the course of this study intensive research on the genetic modification of the 
genome of Herpetosiphon sp. 060 was carried out. These efforts aimed at a knock-
out of the putative siphonazole biosynthetic gene cluster to prove its function. To the 
present date no protocols for the transformation of Chloroflexi or Herpetosiphon 
species are available. The establishment of a working procedure would make this 
group amenable to genetic modifications. The experiments were based on the 
assumption that a plasmid carrying a selection marker and a homologous region to 
the gene cluster would in some cells be integrated into the genome by a single 
crossover event and thus disrupt the gene cluster. Abolishment of siphonazole 
production in successful transformants could then be evaluated by LC-MS (3.6.9) of a 
crude extract.  
 
4.1.1 Antibiotic resistance tests 
Herpetosiphon sp. 060 was tested for resistance against several antibiotic agents to 
select an appropriate selection marker for the knock-out experiments (3.2.5). Table 4-
1 summarises the tested antibiotics and the test results.  
 
Table 4-1: Antibiotic resistance tests with Herpetosiphon sp. 060 
Final antibiotic concentrations in the media are given; (----) indicates no growth, (+) partially 
inhibited growth, (++) uninhibited growth  
Antibiotic Concentration [µg/ml] growth 
Apramycin 50 ---- 
Tetracycline 50 ---- 
Nalidixinic acid 50 + 
Zeocin 50 ++ 
Ciprofloxacin 80 ---- 
Chloramphenicol 170 ---- 
Streptomycin 50 ---- 
Carbenicillin 50 ++ 
Gentamycin 50 ++ 
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Previous tests with the Herpetosiphon strain showed resistance to kanamycin, 
ampicillin and hygromycin (Ö. Erol, personal communication). In these earlier 
experiments, zeocin was selected as a suitable resistance marker, but in this study 
Herpetosiphon sp. 060 exhibited resistance against zeocin to concentrations as high 
as 150 µg/ml. Nalidixinic acid only led to a partial inhibition of growth, which was 
possibly the result of an uneven distribution of the agent in the media or caused by 
chloroform, which is used as solvent for nalidixinic acid. Zeocin, carbenicillin and 
gentamycin merely slowed the growth of the Herpetosiphon strain. Streptomycin, 
chloramphenicol and apramycin were chosen as selective markers for all further 
experiments.  
 
4.1.2 Transformation of vegetative Herpetosiphon cells 
Various methods for delivery of plasmid DNA were applied to Herpetosiphon cells. 
Though extensive research and modifications of available protocols were conducted, 
none of these procedures succeeded in the transformation of Herpetosiphon sp. 060. 
The filamentous growth of the strain proved to be a problem for all methods, as the 
filaments tend to form aggregates. Their uneven distribution in a liquid culture 
impedes the establishment of a growth curve, as a reliable photometric measurement 
of growth is not possible. Alternative quantification methods like microscopic cell 
counting, determination of total protein or cell mass were not feasible either for the 
same reason. Treatment of the cultures with a homogeniser had little effect. 
 
Electroporation (3.3.8) of the cells showed that they readily regenerated even after 
application of high voltage (up to 25kV / 1cm) in mock transfections, but did not grow 
on selective plates. The treatment with glycine (3.3.7) resulted in a breakdown of the 
filaments into smaller fragments and reduced growth rates. An application of 2% 
glycine (w/v) was sufficient to impair the formation of filaments, while the addition of 
5% glycine resulted in severe cell damage. The best time span for electroporation 
seemed to be within the first 24h of growth. Longer incubation resulted in a thick 
culture containing clumps of intertwined cell filaments, which favoured arcing during 
electroporation. 
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Figure 4-1: Effect of glycine on the growth of Herpetosiphon sp. 060 
3% (a) and 5% (b) glycine were added to the medium after 24h and the culture was grown for an 
additional 24h; observation of filaments with phase-contrast microscope (x1000) 
 
In sonication experiments (3.3.9) Herpetosiphon cells proved to be quite resistant to 
ultrasound treatment, as cells in mock transfections readily regenerated even after 
60s of sonication. 
 
Similar observations were made for chemical transformation methods (3.3.3) and 
conjugation experiments (3.3.10). Regardless of varying regeneration periods after 
treatment, transformants of Herpetosiphon were identified neither on selective agar 
plates nor in liquid culture. 
 
4.1.3 Transformation of Herpetosiphon protoplasts 
The formation of protoplasts (3.3.5) was conducted as a means to circumvent 
problems caused by cell filaments or cell wall structures. Protoplast formation was 
observed over a time of four hours. First protoplasts could be detected after 30 min, 
but the filaments remained mainly intact even after two hours incubation with 
lysozyme. Formation of protoplasts was observed at the tips of the filaments, 
sometimes forming small aggregates. Within the filaments, cells seemed to shrink 
leaving spaces between them and revealing the sheath-like structure (1.4.2) of the 
filaments. After four hours the majority of the cells were transformed to protoplasts, 
though fragments of filaments still remained. Neither by filtration nor by gradient 
centrifugation it was possible to completely remove the vegetative cells from the 
protoplasts.  
 
 
(a)              (b) 
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Figure 4-2: phase-contrast micrographs (1000x) of Herpetosiphon sp. 060 
(a) beginning protoplast formation at the ends of a filament after 2h lysozyme treatment; (b) 
aggregation of protoplast at the tip of a filament after 2h lysozyme treatment; (c) protoplasts of 
Herpetosiphon after 4h lysozyme treatment; (d) filaments with retracting cells, revealing a 
sheath-like structure in the clear spacing after 2h lysozyme treatment 
 
Regeneration on non-selective agar plates was readily observed, but due to the 
mentioned presence of vegetative cells it is uncertain if the regenerated cultures 
really originated from the protoplasts. Chemical (3.3.6) and electro-physical (3.3.8.1) 
methods were applied to the protoplasts without yielding successful transformation.  
 
4.2 Genome sequencing of Herpetosiphon sp.  060 
The elucidation of the complete putative biosynthetic gene cluster of siphonazole 
necessitated the access to genome DNA sequence information. For this purpose, 
454 whole genome sequencing was carried out by GATC Biotech AG (Mannheim, 
Germany) on a Roche GS FLX Titanium sequencer (3.4.12). For this reaction 
genomic DNA from Herpetosiphon sp. 060 with a concentration of ~400 ng/µl was 
provided (3.4.5).  
 
In the course of this approach 158,535,259 bp were assembled to 1,663 contigs. 
Taking the genome size of H. aurantiacus with a size of 6,346,587 bp as a reference, 
25fold coverage of the genome was achieved by this sequencing. The average 
contig size was 7,809 bp with the largest contig stretching over 121,725 bp. 
(a)       (b)         (c) 
(d) 
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4.2.1 Genome search for the putatative siphonazole gene cluster 
The genome assembly was screened for contigs harbouring parts of the putative 
siphonazole cluster. For this purpose an .embl formatted file containing the 
sequences of all contigs was generated and used as database in the CLUSEAN 
software (Weber et al., 2009). In previous work by Ö. Erol the fosmids EC9, EC10 
and CF4 were found to carry NRPS or PKS parts. DNA sequences of subclones from 
theses fosmids as well as end sequences of the inserts were provided by Ö. Erol  
(personal communication). This set of sequences was subjected to a BLAST search 
using the genome assembly as reference database. Thus, the subclones were 
aligned to a total of six contigs, which are listed in table 4-2.  
 
Contigs 1518 and 0668 are covered by all three fosmids, while contig 1280 only 
appears on fosmids CF4 and EC10. Contig 1357 is unique to fosmid EC9 and contig 
1462 only aligns with fosmid CF4. These data indicate that the three fosmids are at 
least partially overlapping and may carry parts of the same cluster. Subclones EC-5 
and CF4-7 both align with contig 0668 as well as with 1518, suggesting that the two 
contigs lie in close vicinity to each other. The same can be assumed for contigs 1517 
and 1518, which both align with subclones CF4-4 and CF4-6.   
 
Table 4-2: Contigs identified by alignment with fosmid subclones 
Subclones were sequenced with T7 sequencing primer; subclones homologous to contigs 
0668 and 1518 are displayed in bold letters; subclones homologous to contigs 1517 and 1518 
are underlined 
contig length (bp) homology to subclone 
0668 8496 EC9-5; CF4-7; CF4-9; EC10-1; EC10-3 
1280 23571 CF4-2; CF4-8; CF4-10; EC10-6; EC10-7; EC10-10 
1357 503 EC9-5 
1462 1762 CF4-5 
1517 37170 EC9-2; EC9-7; CF4-4; CF4-6 
1518 9180 EC9-5; CF4-4; CF4-6; CF4-7; EC10-5; EC10-8; EC10-9 
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4.2.2 Annotation of the contigs from genome sequencing 
To gather further information on possible cluster parts, the genome assembly was 
analysed using the CLUSEAN pipeline (3.1.13). Through the implementation of 
different databases all open reading frames (ORFs) with a minimum size of 300 bp 
were assigned putative protein functions. PKS or NRPS related motifs were identified 
for all contigs that aligned with the fosmid subclones. Thus, a truncated A domain 
was identified at one end of contig 0668, followed by parts of a PKS cluster. They are 
encoded in one single ORF, which stretches over the whole contig. Contig 1280 ends 
with a fragment of an A domain, preceded by an AT. The other ORFs on this contig 
have no functions related to a PKS or NRPS pathway. Two ORFs were identified on 
contig 1518, which both contain parts of a PKS cluster including two Ox domains. 
The short contig 1462 harbours an A domain and a PCP domain, while contig 1357 
contains a partial C domain. Fife ORFs encoding for PKS and NRPS modules were 
found at the end of contig 1517. The modules include two Ox domains and a TE. The 
adjacent ORFs seem to be unrelated to the PKS/NRPS cluster. 
 
The AT domain on contig 1280 is the only one that was found on these contigs. The 
arrangement of the predicted domains suggests that contig 1517 encodes the end of 
a putative biosynthetic gene cluster, while contig 1280 contains the start of a trans-
AT type PKS cluster.  
 
The domain predictions were refined by applying a BLASTp (3.1.13) search with the 
translated amino acid sequences of the ORFs in question. An analysis of conserved 
domain structures revealed the AT to be linked to an oxidoreductase function. 
Furthermore, an α/β-hydrolase and an aldolase were found in front of the 
thioesterase on contig 1517.  
 
The specificity of the adenylation domains (see also 4.4.1) was investigated with the 
help of the NRPSPredictor provided by the University of Tübingen (Rausch et al., 
2005). Hence, specificity for threonin was assigned for the A domain on contig 1462 
and for glycine for the A domain on contig 1517. The fragments on contigs 1280 and 
0668 were insufficient to be analysed. Figure 4-3 summarises the results from this 
preliminary annotation. 
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Figure 4-3: predicted domain structure encoded on selected contigs from genome sequencing 
Preliminary annotation without investigation of domain functionality; contig no. is given in 
each box; * indicates a truncated domain; predicted A domain specificity is given above the 
domain; A, adenylation domain; ACP, acyl carrier protein; C, condensation domain; DH, 
dehydratase; Hyd, hydrolase; KR, ketoreductase; KS, ketosynthase; Mt, methyltransferase; OR, 
oxidoreductase; Ox, oxidase; PCP, peptidyl carrier protein; TE, thioesterase 
 
4.2.3 Other gene clusters discovered from genome sequences 
The contigs from the 454 sequencing were subjected to a search for C domains and 
KSs using the NaPDos database (Ziemert et al., 2011). This approach detected 38 C 
domains encoded by ORFs on 12 different contigs. 34 C domains showed between 
30% to 50% identity to enzymes from known pathways, while no homology was 
found for four of the predicted domains. One C domain was detected on contig 1517.  
 
Furthermore, NaPDos predicted 19 KS domains on 13 contigs. 12 of them showed 
between 35 – 61% identity to enzymes from either secondary metabolite pathways or 
fatty acid biosynthesis). One KS exhibited no homology to any pathway in the 
database. The search run found three KSs encoded on contigs 1517 and 1518 each. 
They were all predicted as trans-type PKS and possess the greatest homology to 
domains from the leinamycin biosynthesis with identities of 43% – 55%. The only 
exception was one KS encoded on contig 1517 with 58% identity to the kirromycin 
biosynthetic pathway. A full compilation of all NaPDos- search results is given in the 
appendix (8.2). 
 
        0668                 1357         1462 
       1280                         1518 
                 1517 
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Contigs 1517 and 805 were the only fragments that were identified to contain both a 
KS and a C domain. Contig 805 contains six ORFs (orfA – orfF) that encode a 
complete hybrid cis-AT type PKS/NRPS cluster. This cluster was further 
characterised using BLASTp and the NRPS predictor. The NRPS part comprises 
three epimerisation domains, an ornithine specific A domain and an A domain of 
unknown specificity. The KS of orfB was annotated as iterative type. Additionally, an 
acetyl ornithine aminotransferase function was found in this ORF. BLASTp showed 
that this cluster is homologous to a biosynthetic cluster in H. aurantiacus, whose 
product is yet unknown. OrfA – orfE agree with the order of genes haur1856 – 
haur1861 and exhibit great sequence identity to their counterparts in H. aurantiacus. 
Furthermore, in both strains genes were found in vicinity to this cluster that are 
predicted to encode the enzymes for the biosynthesis of a lantibiotic. 
 
Table 4-3: Hybrid PKS/NRPS cluster on contig 805 
Identities of the translated amino acid sequences from orfA – orfE to the homologous H. 
aurantiacus enzymes and their respective predicted domains; specificities are indicated in 
superior and inferior letters as far as known; OAT, acetyl ornithine aminotransferase 
ORFs on  
contig 805 
closest homolog  
(identity on protein level) 
predicted domains 
orfA Haur1856 (92%) Amp-ligase 
orfB Haur1857 (87%) ACP-KSiter-AT-ACP-OAT-C-A?-Mt-ACP 
orfC Haur1858 (88%) LCL-A
asn-PCP 
orfD Haur1859 (89%) Cepim-DCL-A
thr-PCP-Cepim-DCL-A
ser-PCP 
orfE Haur1860 (84%) KS-AT-KR-ACP 
orfF Haur1861 (84%) LCL-A
orn-ACP-Cepim-DCL-A-ACP-TE 
 
4.3 Complete elucidation of the putative siphonazole gene cluster 
The comparison of the fosmid subclones with the draft genomic data showed that 
four of the six identified contigs were covered by more than one fosmid clone, 
indicating that they may be fragments of one single biosynthetic gene cluster. 
Additionally, with exception of the AT encoded on contig 1280, none of the predicted 
modules contained an AT domain. Thus, it was hypothesised that 1280 could be the 
start of a trans-AT type cluster, whose end could be marked by the TE encoded on 
contig 1517. The presence of two A domains for threonine and one for glycine 
together with the occurrence of Ox domains encoded on two contigs corroborated the 
assumption that the putative cluster parts are involved in siphonazole biosynthesis. 
Therefore, further efforts were taken to obtain the full sequence of the gene cluster. 
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4.3.1 Gap closure and alignment of the contigs 
The coverage of the genome sequences and the number of modules already 
identified on the contigs gave rise to the assumption that the sequence gaps between 
the fragments should lie within the range of a few thousand base pairs and thus 
could be closed by a PCR-based approach (3.4.1). If not stated otherwise, genomic 
DNA isolated from Herpetosiphon sp. 060 was used as template for all reactions. 
 
4.3.1.1 Positioning of contig 1462 
Considering the structure of siphonazole, it was proposed that contig 1462 would 
either precede contig 1517 or 1518. Therefore, PCR-primers were deduced from the 
sequences of the contigs in question and standard PCR-reactions performed. PCR 
with forward primer cb1462_f yielded products of similar size for both reverse primers 
(cb1517_r and cb1518_r). Sequencing of the products revealed homology only to 
contig 1517, but not to 1518. Therefore the latter product was considered an artefact 
due to unspecific primer binding caused by the strong similarities between the 
contigs. These results were confirmed by PCR with the more specific primer pair 
1462ktr. The sequencing of both PCR-reactions led to the closure of the gap 
between contig 1517 and 1462.  
 
4.3.1.2 Gap closure between contigs 0668 and 1280 
The analysis of the sequences suggested that contig 0668 may follow 1280 and that 
the fragments of an A domain encoded on both contigs are actually part of one 
domain. The gap between the contigs was closed with one PCR step (primers 
1280seq_neu & 668seq-1280) and an additional sequencing reaction (3.4.11) from 
fosmid CF4 to ensure accuracy of the sequence. Both sequencing reactions 
confirmed that contig 1280 is indeed directly adjacent to 0668 with no bp in between, 
thus showing that the protein fragments are indeed part of the same A domain. 
 
4.3.1.3 Positioning of contig 1357 
The genome assembly was screened with the SeqMan tool from the DNASTAR 
Lasergene 8 software to search for further reads that align with the small contig 1357. 
Thus, sequences were found that suggested a connection of this fragment to contig 
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1518. This was confirmed by sequencing of a PCR-product generated with a primer 
pair specific to contig 1357 and the end of 1518 (1518-1517 & EC9fwd).  
 
 
              
Figure 4-4: PCR-reactions from genomic DNA bridging the contigs 
M, size marker; -, negative control; (a) PCR connecting contig 1462 to 1517 and 0668 to 1518; 
(b) PCR connecting contig 1357 to 1518; (c) PCR connecting contig 1462 to 1518; c, colony-
PCR; (d) PCR connecting contig 1518 to  0668; G, PCR from genomic DNA; F, PCR from fosmid 
clone EC10 
 
4.3.1.4 Gap closure between contigs 1518 and 1462 
Contig 1518 was hypothesized to lie in front of contig 1462. This was affirmed by a 
PCR with primers 1518-1517 and 1462seq between the ends of the contigs, which 
yielded a product of about 3,000 bp. As a fragment of this size is too long to be 
completely sequenced under standard conditions both ends were sequenced and 
new primer pairs deduced from the gained information. These primers were used for 
a sequencing reaction from fosmid EC9. The obtained sequences were aligned in a 
preliminary assembly. To close the last gaps and cover regions that had not been 
sequenced properly, the three primer pairs gap1, gap2 and gap3 were constructed. 
PCR with these primers resulted in overlapping products that covered the whole gap 
between the contigs. Together with the already obtained information, the gap could 
be closed, hereby also confirming the alignment of contigs 1518 and 1357.  
 
Through the additional sequence information a pair of cyclisation domains was 
discovered. It was also revealed that contig 1357 is actually part of the first of these 
domains rather than a fragment of a classical C domain. 
 
(a)       (b)             (c)      (d) 
M         1462-   -     668-   - 
             1517        1518 
M      -      -         1357- 
                           1518 
M     c          1462- 
                    1518   
M            G            F   
  (bp) 
  3,000 - 
 
  1,000 - 
 
   
   500   - 
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Concurrently, differences between the sequence of contig 1462 from the genome 
sequencing and the PCR-products were discovered. Therefore, a thorough PCR-
screening was carried out with primer pairs covering contig 1462 and adjacent 
regions (1462-A fwd & rev) to gather reliable sequence information. The fragments 
were aligned and compared to the existing contig 1462, which confirmed the 
discovered differences and revealed more deviations. The new construct was 
analysed with BLASTp, which yielded the prediction of an A domain containing the 
complete conserved region. Thus, it was concluded that the PCR originated 
alignment was correct and the provided sequence for contig 1462 proved to be 
erroneous. The corresponding sequences were replaced with the new results, 
thereby also removing two incorrect stop codons. The corrected sequences were 
used further on in this study. 
 
4.3.1.5 Gap closure between contigs 1518 and 0668 
The cluster information obtained up to this point was compared with the chemical 
structure of siphonazole for a first evaluation of the identified PKS and NRPS 
modules. A rough assignment of cluster parts to the skeleton of the compound 
revealed that sequences for one complete NRPS module was still missing to provide 
the first threonine unit of siphonazole. Considering the average sizes of the DNA 
sequences econding the necessary domains, the gap between contigs 1518 and 
0668 was estimated to be at least 3,000 bp long. PCR-reactions from genomic DNA 
yielded only products of less than 1,000 bp in size and were therefore considered 
artefacts. To minimise the gap, sequencing reactions were carried out from the contig 
ends and new primers designed with the obtained information (primers 1518-EC10-
fwd & EC10seq-rev). A PCR with fosmid EC10 as template (primers 668seq & 
1518seq) successfully generated a product between 4,000 and 5,000 bp. In parallel 
to chapter 4.3.1.4 multiple PCR and sequencing steps (primers EC10seq2 fwd & rev 
and 1518seq_neu) were carried out and overlapping DNA fragments generated and 
aligned to the final sequence using BLAST and ClustalW2 alignment software (Larkin 
et al., 2007; Goujon et al., 2010).  
 
An analysis of the gathered sequence information revealed the presence of a whole 
NRPS cyclisation module, comprising a pair of cyclisation domains, an A domain and 
two PCPs. 
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4.3.2 Organisation of the putative siphonazole gene cluster 
The ORFs adjacent to those encoding the AT and the TE were translated into amino 
acid sequences and analysed with BLASTp to evaluate a possible role in the 
biosynthesis of siphonazole. The proteins encoded by orf1 and orf2 showed 
homology to enzymes from the primary metabolism of H. aurantiacus. The small 
protein encoded by orf13 could not be assigned to a specific function, while orf14 
aligns with a DNA-polymerase. All four ORFs were considered to be unrelated to 
PKS or NRPS functions.  
 
Table 4-4: BLASTp search results for the translated amino acid sequences from the ORFs 
surrounding the sph genes; length of the sequence is given in column two; identity is given as 
percentage of aligned amino acids 
Gene size 
(aa) 
Highest Homology 
(protein level) 
Identity 
(aa) 
Accession No. 
orf1 863 phosphoenolpyruvate synthase  
[Herpetosiphon aurantiacus DSM 785] 
575/871 
(66%) 
YP_001544722 
orf2 304 GCN5-like N-acetyltransferase  
[Herpetosiphon aurantiacus DSM 785] 
175/299 
(59%) 
YP_001544430 
orf13 205 hypothetical protein OTW25_04915 
[Ornithinibacillus sp. TW25] 
113/188 
(60%) 
ZP_08784265 
orf14 358 DNA polymerase IV [Clostridium 
perfringens B str. ATCC 3626] 
117/341 
(52%) 
ZP_02634987 
 
These findings suggest that the putative siphonazole gene cluster comprises ten 
ORFs (figure 4-5), which extend over 50 kb. The genes were consequently 
denominated sphA – sphJ. Their translated protein sequences were subjected to a 
BLASTp alignment and an additional analysis with CLUSEAN. The deduced protein 
functions and predicted PKS or NRPS domains are summarised in table 4-5. 
 
 
Figure 4-5: Organisation of the putative siphonazole gene cluster 
Genes contributing to the biosynthesis of siphonazole are shown in blue; open reading frames 
without predicted NRPS/PKS functions are shown in gray; representations are drawn to scale 
according the length of the amino acid sequence 
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Table 4-5: BLASTp search results for the translated amino acid sequences from sph genes 
Length of the amino acid sequence is given in column two; identity is given as percentage of 
aligned amino acids; column five shows the protein functions and NRPS and PKS domains 
according to the predictions derived from CLUSEAN and BLASTp search 
Gene Size 
(aa) 
Highest Homolgy 
(GenBank accession) 
Identity 
(aa) 
Predicted domains 
sphA 762 polyketide synthesis protein 
[Bacillus subtilis] 
(YP_004207767) 
387/768 
(50%) 
trans-AT-OR 
sphB 221 O-methyltransferase, family 3 
[Bacillus thuringiensis] 
(ZP_04094215) 
127/220 
(58%) 
O-methyltransferase 
sphC 5451 AMP-dependent synthetase 
and ligase [Clostridium 
papyrosolvens] 
(YP_002505214) 
803/2275 
(35%) 
A-ACP-ACP-KS-DH-KR-
ACP-KS-PCP-Cyc-Cyc-
A-PCP-PCP-Ox-Ox-KS 
sphD 2089 beta-ketoacyl synthase 
[Clostridium cellulolyticum] 
(YP_002505214) 
719/1951 
(37%) 
 
ACP-KS-ACP-ACP-KS-
ACP 
sphE 2693 Beta-ketoacyl synthase 
[Clostridium papyrosolvens] 
(ZP_08192883) 
329/730 
(45%) 
Cyc-Cyc-A-PCP-PCP-
Ox-Ox-KS-ACP 
sphF 2059 NRPS/PKS [Streptomyces 
albus] (YP_002505214) 
867/2062 
(42%) 
C-A-PCP-KS-DH 
sphG 1186 beta-ketoacyl synthase 
[Clostridium cellulolyticum] 
(YP_002505214) 
527/1214 
(43%) 
KR-ACP-KS-ACP 
sphH 1228 Polyketide synthase 
[Sorangium cellulosum] 
(YP_001614779) 
254/780 
(33%) 
DH-KR-ACP-Hydrolase 
sphI 348 phospho-2-dehydro-3-
deoxyheptonate aldolase 
[Sphaerobacter thermophilus] 
(YP_003320125) 
184/285 
(65%) 
Aldolase 
sphJ 243 thioesterase LchAD [Bacillus 
licheniformis] (YP_077643) 
100/231 
(43%) 
TE 
 
4.4 NRPS domains and modules 
The putative siphonazole gene cluster encodes four NRPS and eight trans-AT type 
PKS modules. The functionality of the individual domains was evaluated by an 
examination of conserved regions within the amino acid sequence. Following a 
BLASTp search the domain sequences were aligned with homologous proteins 
derived from the BLAST hits and reference proteins taken from the conserved 
domain database (Marchler-Bauer et al., 2004, 2009, 2011). Thus, known signature 
motifs and catalytic residues were identified and assessed for integrity. 
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Figure 4-6: Modular organisation of the putative siphonazole biosynthetic enzymes 
PKS parts are shaded yellow and NRPS parts red; other parts are shaded grey; thioesterase 
(TE) is shaded green; AT, acyltransferase; OR, oxidoreductase; O-MT, O-methyltransferase 
 
The predicted domain functions show that NRPS-module 1 represents the initiation 
module of the cluster and characteristically lacks a C domain. In NRPS-modules 2 
and 3 the normal C domain is replaced by tandem Cyc domains, while module 4 
exhibits a canonical domain organisation. In the following, the domains are either 
simply numerated (carrier proteins and KSs) or named after their respective proteins 
and, if necessary, their order within a peptide sequence (e.g. SphF-C, SphC-A1). 
 
4.4.1 Adenylation domains 
The A domains are responsible for the selection of cognate amino acids and their 
activation as aminoacyl adenlyate. Stachelhaus and co-workers determined ten 
amino acids that form the substrate-binding pocket and confer specificity and derived 
a prediction model for the substrate specificity of an adenylation domain. In this study 
the prediction was carried out with the NRPSPredictor software (Rausch et al., 2005) 
for the four A domains that are encoded in the putative siphonazole cluster. As SphC-
A2 and SphE-A are 100% identical in their DNA sequence, their prediction results 
were summarised.  
 
Table 4-6: Results of the NRPSPredictor for the A domains encoded in the putative siphonazole 
cluster; the first line shows the sequence from which the Stachelhaus-code is deduced; 
predictions are based on the assumption that either several (large clusters) or only few (small 
clusters) substrate amino acids have the same properties; specificity alignments are based on 
comparison with known A domains; a) and c) show individual predictions; b) summarises the 
predictions for two genetically identical A domains 
a) SphC-A1 
Residues 8Å around substrate    RWLTFMPSLWEGAAICGGELNDYGATENGVLFNE 
Stachelhaus-code MPWAIGDVLK 
Predictions (large clusters) asp=asn=glu=gln=aad-like specificity 
Score:0.232448685175 
Predictions (small clusters) val=leu=ile=abu=iva-like specificity 
Score:0.135284593626 
Specificity alignments none 
 
Results  71 
 
b) SphC-A2 and SphE-A 
Residues 8Å around substrate    LTTHFDFSVWEGNQVFGGEINMYGITETTVHVTY 
Stachelhaus-code DFWNVGMVHK 
Predictions (large clusters) ser=thr=ser-thr=dht=dhpg=dpg=hpg-like specificity  
Score:1.3927863256 
Predictions (small clusters) thr=dht-like specificity  
Score:1.31193117612 
Specificity alignments threonine 
 
c) SphF-A 
Residues 8Å around substrate    FAMTFDIAGLELQALCGGEWNLYGPTETTIWSTA 
Stachelhaus-code DILQLGLIWK 
Predictions (large clusters) gly=ala=val=leu=ile=abu=iva-like specificity  
Score:1.688107797 
Predictions (small clusters) gly=ala-like specificity  
Score:1.2144130992 
Specificity alignments glycine 
 
The Stachelhaus-code of SphC-A1 showed no homology to any A domain of known 
specificity. Also, the small and large cluster predictions have very low score in this 
case. According to the structure of siphonazole, SphC-A1 supposedly activates a 
dihydroxy-benzoic acid, which does not agree with the prediction of an aspartate or 
valine like specificity. SphC-A2 and SphE-A were clearly assigned specificity for 
threonine and SphF-A was predicted to adenylate glycine. These findings match the 
arrangement of amino acids in siphonazole. 
 
The A domain sphC-A1 was subjected to a further analysis by the NRPSPredictor 2 
software (Röttig et al., 2011). Additionally to the already attained results, specificity 
for a hydrophilic substrate was predicted with a score of 0.118492 and a precision of 
0.94. The nearest neighbour based on the Stachelhaus-code has a similarity of 50% 
and is specific for phenylalanine, which clusters in the hydrophobic-aromatic group of 
substrates.  
 
4.4.2 Peptidyl carrier proteins 
PCP domains belong to the superfamily of PP-binding proteins (GenBank accession: 
cl0936). They are characterised by a conserved serine residue, which accepts a 
phosphopantetheine arm as prosthetic group. This arm is essential for the transport 
of amino acids and peptides within the cluster. Marahiel and co-workers identified the 
signature motif L-G-G-(DH)-S-L around this residue (Schwarzer et al., 2003). Five 
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PCP domains were found in the analysis of the putative siphonazole gene cluster 
and examined by multiple sequence alignment. 
 
PCP1  A Y G L D S I 32 
PCP2  S A G A T S L 30 
PCP3  S A G A T S L 30 
PCP4  S A G A T S L 30 
PCP5  S A G A T S L 30 
 
Figure 4-7: Multiple sequence alignment of PCP domains derived from sph genes 
Residues critical for the domain function are coloured green; other residues corresponding to 
the consensus motif are coloured yellow 
 
The alignment (figure 4-7) confirms the presence of the essential serine in all 
domains. The signature, however, is poorly conserved with the exception of a glycine 
and a lysine residue. 
 
4.4.3 The condensation domain of sphF 
Marahiel and co-workers described seven consensus motifs for condensation 
domains in NRPS systems (Marahiel et al., 1997; table 4-7). The active site is 
composed of an H-H-x-x-x-D-G core motif, in which the second histidine and the 
glycine residue are critical for the condensation activity of the domain (Stachelhaus et 
al., 1998). The aspartate was found to be of structural importance, while the first 
histidine participates in the correct folding of the domain. In further works R62, R67 
and W202 were identified as additional important residues for the structure and 
folding of the C domain (Bergendahl et al., 2002; Rausch et al., 2007). 
 
Table 4-7: signature motifs for condensation domains (according to Marahiel et al., 1997) 
Catalytic and other important residues are printed in bold letters 
C1 S-x-A-Q-R-(LM)-(WY)-x-L 
C2 R-H-E-x-L-R-T-x-F 
C3 M-H-H-x-I-S-D-G-(WV)-S 
C4 Y-x-D-(FY)-A-V-W 
C5 (IV)-G-x-F-V-N-T-(QL)-(CA)-x-R 
C6 (HN)-Q-D-(YD)-P-F-E 
C7 R-D-x-S-R-N-P-L 
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A sequence alignment of SphF-C was performed (figure 4-8) with C domains from 
gramicidin (GrsB) and surfactin (SrfA-C) biosynthesis and two similar proteins from 
Streptomyces albus and Clostridium cellulolyticum derived from BLASTp analysis. 
 
               Motif C1     Motif C2 
SphF-C S E G Q K A L W 11  R H P L L A A R L 58 
S.albus S A G Q R A L S 11  R H P Q L R A R I 58 
C.cel. S E G Q K G L W 54  R H P A L R T R I 101 
GrsB S P M Q E G M L 23  R Y D V F R T T F 70 
SrfA-C S P M Q E G M L 23  R Y D V F R T V F 70 
 
               Motif C3     Motif C4 
SphF-C V H H I M F D G V S 136  F G D F V A W 172 
S.albus F H H I V F D G L S 133  F A D F V D W 164 
C.cel. F H H I I Y D G M S 180  Y K D Y V Y W 216 
GrsB F H H I L M D G W C 156  Y K Q F I K W 185 
srfA-C Y H H I I L D G W C 156  Y K D Y I K W 185 
 
               Motif C5     Motif C6 
sphF-C I G Y F M N M V V I 290  H G D Y P L F 323 
S.albus L G Y F M N M V V L 282  H S D Y P L F 315 
C.cel. L G Y F M N I V V I 343  H S D Y P V S 367 
GrsB V G L F I N T L P L 305  H E Y F P L Y 338 
SrfA-C V G L F I N V V P R 304  H Q Y V P L Y 337 
 
               Motif C7   Trp important for folding 
SphF-C F Y F Q N W V A 346  Y W L 190 
S.albus F Y F Q N W V E 338  Y W L 182 
C.cel. F Y F Q N W M D 395  Y W L 234 
GrsB M V I E N Y P L 362  Y W K 203 
SrfA-C I V F E N Y P L 358  Y W R 203 
 
Figure 4-8: Multiple sequence alignment of the C domain from SphF 
Catalytic residues are coloured green; residues important for structure or folding are coloured 
blue; other residues corresponding to the consensus motifs are coloured yellow; reference 
sequences were taken from gramicidin (GrsB, P0C064) and surfactin (SrfA-C, 2VSQ_A) 
biosynthesis and similar proteins from Streptomyces albus (S.albus, ABS90470) and 
Clostridium cellulolyticum (C.cel., YP_002505216) 
 
 
 
 
74  Results 
Motifs C1 and C2 only show partly correspondence to the canonical consensus 
sequences, while the catalytic core moieties in C3 are strictly conserved. In motif C4 
the order of the valine and alanine residue are switched in SphF-C. Almost no 
homology to the consensus sequence could be observed in motif C7, where only the 
asparagines seems to be conserved, followed by an additional tyrosine in GrsB and 
SrfA. The sequence alignment identified R50 and W189 in SphF-C as the residues 
correlating to the structurally important R62 and W202 of the reference protein 
(TycB1; Bergendahl et al., 2002). Only for R67 (R55 in SphF-C) no direct 
correspondent was found, though there is an arginine present at position 57, which 
may take over the same function. Due to the presence of virtually all critical residues, 
SphF-C was characterised as an active domain. 
  
4.4.4 Heterocyclisation modules 
In this module type the usual C domain is replaced by a Cyc domain, which not only 
catalyses the condensation reaction, but also the formation of heterocycles from 
serine, threonine or cysteine side chains (Roy & Walsh, 1999). The resulting 
oxazoline and thiazoline rings can be oxidised to thiazole and oxazole rings by 
optional Ox domains. The two cyclisation modules in SphC and SphE exhibit several 
peculiarities. An alignment of the modules revealed a 98% identity of their DNA 
sequence over a range of 4,750 bp. This area stretches from the Cyc domains to the 
carrier proteins, but does not include the Ox domains. Through an analysis using the 
Artemis software (Rutherford et al., 2000; Carver et al., 2011), a deviance in the GC-
content of this region was detected (figure 4-9). While the average GC-content of the 
sph genes lies at 53.1%, the ratio raises to 68% within the cyclisation modules. 
 
                   
Figure 4-9: GC-content of the putative siphonazole biosynthetic genes 
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4.4.4.1 Cyclisation tandem domains 
In NRPS-modules that form thiazoline or oxazoline rings by intramolecular 
heterocyclisation the C domain is replaced by a Cyc domain (Keating et al 2002). 
These domains are capable of catalysing the necessary condensation, cyclisation 
and dehydration reactions (Marshall et al., 2002). In the putative siphonazole cluster 
an unusual arrangement of two pairs of tandem Cyc domains was identified in SphC 
and SphE. As this suggests a redundancy or inactivity within these domains 
(Marshall et al., 2002), they were subjected to a careful analysis of signature motifs.  
 
The catalytic core motif H-H-x-x-x-D-G (Stachelhaus et al., 1998) of regular C 
domains is replaced by a D-x-x-x-x-D-x-x-S motif in Cyc domains, in which the two 
aspartate moieties are essential for the condensation and cyclisation reactions 
(Keating et al., 2000). Seven further signature sequences are described for Cyc 
domains (Schwarzer et al., 2003; table 4-8). These conserved regions were analysed 
by a multiple sequence alignment with Cyc domains from the bleomycin, bacitracin, 
epothilone and pyocheline biosynthesis. The results are given in figure 4-10. 
 
Table 4-8: Signature motifs for cyclisation-domains (according to Schwarzer et al., 2003) 
Catalytic core residues are printed in bold letters 
Cy1 F-P-L-(TS)-x-x-Q-A-Y-x-x-G-R 
Cy2 R-H-x-(IM)-L-(PAL)-x-(ND)-G-x-Q 
C3 D-x-x-x-x-D-x-x-S 
Cy3 L-P-x-x-P-x-L-P-L-x-x-x-P 
Cy4 (TS)-(PA)-3x-(LAF)-6x-(IVT)-L-x-x-W 
Cy5 (GA)-D-F-T-x-L-x-L-L 
Cy6 P-V-V-F-T-S-x-L 
Cy7 (ST)-(QR)-T-P-Q-V-x-(LI)-D-13x-W-D 
 
Motif Cy1 
SphC-Cyc1            F G L S A V Q E A F V V G Q 17 
SphC-Cyc2           L P L S A V Q R S Y L L A R 17 
SphE-Cyc1  R S V D G G N D I W V V G R 21 
SphE-Cyc2            L P L S A V Q R S Y L L A R 17 
BlmIV-Cyc        F P L T D V Q R A Y Y V G R 73 
BacA-Cy           F P L T G I Q L A Y L V G R 49 
EposP-Cyc  F P L T D I Q E S Y W L G R 85 
PchE-Cyc         F E L S S V Q Q A Y W L G R 118 
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Motif Cy2                Core Motif C3 
SphC-Cyc1            R H P M L T M Q 63  D [4] D A A S 142 
SphC-Cyc2            A H P G L R M T 58  D [4] D G R S 126 
SphE-Cyc1  R H P M L T M Q 74  D [4] D A A S 153 
SphE-Cyc2            R P S R P A H D 58  D [4] D G R S 127 
BlmIV-Cyc        R H P M L R A V 120  D [4] D A H S 198 
BacA-Cy           R H P M L R T I 95  D [4] D D S S 174 
EposP-Cyc  R H D M L R A H 131  D [4] D L G S 209 
PchE-Cyc         R H P M L R A R 165  D [4] D V E S 243 
 
Motif Cy3 
SphC-Cyc1            I T G G P A L P W [4] P 209 
SphC-Cyc2            R P L G P T L P S [3] Q 189 
SphE-Cyc1  I T G G P A L P W [4] P 220 
SphE-Cyc2            R P L G P T L P S [3] Q 190 
BlmIV-Cyc        L P P G P E L P L [3] P 266 
BacA-Cy           F P S A P E L P L [3] P 242 
EposP-Cyc  L P P P P T L P M [3] P 277 
PchE-Cyc         L P D A P A L P L [3] P 310 
 
Motif Cy4 
SphC-Cyc1            A P [3] L [6] I L R S A 266 
SphC-Cyc2            S L [3] L [6] V L A A W 229 
SphE-Cyc1  A P [3] L [6] I L R S A 277 
SphE-Cyc2            S L [3] L [6] V L A A W 230 
BlmIV-Cyc        S P [3] L [6] V I T A W 315 
BacA-Cy           T P [3] L [6] I L A Y W 291 
EposP-Cyc  T P [3] I [6] V I G R W 326 
PchE-Cyc         T L [3] F [6] V L A R W 359 
 
Motif Cy5     Motif Cy6 
SphC-Cyc1           A P V V S T T L V 303 P V V F T A M L 360 
SphC-Cyc2           G D F T A L R W L 264 P L V F T E L L 319 
SphE-Cyc1 A P V V S T T L V 314 P V V F T A M L 371 
SphE-Cyc2           G D F T A L R W L 265 P L V F T E L L 320 
BlmIV-Cyc        G D F T S L S L L 350 P V V F T S D L 409 
BacA-Cy          G D F T S L M L L 326 P I V F T S V L 386 
EposP-Cyc G D F T S M V L L 361 P V V L T S A L 420 
PchE-Cyc         G D F T T L L L L 394 P V V F A S N L 450 
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Motif Cy7 
SphC-Cyc1            T Q T P N V W L D [13] W D 404 
SphC-Cyc2            S Q T P G V A I D [14] W D 357 
SphE-Cyc1  T Q T P N V W L D [13] W D 415 
SphE-Cyc2            S Q T P G V A I D [14] W D 358 
BlmIV-Cyc        S Q T P Q V H L D [13] W D 458 
BacA-Cy           T R T S Q V Y I D [13] W D 431 
EposP-Cyc  T Q T P Q L L L D [13] W D 464 
PchE-Cyc         S Q T P Q V W L D [13] W D 495 
 
Figure 4-10: Multiple sequence alignment of the Cyc domains from SphC and SphE 
Residues corresponding to the consensus motifs are coloured yellow; C3 shows the alignment 
for the catalytic core; catalytic residues are coloured green; reference sequences were taken 
from the biosynthesis of bleomycin (BlmIV-Cyc, AAG02364), bacitracin (BacA-Cy, O68006), 
epothilone (EposP-Cyc, AAF26925) and pyochelin (PchE-Cyc, AAD55800) 
 
The two Cyc domain pairs of SphC and SphE show great similarity to each other and 
have identical DNA sequences over long stretches. SphE-Cyc1 differs from SphC-
Cyc1 only in a section of 29 bp. Due to this deviation, SphE-Cyc1 shows almost no 
homology to signature motif Cy1, which is at least partly conserved in the 
corresponding domain SphC-Cyc1. SphE-Cyc2 deviates from SphC-Cyc2 in a stretch 
of 69 bp, which results in a different conservation of motif 2. All domains exhibit the 
essential catalytic aspartate moieties in the core motif C3. Motif Cy5 seems to be 
only conserved in the second cyclisation domain of each pair. Motif Cy2 generally 
shows the weakest conservation in all compared sequences. With the exception of 
the core motif and Cy7, the two domains of each pair in SphC and SphE exhibit 
differences in the conserved residue of the signature motifs, which complement each 
other. However, from this bioinformatic data alone it cannot be told, whether each 
tandem pair catalyses condensation and cyclisation in concerted action or whether 
one domain of a pair is redundant.  
 
4.4.4.2 Oxidation domains  
The ORFs sphC and sphE both encode a pair of Ox domains, which were identified 
as members of the McbC-like oxidoreductase superfamiliy (GenBank accession: 
cl02142). These oxidases are generally associated with cyclisation modules and are 
responsible for the oxidation of formed thiazoline and oxazoline rings to thiazole and 
oxazole rings. The domain architecture of the putative siphonazole gene cluster 
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follows the canonical arrangement, in which the Ox domain follows the corresponding 
PCP of the module (Schwarzer et al., 2003). Although little biochemical data is 
available for Ox domains, three signature motifs are described by Schwarzer and co-
workers (table 4-9). A multiple sequence alignment was performed with Ox domains 
from epothilone, tubulysin and rhizoxin biosynthesis. 
 
Table 4-9: Signature motifs for oxidation domains 
Ox1 K-Y-x-Y-x-S-x-G-x-x-Y-(PG)-V-Q 
Ox2 G-x-x-x-G-(LV)-x-x-G-Y-Y-Y-(HD)-P 
Ox3 I-x-x-x-Y-G 
 
   Motif Ox1 
SphC-Ox1  K Y L H A S A G G K Y A I Q 74 
SphE-Ox1  K Y L Y A S A G G K Y A V Q 54 
SphC-Ox2  L T L E A L E A - - - - I T 63 
SphE-Ox2  - - L S S D A G - - - - I E 58 
EpoB  K F R Y P S A G S T Y P V Q 74 
TubD  R Y L Y A S A G G L Y P V Q 91 
RhiB  K Y L Y S S A G G L N A I Q 67 
 
   Motif Ox2 
SphC-Ox1  G G I E G L A A G C Y Y Y H P 96 
SphE-Ox1  G A I Q G L V A G C Y Y Y H P 76 
SphC-Ox2  Q G V I G V D A G I Y R Y D R 85 
SphE-Ox2  E R I A G Y T G G V Y R Y N V 80 
EpoB  G R I E G V D E G F Y Y Y H P 96 
TubD  G R A R G L E P G T W Y Y D P 113 
RhiB  E R I D G L A G G V Y Y Y Q P 89 
    
Motif Ox3 
SphC-Ox1 L R P I Y Q 132 
SphE-Ox1 L R P V Y Q 115 
SphC-Ox2 L P S H Y A 133 
SphE-Ox2 L R E R F G 129 
EpoB I E S L Y G 143 
TubD V E P V Y A 162 
RhiB I A P I Y N 137 
 
Figure 4-11: Multiple sequence alignment of the Ox domains from SphC and SphE 
Residues corresponding to the consensus motifs are coloured yellow; reference sequences 
were taken from the biosynthesis of epothilone (EpoB, AAF62881), tubulysin (TubD, CAF05649) 
and rhizoxin (RhiB, CAL69889) 
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The alignment (figure 4-11) shows a high correspondence to the Ox1 motif in the first 
Ox domains of SphC and SphE where only the (PG) residue is not conserved. In 
SphC-Ox1 also one tyrosine is replaced by a histidine. The second motif completely 
follows the consensus sequence, while in motif Ox3 the tyrosine moiety is the only 
residue that is stringently conserved.  
 
The second domains of the cyclisation modules show virtually no conservation of the 
first motif and also exhibit deviations from Ox2. In SphE-Ox2 the tyrosine in motif Ox3 
is replaced by phenylalanine. These results suggest a redundancy or inactivity for 
both SphC-Ox2 and SphE-Ox2. 
 
4.5 PKS domains and modules 
The domain prediction revealed that SphA represents the only AT of the cluster and 
that none of the eight PKS modules contains an AT of their own. They were therefore 
all classified as trans-AT type PKS modules. 
  
4.5.1 The trans-AT and oxidoreductase SphA 
A BLASTp analysis of SphA shows that the protein can be divided into two distinct 
domains. The N-terminal part (amino acids 1 – 295) encodes an AT, belonging to the 
acyl transferase 1 superfamily (GenBank accession: cl08282). ATs of PKS systems 
catalyse the transfer of acyl moieties between CoA and ACP using a serine-histidine 
catalytic diad. They exhibit a characteristic, highly conserved G-H-S-x-G motif 
surrounding the catalytic serine (Yadav et al., 2003). 
 
Previous studies have shown that the substrate specificity of PKS ATs is influenced 
by conserved motifs in the peptide sequence. ATs with a specificity for 
methylmalonyl-CoA exhibit a [RQSED]-V-[DE]-V-V-Q motif 30 amino acids upstream 
of the catalytic serine, while malonyl-CoA specific ATs have a Z-T-x-$-[AT]-[QE] 
sequence instead, with Z being a hydrophilic and $ an aromatic amino acid (Smith & 
Tsai, 2007). Furthermore, it was observed that the X in the G-H-S-x-G motif is 
frequently a branched hydrophobic amino acid like valine or isoleucine. In other ATs 
usually glutamine or methionine is found in this position. Finally, the specificity is 
influenced by a further motif 100 amino acids downstream of the active serine. The 
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[YVW]-A-S-H sequence confers specificity for methylmalonyl-CoA, while a [MILV]-A-
F-H motif is found in malonyl-specific ATs. Figure 4-12 depicts an alignment of the 
conserved regions with similar ATs derived from the BLAST analysis. 
 
  Motif 1 
SphA  G H S V G 90 
BaeE  G H S L G 87 
PksE  G H S L G 92 
DfnA  G H S L G 89 
ChiA  G H S L G 89 
   
Motif 2    Motif 3 
SphA  Q T Q Y T Q 60  G A F H 193 
BaeE  Q T Q F T Q 56  G A F H 191 
PksE  Q T Q Y T Q 61  G A F H 196 
DfnA  K T Q F T Q 58  G A F H 192 
ChiA  Q T Q Y T Q 58  G A F H 192 
 
Figure 4-12: Multiple sequence alignment of the acyltransferase SphA 
Residues corresponding to the consensus motifs are coloured yellow; reference sequences 
were taken from the biosynthesis of bacillaene (BaeE, YP_001421287), difficidin (DfnA, 
YP_001421800) and similar proteins from Paenibacillus mucilaginosus (PksE, YP_004640302) 
and Pseudomonas fluorescens (ChiA, AAM12912) 
 
The signature motif around the catalytic serine is completely conserved in SphA and 
follows, like the reference proteins, the canonical consensus for malonyl-specific ATs. 
The first motif contains glutamine at the hydrophilic and tyrosine at the aromatic 
position. The [MILV]-A-F-H motif differs only in the first position. Regarding the 
alignment this seems to be a frequent deviation. The X position after the active serine 
is occupied by a valine residue, which supports a prediction for malonyl-CoA 
specificity. 
 
The C-terminal part of the protein (amino acids 296 – 762) contains an 
oxidoreductase domain of the TIM phosphate binding superfamiliy (GenBank 
accession: cl09108). The primary structure was analysed with regard to the putative 
catalytic histidine residue (Ha et al., 2006) and subjected to multiple sequence 
alignment (figure 4-13) with oxidoreductases of analogous proteins from the 
biosynthesis of other secondary metabolites. 
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SphA  G G T T G 518 
MmpIII  G G H T D 904 
CorA  G G H T D 905 
PksE  G G H T D 504 
ChiA  A G S S D 544 
DszD  G G P T D 589 
 
Figure 4-13: Multiple sequence alignment of the oxidoreductase of SphA 
The putative catalytic histidine is highlighted in green; deviations in this position are printed in 
red; reference sequences were taken from the biosynthesis of disorazoles (DszD, AAY32968), 
chivosazole (ChiA, AAY89048), corallopyronin A (CorA, ADI59523), bacillaene (PksE, 
YP_004640302) and mupirocin (MmpIII, YP_439869 
 
It was shown that the catalytic histidine is replaced by a tyrosine moiety in SphA. 
Likewise, substitution by serine and proline, respectively, was observed in the 
corresponding genes of chivosazole and disorazole biosynthesis, while the histidine 
residue is present in genes from the mupirocin, corallopyronin and bacillaene 
clusters. A function as enoylreductase was suggested for these oxidoreductase 
domains (Bumpus et al., 2008), but often remained putative as in the case of ChiA 
(Perlova et al., 2006) and DszD (Carvalho et al., 2005). The lack of the catalytic 
histidine suggests that the OR of SphA may be non-functional.  
 
4.5.2 Ketosynthases 
PKS KSs belong to the superfamily of condensing enzymes (GenBank accession: 
cl09938) and catalyse a decarboxlating Claisen-condensation. The active centre is 
formed by cysteine and two histidines, which are distributed between the N- and C-
terminus of the peptide chain. The N- and C-terminal domains can be assigned to the 
beta-ketoacyl synthase superfamily (genebank accession cl09934 and cl08367 
respectively). Structurally the beta-ketoacyl synthases are related to the thiolase 
family (pfam00108). 
 
The active site of KSs consists of a highly conserved C-H-H catalytic triad (Zhang et 
al., 2006), in which the cysteine residue is part of a G-P-7x-C-S-S signature motif 
(Cortes et al., 1990). Eight KS domains were found to be encoded in the putative 
siphonazole gene cluster within the genes sphC to sphG. Multiple sequence 
alignment was used to screen for the active site residues. The results are given in 
figure 4-14. 
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  Motif 1                       Motif 2   Motif 3 
KS1  G P 7x C S S 173  H G T G T 302  G H 341 
KS2  G P 7x C S S 175  H G T G T 303  G H 344 
KS3  G P 7x C S S 175  A A T G S 303  G H 340 
KS4  G P 7x C S S 172  H G T G T 305  G H 343 
KS5  G P 7x C S S 172  Q G T G T 302  G H 341 
KS6  G P 7x C S S 172  A A N G T 304  G H 342 
KS7  G P 7x C S S 170  H G T G T 300  G H 344 
KS8  G P 7x C S S 173  H G T G T 302  G H 340 
 
Figure 4-14: Multiple sequence alignment of the KS domains 
Highly conserved residues are coloured yellow; residues of the catalytic triad are coloured 
green; deviations in the catalytic core are printed in red 
 
The alignment shows that the cysteine signature box is highly conserved in all KSs. 
KS 3, 5 and 6 lack the first catalytic histidine, which is supposed to play a role in the 
activation of a catalytic water molecule during the condensation reaction. KS domains 
lacking the conserved H-G-T-G-T motif were found to be non-elongating (Nguyen et 
al., 2008). Therefore KS3, KS5 and KS6 were considered inactive in the cluster.  
 
4.5.3 Acyl carrier proteins 
ACP domains show the same G-G-(DH)-S-L signature motif as PCPs. Similarly, the 
conserved serine is essential for the attachment of the phosphopantetheine 
prosthetic group.  
 
ACP1  E L G F D S V 32 
ACP2  E L G F D S V 32 
ACP3  E F G L D S I 32 
ACP4  I Y G I N S Q 32 
ACP5  E Y G F D A I 32 
ACP6  E Y G F D S V 32 
ACP7  N Y G I D S V 32 
ACP8  R Y G F N S L 32 
ACP9  N Y G F D S I 32 
ACP10  S Y G V D S V 32 
ACP11  E Y G L D A P 32 
ACP12  N Y G V D S L 32 
 
Figure 4-15: Multiple sequence alignment of the ACP domains 
Residues corresponding to the consensus motifs are coloured yellow; the essential serine 
moiety is coloured green; deviations in this location are printed in red 
 
Results  83 
 
In ACPs 5 and 11 the essential serine is replaced by an alanine residue (figure 4-15). 
This prevents the attachment of the prosthetic group, thus rendering these domains 
inactive. Like in the PCP domains, the preceding glycine residue is highly conserved 
in all domains, as well as the aspartate on position 30, which is changed only in 
ACPs 4 and 8. The remaining amino acids show a partly conserved pattern that 
differs from the canonical consensus sequence. 
 
4.5.4 Dehydratases 
The three DH domains encoded within genes sphC, sphF and sphH were all 
recognised by BLASTp as members of the PKS DH superfamily (GenBank 
accession: cl11739). DHs are characterised by a NADPH-binding motif with the 
conserved sequence H-x-x-x-G-x-x-x-x-P, which also contains the active histidine 
and proline residues (Donadio & Katz, 1992).  
 
A sequence alignment showed that the motif is fully conserved in SphC-DH and 
SphF-DH, while in SphG-DH the active histidine is replaced by a tyrosine and the 
conserved glycine by aspartate. Alteration of the non-catalytic glycine also occurs in 
other PKS DHs, while the catalytic histidine and proline moieties are strictly 
conserved and essential for the function of the enzyme (figure 4-16). 
 
SphC-DH  H R W E G Q A L L P 40 
SphF-DH  H I V Q G Q R V L P 40 
SphG-DH  Y Q V A D S Q R L P 43 
SorB  H R V L D M H L L P 33 
Ery chain A  H V V G G R T L V P 42 
Beggiatoa  H V V G S Q K T L P 39 
 
Figure 4-16: Multiple sequence alignment of the DH domains of SphC, SphG and SphH 
Residues corresponding to the consensus motif are coloured yellow; catalytic residues are 
coloured green, deviations in these locations are printed in red; reference sequences were 
taken from the biosynthesis of sorangicin (SorB, ADN68477), erythromycin (Ery chain A, 
3EL6_A) and a similar protein from Beggiatoa sp. SS (Beggiatoa, ZP_01997443) 
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It can be assumed that the alterations in the signature sequence are responsible for 
the fact that SphG-DH was not annotated during the CLUSEAN analysis, but was 
only detected by a manual BLAST search of SphH. DH domains from other gene 
clusters (e.g. nystatin biosynthesis), in which only the proline is conserved, are 
known to be non-functional (Pawlik et al., 2007). For this reason, it can be assumed 
that SphG-DH is also inactive. 
 
4.5.5 Ketoreductases 
CLUSEAN search identified three KRs encoded in sphC, sphG and sphH. Conserved 
domain analysis by BLASTp assigned them to the class of ketoreductases subclass 2 
complex short chain dehydrogenase/reductase (SDR) proteins (GenBank accession: 
cd08953) and members of the Rossman fold NADP(+)-binding proteins superfamily 
(GenBank accession: cd09931). This family contains a characteristic G-x-G-x-x-G-x-
x-x-A NADPH-binding motif. The catalytic triad in PKS KRs consists of a Y-x-x-x-N 
motif and an active serine upstream of this sequence. A conserved lysine is located 
~23 amino acids upstream of the serine moiety. The positions of this lysine and the 
asparagine seem to be switched in regard to classical SRDs (Reid et al., 2003). 
 
              NADPH-binding motif 
SphC-KR  G L G G V G L L C A 1889 
SphG-KR  G K G A L G A I F A 166 
SphH-KR  G A G N V G F K L C 504 
A.var.  G T S A V G T E I A 1220 
PksM  G A G Y I G E A W S 1540 
H.che.  G L G K I G L A L A 1125 
 
                    Catalytic Core 
SphC-KR  K [23] S [12] Y G Y A N 2024 
SphG-KR  K [23] S [12] Y A Y A N 297 
SphH-KR  K [23] S [12] Y A A G C 639 
A.var.  K [23] S [14] Y A A A N 1373 
PksM  K [23] S [12] Y A S G C 1675 
H.che.  K [23] S [12] Y A A A N 1347 
 
Figure 4-17: Multiple sequence alignment of the KR domains of SphC, SphG and SphH 
Residues corresponding to the consensus motif are highlighted in yellow; catalytic residues 
are highlighted in green, deviations in these locations are printed in red; reference sequences 
were taken from similar proteins from Anabaena variabilis (A.var., YP_324485), Bacillus subtilis 
(PksM, P40872) and Hahella chejuensis (H.che., YP_434161) 
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The NADPH-binding motifs follow the consensus sequence in all three KR domains 
with only a single alteration in SphH-KR. The catalytic residues are in agreement with 
similar reductases encoded by other gene clusters as shown in figure 4-17. In SphH-
KR the asparagine is replaced by a cysteine residue, which is also the case in PksM. 
The catalytic role of the asparagine moiety is still uncertain, but the KRs in PksM 
have been reported as functional (Butcher et al., 2007). Therefore, the same was 
assumed for SphH-KR. McDaniel and co-workers identified a diagnostic aspartate 
residue, which is present in all KRs that catalyse reductions to D-configuration and 
absent in KRs that reduce to L-configuration. This residue was found in the KR 
domains of SphC and SphG, but not SphH. Further motifs for the classification of 
KRs were identified by the Leadly group (O’Hare et al., 2006; Baerga-Ortiz et al., 
2006). Neither the signature motifs L-D-D and P-x-x-x-N for type B KRs nor the PQQ 
signature and the W141 for type A KRs could be identified unambiguously in either of 
the KRs. A definite categorisation of the KR domains could therefore not been made.  
 
4.5.6 The thioesterase SphJ 
A BLASTp search with the amino acid sequence of SphJ confirmed the assignment 
of the enzyme to the protein familiy of thioesterases (pfam00975). Like ATs they 
contain an α/β-hydrolase fold domain and also share the same G-x-S-x-G motif 
around a catalytic serine. About 140 amino acids downstream of this sequence a G-
x-H-F signature was identified surrounding a conserved histidine residue (Schneider 
& Marahiel, 1998). The BLAST search revealed that SphJ shows the greatest 
homology to thioesterases from Bacillus species (see table 4-5). 
 
A multiple sequence alignment was performed with similar TE domains to identify the 
signature sequences. SphJ contains a strongly conserved G-H-S-x-G sequence, 
while the phenylalanine in the second motif is replaced by a methionine in all of the 
examined sequences (figure 4-18). 
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SphJ  G H S L G 89  G P H M Y L 220 
LchAD  G H S M G 89  G G H M Y L 220 
B. cereus AH1134  G H S M G 90  G G H M F L 221 
B. thuringiensis IBL 200  G H S M G 86  G G H M F L 217 
 
Figure 4-18: Multiple sequence alignment of the thioesterase SphJ 
Residues corresponding to the consensus motif are coloured yellow; catalytic residues are 
coloured green; reference sequences were taken from the biosynthesis of surfactin (B. cereus, 
EDZ49042), lichenysin (B. thuringiensis, ZP_04072876) and a similar protein from B. 
licheniformis (LchAD, AAU22005) 
 
4.6 Non-PKS/NRPS cluster parts 
Some of the protein functions encoded within the gene cluster could not be attributed 
to a PKS or NRPS domain. They include the O-methyltransferase SphB, a hydrolase 
function in SphH and the aldolase SphI. These enzymes were subjected to a 
conserved domain analysis according to their BLASTp results and a mult iple 
sequence alignment with related proteins. 
 
4.6.1 SphB - an O-methyltransferase 
A homology search with BLASTp annotated SphB as an O-methyltransferase and 
member of the S-adenosylmethionine-dependent methyltransferases (SAM or 
AdoMet-MTase), class I familiy (GenBank accession: cd02440). SphB shows strong 
homology to other O-methyltransferases family 3. 
 
Three conserved regions that are supposed to participate in the binding of S-
adenosylmethionine are described (Kagan and Clarke, 1994; table 4-10). Motifs 1 
and 3 contain highly conserved glycine residues, and motif 2 includes an invariant 
aspartate moiety. 
 
Table 4-10: Signature motifs for methyltranserases 
Motif1 (VIL)-(LV)-(DE)-(IV)-G-(GC)-G-(TP)-G 
Motif2 (PG)-(QT)-(FYA)-D-A-(IVY)-(FI)-(CVL) 
Motif3 L-L-(RK)-P-G-G-(RIL)-(LI)-(LFIV)-(IL) 
 
 
Results  87 
 
   Motif 1      Motif 2 
SphB  M L E I G T F T G 72  N Y F D F V Y I 142 
N. punct.  T L E V G V F T G 72  E T F D F A F I 142 
R. brookii  T L D I G V F T G 72  E T F D F A F I 142 
B. cereus  V L E V G T F T G 76  N I F D F I F I 146 
 
   Motif 3 
SphB  L V R P G G I I G I 168 
N. punct.  L L R P G G L I A I 168 
R. brookii  L I R S G G L I A V 168 
B. cereus  L I R P G G I V A V 172 
 
Figure 4-19: Multiple sequence alignment of the O-methyltransferase SphB 
Residues corresponding to the consensus motifs are coloured yellow; reference sequences 
were taken from similar proteins from Nostoc punctiforme (N. punct., YP_001867016), 
Raphidiopsis brookii D9 (R. brookii, ZP_06306391) and Bacillus cereus BGSC 6E1 (B. cereus, 
EEK53069) 
 
In the first motif only the glycines at positions 5 and 9 are conserved, but not the 
residue at position 7 (figure 4-19). The aspartate moiety of the second motif is always 
present, as well as the two glycines in motif 3.   
 
4.6.2 The α/β-hydrolase encoded by sphH 
The C-terminus of SphH contains a domain classified as a member of the α/β-
hydrolase 6 familiy (pfam12697), which contains a wide range of hydrolytic enzymes 
of diverse specificity. They share the α/β-hydrolase fold as a structural motif, 
consisting of a central β-sheet surrounded by several α-helixes (Ollis et al., 1992). 
The catalytic triad is formed of a nucleophile, a histidine and an acidic residue 
(Kourist et al 2010). Most commonly the nucleophile is represented by serine, which 
is part of highly conserved G-x-S-x-G-G consensus motif, which is shared with the 
lipase superfamily (cl12031). The catalytic residues were identified by an alignment 
with similar hydrolases derived from BLASTp (figure 4-20).  
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SphH-Hyd  G S C F G G 51  G N L D 173  A G H 201 
S. sp.   G T S F G G 75  G G V D 184  A G H 212 
LnmJ  G A S F G G 66  G R H D 176  A G H 204 
PksE  A A S W G G 75  G E K E 172  A G H 200 
MmpIV  G W S M G G 76  G S D D 179  A G H 207 
 
Figure 4-20: Multiple sequence alignment of the α/β-hydrolase of SphH 
Residues corresponding to the consensus motifs are coloured yellow; reference sequences 
were taken from the biosynthesis of leinamycin (LnmJ, AAN85523) and similar proteins from 
Streptomyces sp. SPB74 (S. sp., ZP_06822181), Bacillus subtilis (PksE, ABH03699) and 
Cellvibrio japonicus Ueda107 (MmpIV, YP_001983454) 
 
The alignment shows that in SphH the highly conserved serine in the G-x-S-G-G 
motif is substituted with a cysteine moiety. The acidic residue follows the most 
common pattern being either aspartate or glutamate. Additional sequence 
homologies were observed in the amino acids preceding the acidic moiety and the 
histidine. The specificity prediction according to the composition of the catalytic elbow 
established by Kourist and co-workers (Kourist et al., 2010) could not be applied to 
the SphH hydrolase, as its signature sequences match none of the described 
classes. 
 
4.6.3 SphI – an aldolase 
Database search annotated SphI as a phospho-2-dehydro-3-deoxyheptonate 
aldolase, which is also known as 3-deoxy-D-arabino-heptulosonate 7-phosphate 
(DAHP) synthase. These enzymes catalyse the condensation of 
phosphoenolpyrovate (PEP) and erythrose 4-phosphate (E4P). This reaction is the 
first committed step of the shikimate pathway, in which chorismate and prephenate 
are formed as intermediates for the biosynthesis of aromatic amino acids as well as 
catechols and hydroxybenzoic acids (van Lanen et al 2008). Conserved domain 
database classified SphI as a member of DAHP synthase I family (pfam0793). A 
sequence alignment (figure 4-21) with reference DHAPs clearly assigns SphI to the 
DAHP subfamily AroAIβ as defined by Jensen and co-workers (Subramaniam et al 
1998). This classification corresponds to DAHP class I according to Birck and 
Woodard (Birck & Woodard, 2001). Figure 4-21 shows a multiple sequence 
alignment of the putative catalytic regions with enzymes from the same group. A 
complete alignment for all conserved regions is given in the appendix (8.4).  
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S. thermophilus  G P C S 104  K P R T S 136  I G A R 187 
T. roseum  G P C S 104  K P R T S 136  I G A R 187 
SphI  G P C S 104  K P R T S 136  I G A R 187 
B. subt. AroA  G P C A 127  K P R T S 159  I G A R 210 
S. xyl. AroA  G P C S 32  K P R T S 64  I G A R 115 
 
Figure 4-21: Multiple sequence alignment of the DAHP synthase SphI 
Residues corresponding to the catalytic motifs are shaded green; reference sequences are 
taken from Sphaerobacter thermophilus DAHP (S thermophilus; YP_003320125), 
Thermomicrobium roseum DAHP (T. roseum; YP_002521366), Bacillus subtilis chorismate 
mutase (B. subt. AroA; P39912) and Staphylococcus xylosus chorismate mutase (S xyl. AroA; 
CAA64712) 
 
4.7 Domain structure of the putative siphonazole biosynthetic 
enzymes 
Based on the domain predictions from CLUSEAN and BLASTp and the results of the 
multiple sequence alignments a model for the modular and domain organisation of 
the putative siphonazole biosynthetic gene cluster was established (figure 4-22). The 
initiation module belongs to the NRPS part and is deficient of a C domain. The two 
cyclisation modules contain all domains in duplicate with the exception of the A 
domain. The PKS part of the cluster contains three non-elongating modules with 
mutations in the catalytic core of their C domains (PKS 5, 7 and 9) and one module 
(PKS 6) with an additional ACP domain. 
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Figure 4-22: Hypothetical pathway for the biosynthesis of siphonazole 
Modules are marked by black bars; A, adenylation domain; ACP, acyl carrier protein; Cyc, cyclisation domain; C, condensation domain; DH, 
dehydratase; Hyd, hydrolase; KR, ketoreductase; KS, ketosynthase; KS0, non-elongating KS; MT, methyltransferase; OR, oxidoreductase; Ox, 
oxidation domain; PCP, peptidyl carrier protein; TE, thioesterase; domains marked with ‘0’ are non-functional; functionality of DH* in module 12 is 
uncertain; ‘?’ marks module with uncertain function 
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4.7.1 Classification of carrier proteins in view of the domain structure 
The predicted domain structure exhibits some unusual assignments of carrier 
proteins. The NRPS-initiation module and the fourth NRPS unit both contain ACP 
domains instead of PCPs. PKS module 3 in contrast comprises a PCP. Due to these 
aberrations, the classification by CLUSEAN was re-examined (table 4-11).  
 
Table 4-11: Classification of carrier domains as predicted by CLUSEAN 
Scores and E-values from Hidden Markov Model (HMM)-prediction for both domain types are 
listed; for ACP11 the software provided only results for the ACP prediction 
Carrier protein Score ACP E-value ACP Score PCP E-Value PCP 
ACP 1 57.9 8e-17 54.6 7.7e-16 
ACP 2 46.8 1.7e-13 46.6 2e-13 
ACP 3 70.5 1.3e-20 43.6 1.6e-12 
PCP 1 44.2 1e-12 35.4 4.8e-10 
PCP 2 37.2 1.3e-10 25.0 2.7e-07 
PCP 3 39.4 2.9e-11 25.7 2.2e-07 
ACP 4 29.3 3.1e-08 3.4 7.5e-05 
ACP 5 43.3 2e-12 0.4 0.00015 
ACP 6 34.8 6.9e-10 22.0 1.2e-06 
ACP 7 50.9 1e-14 41.3 7.6e-12 
PCP 4 39.2 3.2e-11 26.3 1.9e-07 
PCP 5 40.1 1.8e-11 26.0 2.1e-07 
ACP 8 52.1 4.3e-15 37.5 1.1e-10 
ACP 9 41.2 8.2e-12 30.5 1.4e-08 
ACP 10 45.4 4.5e-13 8.9 2.2e-05 
ACP 11 31.1 8.9e-09 n.a. n.a. 
ACP 12 65.3 4.6e-19 22.7 1e-06 
 
The two carrier proteins of the initiation module (ACPs 1 and 2) were only marginally 
distinguished as ACPs, while the differentiation of ACP 9 in the fourth NRPS-module 
was more distinct and comparable to the values of the other thiolation domains. The 
same applies to the PCP domain in PKS module 3 (PCP 1), which can also be 
clearly distinguished from an ACP. In most cases however, the values for the refused 
domain type are close to those of the accepted type. Only in the case of ACPs 4, 5, 
10 and 12 the discrimination is definite. 
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4.8 Construction of the complete cluster from the fosmid library 
After the bioinformatic characterisation of the putative siphonazole gene cluster the 
following work concentrated on the assembly of the complete cluster from partial 
sequences encoded on fosmid clones from the genomic library. These experiments 
aimed at providing a basis for further studies. The in silico completion of the putative 
siphonazole biosynthetic gene cluster allowed an exact assessment of the cluster 
parts that are covered by the genomic library. The ends of fosmids EC9, EC10 and 
CF4, which were identified to carry parts of the cluster, were sequenced (3.4.11) and 
aligned with the sph-genes and their adjacent regions. Thus, it was shown that the 
insert of EC10 starts ~5.5 kb upstream of sphA and ends within the sequences 
encoding the Cyc domains of sphE. Fosmid CF4 covers a similar area reaching from 
~4.8 kb upstream of sphA to the sequence encoding the KS in sphE. The insert of 
EC9 contains a cluster part encoding the domains from the DH of sphC to the KS of 
sphG. These results indicate that an area of approx. 7 kb, which contain the final part 
of the cluster, was not covered by the identified fosmids (figure 4-24). 
 
4.8.1 Screening of the genomic library 
To enable further experiments for a full characterisation of the putative siphonazole 
gene cluster, the fosmid genomic library was screened (3.4.13) for clones that 
contain the final 7 kb of the gene cluster comprising genes sphH, sphI, sphJ and 
parts of sphG. For later recombination steps it was also desirable to screen for a 
fosmid that overlaps with the insert of fosmid EC9 or CF4. Therefore, three specific 
primer pairs were derived from the DNA sequence to probe the TE domain (TE-end 
fwd & rev) and the sequence ends of CF4 (CF4-end fwd & rev) and EC9 (EC9-end 
fwd & rev) within sphE and sphG, respectively. 56 pools of clones from the fosmid 
library were screened with the CF4 primer pair by whole cell PCR (3.4.1.1), each 
pool containing the 12 clones of a row on a designated 96-well plate. The screening 
yielded positive results for pool IC an IIIA, which were subsequently subjected to a 
further screening with the remaining two primer pairs. Only pool IC proved positive 
for all three probes. PCR-screening of the individual clones of IC identified the 
fosmids IC2 and IC3, which both showed positive PCR results for all three fragments. 
These two fosmids were isolated from 100 ml cultures and the ends of the inserts 
sequenced. Thus, it was revealed that IC2 and IC3 virtually cover the same 
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sequence area and only differ in as little as 34 bp. The inserts begin within the Ox 
domains encoded by sphE and end ~10.8 kb downstream of sphJ. Fosmid IC2 was 
selected for all further experiments (figure 4-23). 
 
 
              
Figure 4-23: PCR-screening of the final cluster part 
(a) agarose gel with PCR-products from pool Ic and IIIa, probed for thioesterase (TE) and 
connection to fosmids CF4 and EC9; (b) agarose gel with PCR products from clones IC2 and 
IC3, probed with the same primer pairs; positive control was always genomic DNA from 
Herpetosiphon sp. 060 
 
4.8.2 Yeast recombinational cloning 
As knock-out studies of the putative cluster in Herpetosiphon sp. 060 proved 
unfeasible due to the genetic inaccessibility of the wild type organism, studies in 
heterologous expression systems must be addressed for a further characterisation of 
the cluster. This purpose requires a vector construct containing the complete 
sequence information of the gene cluster. Specific screening of the genomic library 
(4.8.1) yielded a fosmid (IC2) that comprises the final part of the cluster and overlaps 
with fosmid CF4, so that the whole sequence was contained on two fosmids only.  
 
The method of yeast recombinational cloning (3.5.3) was applied to combine the 
inserts into one vector with the complete DNA sequence of the siphonazole gene 
cluster.  
 
(a)             (b) 
TE              CF4              EC9                                                   TE                    EC9                  EC10 
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Figure 4-24: Linear representation of fosmid clone inserts 
Incomplete reading frames are depicted in white; insert range is shown as black bars; vector 
backbone is represented by striped (EpiRP primers site) and crossed bars (T7 primer site), 
respectively; sizes not drawn to scale; restriction sites indicated for yeast recombination and 
λ–Red experiments 
 
The pCC1FOS vector allows the inserts to be released by a digestion with BamHI  
(3.4.7). An analysis of the restriction sites in the cluster and the adjacent regions 
revealed recognition sites for PciI 1,375 bp upstream of the start codon of sphA and 
3,387 bp downstream of the stop codon of sphJ. Thus, the desired fragments of the 
fosmids could readily be cut out by a double digestion with PciI and BamHI. The 
vector pENTRC1FOS, which is a hybrid of pCC1FOS and yeast specific genes for 
replication and selection, was chosen for the recombination in yeast. As a selective 
marker the ura3P gene on the plasmid was used, which enables ura3p deficient 
yeast to grow on media lacking uracil. To connect the inserts with the vector, PCR-
products of ~1kb in size which cover the ends of the fragments and their adjoining 
regions were amplified with a primer-generated 20 bp overhang to the vector (primer 
pairs Hefe-start and -end). 
 
Transformation experiments regularly yielded a number of clones in the range of 101 
to 10². Transformants were screened for the presence of cluster parts by whole cell 
PCR (3.4.1.1) with primer pairs used for the fosmid library screening and gap closure 
(4.8.1 and 4.3.1). The respective primers are given in the appendix and were tested 
against the empty vector to exclude false positives. By this screening a clone was 
identified which was PCR-positive for probes in sphA, sphE and sphJ. The PCR 
reactions were repeated with the same conditions three days later with the original 
yeast clone, a liquid culture and a plasmid isolated (3.5.3.1) from the liquid culture, 
which all yielded no product.  
 
EC10 
EC9 
IC2 
CF4 
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Figure 4-25: PCR reactions from yeast recombination 
(a) colony-PCR with TE-primers from yeast clone; +, positive control, -, negative control; (b) 
colony-PCRs from the same clone; c, original colony; a, agar culture inoculated from original 
colony; l, liquid culture from clone; (c) PCR with TE-primers from isolated plasmid of pooled 
yeast clones; (d) colony-PCR probing for empty vector pENTRC1FOS from E. coli clones 
 
Following transformations regularly produced yeast clones that showed positive 
results in PCR screening. Repeatedly, it was observed that PCR-reactions performed 
with the same clones two or three days later stayed negative. Therefore, yeast 
clones were pooled and directly subjected to plasmid isolation. Pools and isolated 
plasmids both showed positive results for all PCR probes. Subsequently, the plasmid 
was used for the electroporation of electro-competent EPI300 E. coli cells (3.3.4). 
Repetitive transformation experiments yielded about 1 to 30 clones per 
transformation, which all proved negative in PCR screening. As a control, a primer 
pair (Ura3P_mid_fwd and Cat_mid_rev) was derived from the vector backbone of 
pENTRC1FOS, which probes the region adjacent to the integration site of the inserts. 
A screening of E. coli clones with this primer pair discovered that the clones virtually 
all yielded a PCR-product of 1,900 bp, indicating an empty vector. Clones that did not 
yield any product were tested again for the presence of cluster parts, but proved to 
be negative. 
 
 
 
 
 
(a)          (b)       (c)          (d) 
M   +   -          E. coli clones                                                      +    -    c        M 
M   +    -    c    a    l M   +    -     c    p 
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4.8.3 Λ-Red mediated recombination 
Due to the unsuccessful yeast recombinational cloning, another strategy was 
addressed to recombine the cluster parts to one construct. The end sequencing of 
the identified fosmids showed that the inserts of EC9, EC10 and IC2 all have the 
same orientation within the pCC1FOS vector, i.e. the reading frames are all directed 
from the EpiRP-primer site to the T7-primer site (figure 4-24). The insert of CF4 has 
the opposite orientation. This arrangement allowed a recombination approach based 
on a λ-Red mediated strategy (3.5.1). An analysis of the restriction sites on the vector 
backbone and within the cluster revealed the possibility to generate fragments of 
EC10 and IC2, which both contain homologous regions to the insert of EC9 and to 
the vector backbone. Thus, it was possible to recombine the cluster in two 
subsequent recombination steps by complementation of EC9 with the beginning and 
the end of the cluster. Therefore, fosmid EC9 was transformed into BW25113 E. coli 
cells, which are capable of λ-Red recombination. 
To enable the selection of successful transformants, a streptomycin (primers Str-
FRT-fw-EC10 & Str-FRT-re+EC10) and an apramycin resistance cassette (primers 
Apr-FRT-fwd+IC2 and Apr-FRT-rev+IC2) were amplified together with an adjoining 
oriT from the plasmids pIJ778 and pIJ773 and cloned upstream of sphA and 
downstream of sphJ, respectively. Flanking FRT-sites were included to enable later 
deletion of the cassettes. Using primers with 40 bp homology extensions, the 
streptomycin cassette was inserted into fosmid EC10, thus deleting 2,884 bp of the 
upstream region. By application of the same procedure, the apramycin cassette was 
inserted into IC2, concurrently with the deletion of 3,316 bp.  
 
By digestion with ApaLI and BsrGI an 18,842 bp fragment was generated from 
fosmid IC2 (3.5.1.1), which harbours a 266 bp homology region to the vector and 
2,706 bp homology to the insert of EC9. Fosmid EC10 was digested with EcoRV and 
NotI to obtain a 15,619 bp fragment with 278 bp homologous to the vector and 3,016 
bp overhang to EC9. In two subsequent steps of electroporation (3.3.4) and selection 
these two fragments were transformed and recombined with EC9, thus obtaining a 
pCC1FOS construct of 71,275 bp, which harbours the complete putative siphonazole 
gene cluster.  
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Figure 4-26: Completion of the putative siphonazole cluster by λ-Red recombination 
(a) Test-PCRs with two clones (1, 2) after final λ-Red recombination; PCRs for: I, aadA; II, front 
cluster part; III, middle part; IV, final part; V, aac(3)IV; (b) restriction digestion with HindIII of the 
isolated fosmid bearing the complete cluster; white arrow indicates undigested fosmid; black 
arrow denotes unaligned band 
 
Clones obtained from this procedure were screened by PCR (3.4.1) for the presence 
of the resistance cassettes (corresponding primers see above) and the front (primers 
1280seq_neu & 668seq-1280), middle (primers gap1) and final part of the cluster 
(primers TE-end). The reactions confirmed incorporation of all parts. The generated 
construct was readily isolated from liquid culture. A further analysis was carried out 
by a diagnostic restriction digestion with HindIII (3.4.7). The obtained restriction 
pattern agreed with the predictions made with the CloneManager 9 and NEBCutter2 
software with the exception of one additional band at 10 kb, which could not be 
assigned to any restriction fragment. As there were also traces of undigested fosmid 
detectable, this band was attributed to a product of incomplete digestion. 
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Figure 4-27: Reconstitution of the putative siphonazole cluster 
Λ-Red based cloning of resistance markers and cluster fragments into fosmid clones; 
fragments from EC10 and IC2 were inserted into EC9 to complement the cluster; cluster genes 
are depicted in orange, resistance genes in red and gene fragments in yellow 
Results  99 
 
4.9 Protein expression and purification 
Several proteins from the putative siphonazole cluster were expressed 
heterologously (3.6.1) and purified from E. coli cells (3.6.3) for ensuing enzymatic 
assays. If not stated otherwise, the corresponding coding sequences were amplified 
by PCR with specific primers (8.3). The primers were extended by suitable restriction 
sites that enabled insertion of the DNA fragment into the pET28a(+) vector, which 
links the proteins to a N-terminal 6x his-tag upon expression. Cloning and 
transformation reactions were performed according to the described methods (3.5.2 
and 3.3.3). After screening and verification of the insert (3.4.11), the recombinant 
plasmids were transformed into the E. coli strain BL21 for expression of the proteins. 
Purification was performed by affinity chromatography on Ni-NTA columns according 
to the described protocol (3.6.3) in five elution steps with increasing concentrations of 
imidazole. 
 
4.9.1 Heterologous expression of the O-methyltransferase SphB 
The O-methyltransferase encoded by sphB was amplified (primer pair OMt) and 
cloned into the pET28a(+)-vector using BamHI and HindIII restriction sites. The 
recombinant protein was successfully expressed with an N-terminal his-tag and 
purified from BL21 E. coli cells. The analysis by denaturing SDS-PAGE 
demonstrated very high expression levels of a protein with a molecular weight around 
25 kDa. The eluted protein thus seems to be smaller than the calculated mass of 
28.95 kDa for the recombinant protein SphB, but it is possible that the 
chromatography is distorted by the large amount of protein. Through affinity 
chromatography an estimated purity of 95-99% was achieved in the final elution 
steps. Elution fractions 3 – 5 were pooled and used for subsequent assays. Though 
the protein was always present in the soluble protein fraction of the cell lysate, it 
precipitated rapidly when exposed to low temperatures or during concentration 
procedures. Therefore, purification had to be carried out at room temperature and 
assays performed directly afterwards to avoid loss of activity. According to the protein 
concentrations determined by photometric measurement (3.6.7), an average total of 
3 mg protein was purified from elution fractions 3 – 5 of a 100 ml culture. 
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Figure 4-28: purification of SphB by affinity-chromatography on Ni-NTA column 
Protein gel shows fraction from the purification; Ft, flow through; W1, wash1 (20 mM 
imidazole); W2, wash2 (40 mM imidazole); E1 – E5, elution fractions with 100 to 300 mM 
imidazole; M, size marker  
 
4.9.1.1 In vitro methylation of protocatechuic acid by SphB 
The O-methyltransferase SphB was hypothesized to catalyse the transfer of a methyl 
group to the 4-OH group of the hydroxybenzoic acid precursor of the starter unit. 
Feeding experiments identified S-adenosylmethionine (SAM) as donor of the methyl 
group (1.5). To support this hypothesis, the activity of the protein was investigated in 
an in vitro methylation assay (3.6.8). In consideration of the structure of siphonazole 
3,4-dihydroxybenzoic acid (protocatechuic acid) was chosen as substrate in this 
assay, which is a major metabolite in the degradation of aromatic compounds 
(Buchan et al., 2004). Methylation of the 4-OH group as in siphonazole would yield 
isovanillic acid as product.  
 
Subsequent to incubation of the enzyme with substrate and SAM, the samples were 
separated by HPLC on a C18 column (3.6.8.1). Thus, two peaks at 8.29 min and 
11.41 min were identified, which exhibit the characteristic absorption spectrum of 
protocatechuic acid with maxima at wavelengths of 216 nm, 257 nm and 293 nm 
(Zazza & Sanna, 2010). The corresponding spectra are given in the appendix (8.5). 
By comparison with the spectra and retention times of protocatechuic and isovanillic 
acid as reference substances the peak at eight minutes could be assigned to the 
substrate and the peak at eleven minutes to the product (figure 4-29). This is in 
accordance with the finding that the product peak does not appear in a control 
reaction without SAM. This control also lacked a peak at three minutes, which was 
therefore attributed to SAM.  
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Figure 4-29: UV absorption spectra from HPLC 
(a) Methylation assay reaction; SAM at 2.96 min; educt at 8.29 min; product at 11.41 min;        
(b) control reaction without SAM; (c) protocatechuic acid standard; (d) isovanillic acid standard 
 
4.9.2 Heterologous expression of the first A domain of SphC 
The A domain of the initation module (SphC-A1) is located at the N-terminus of 
SphC. The forward primers for amplification of the insert were positioned either at the 
natural start codon of the ORF (primer A-dom_orfstart) or in proximity to the 
sequence encoding the domain. As the ORF continues downstream, a stop codon 
was always included in the reverse primers. The boundaries of the A domain 
sequence were determined according to the predictions with CLUSEAN and the 
NRPSPredictor, as well as comparative sequence analysis with BLASTp. Integration 
into the pET28a(+) vector was accomplished by utilisation of BamHI and HindIII 
restriction sites (3.5.2). A comprehensive list of the tested primer pairs is given in the 
appendix (8.3.2). 
 
In the first expression experiments no recombinant protein could be detected after 
purification in the analysis by SDS-PAGE (3.6.4). Variation of IPTG concentration 
and growth temperature stayed fruitless. By moving the primer sites different 
constructs were created (primer pairs A-fwd-BamHI & A-rev-HindIII and A_domain 
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  (a)    2.96 min          8.29 min   (b)        8.35 min 
  (c)            8.45 min   (d)         11.44 min 
11.41 min 
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fwd & rev). One primer pair was located directly at the boundaries of the domain 
(primer pair DHB_A-Dom), while a longer fragment spanned the A domain and the 
downstream carrier protein (A-PCP-rev). As none of these constructs produced any 
detectable amount of the target protein, the expression performed in the cold-
adapted ArcticExpress (DE3) cells, but without success.  
 
Consequently, the expression was carried out with the Champion™ pET expression 
system by Invitrogen, using the pET151 vector and the BL21 star™ expression cells. 
The primer pair sphC-A, employed for generation of the insert, used the same primer 
sites as before (A-dom_orfstart and DHB_A-dom_rev, respectively). An overnight 
expression of a 300 ml culture at 16°C yielded a protein with a size just below 60 
kDa, which corresponds to the expected size of 58.16 kDA for the recombinant A 
domain. Most of the protein was located in the insoluble fraction of the pellet, but 
smaller amounts eluted in the fractions 2 – 4 (figure 4-30). Fraction 2 contained a 
large amount of impurities and was therefore not used in further assays. An 
estimated purity of 85 – 90% was achieved in fraction three and more than 95% 
purity in the fourth elution step. These fractions were pooled and used for further 
processing. 
 
 
 
Figure 4-30: Purification of SphC-A1 by affinity-chromatography on Ni-NTA column 
Protein gel shows fraction from the purification; Ft, flow through; W1, wash1 (20 mM 
imidazole); W2, wash2 (40 mM imidazole); E1 – E5, elution fractions with 100 to 300 mM 
imidazole; M, marker 
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4.9.2.1 ATP – PPi exchange assay 
The substrate specificity could not be predicted by analysis of the Stachelhaus-code. 
Therefore, the activation of various substrates by the A domain was investigated by 
an ATP-PPi exchange assay (Phelan et al., 2009). The measurement of the 
conversion of γ-18O4-labelled ATP to 
16O4-ATP allows conclusions about the 
substrate acceptance of the investigated A domain (3.6.10). 
 
Purified SphC-A1 was incubated with protocatechuic acid, isovanillic acid, glycine, 
tyrosine, phenylalanine and aspartate as substrates. The exchange rate of 18O4-ATP 
to 
16O4-ATP was quantified by MALDI-TOF-MS. However, the chromatograms did not 
show any detectable formation of unlabelled ATP above background level for any of 
the assayed substrates. The chromatograms are given in the appendix (8.6). 
 
4.9.3 Heterologous expression of the DAHP synthase SphI 
The expression of the recombinant protein SphI was accomplished in an analogous 
way to the expression of the A domain (4.9.2). The primers sphI-fwd and sphI-rev 
were designed to contain start and stop codon of the gene and used for the 
amplification of the DNA fragment. The insert was cloned into the pET151 vector and 
the protein expressed in BL21 star™ cells. For cultivation and purification the same 
conditions as for the A domain were applied. The purification yielded a protein 
between 40 and 50 kDa, which mainly resided in the insoluble fraction (figure 4-31). 
The protein size is in agreement with the calculated weight for SphI of 41.27 kDa. 
Smaller amounts eluted in fractions 2 – 4. Fraction two still contained several 
impurities, of which a protein of ~60 kDa was the most prominent. This protein was 
also present in smaller amounts in fraction three, while the target protein could be 
obtained with great purity in the fourth elution step. 
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Figure 4-31: Purification of SphI by affinity-chromatography on Ni-NTA column 
Protein gel shows fraction from the purification; FT, flow through; W1, wash1 (20 mM 
imidazole); W2, wash2 (40 mM imidazole); E1 – E5, elution fractions with 100 to 300 mM 
imidazole; M, marker; P, pellet (insoluble fraction) 
 
4.10  Expression profile of siphonazole in Herpetosiphon sp. 060 
To the date of the present study, there are no investigations on the time point of 
siphonazole biosynthesis and the localisation of the compound within a 
Herpetosiphon colony. Therefore, two different series of experiments were conducted 
to elucidate the temporal expression profile of the gene cluster and the spatial 
distribution of siphonazole within a solid culture of Herpetosiphon sp. 060. 
 
4.10.1 mRNA expression of sph genes 
The presence of mRNA indicates the expression of the investigated gene at the time 
of investigation. In prokaryotes genes are commonly transcribed into polycistronic 
mRNA carrying the information of several ORFs, which are regulated together in one 
operon (Zhou & Yang, 2006). PCR-probing of the intergenic regions allows 
conclusions on the expression pattern of the gene cluster.  
 
Total RNA was isolated (3.4.14) from Herpetosiphon cultures after 1, 2, 3, 4 and 7 
days and tested for contamination with genomic DNA by a PCR reaction (3.4.1) using 
primers that bind within the coding region of sphE. RNA isolates that yielded no PCR 
product were considered pure. Employing oligo dT-primers, a reverse transcription 
reaction was performed on these isolates to synthesize cDNA of messenger RNAs. 
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Specific primer pairs (A – J) were derived from the sequence of the putative 
siphonazole gene cluster to probe the intergenic regions between the sph genes. The 
pairs always covered the end of an open reading frame and the start of the following 
gene. An additional primer pair was designed for the upstream region (approx. 200 
bp) of sphA. All primers were tested on fosmid DNA containing the whole gene 
cluster, before performing PCR reactions on the cDNA (figure 4-32). 
 
 
 
 
                      
Figure 4-32: Test PCRs for RNA expression analysis 
(a) Schematic representation of PCR probes; (b) PCR from isolated mRNA from days 1, 2, 3, 4 
and 7 with primer pair gap1; M, marker; +, positive control from fosmid DNA; (c), PCRs from 
fosmid DNA with primer pairs A – J 
 
PCR with standardised amounts of cDNA as template yielded products only for the 
first three days of cultivation (figure 4-33). Evaluation of the agarose gels (3.4.2) 
indicated that the expression is strongest on the second day and already very weak 
on the third day. PCR products were detected for all probes with the exception of the 
intergenic region between sphB and sphC. This finding suggests that the two distinct 
genes sphA and sphB are not part of the same operon as the reading frames that 
contain the actual PKS and NRPS modules. Furthermore, the upstream region of 
sphA also yielded a product for all three days, indicating that sphA and sphB are not 
transcribed as bicistronic mRNA, but may be part of a larger operon. Finding that no 
expression could be detected on days four and seven suggests that siphonazole is 
produced exclusively in an early phase of the culture. 
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Figure 4-33: RT-PCR from RNA samples 
(a) RT-PCR from days 1 and 2; lanes 1 – 10 correspond to primer pairs A – J; (b) day 3; (c) days 
4 and 7; M, size marker 
 
4.10.2 Imaging mass spectrometry (IMS) 
A Herpetosiphon culture was grown on a MALDI plate and subjected to IMS (3.2.6). 
Thereby, a mass corresponding to siphonazole was detected (m/z 464), which 
localises around the growing edge of the culture, but not in the centre of the colony. 
A detected mass with m/z = 486 shows the same distribution and was therefore 
considered to be the sodium adduct of the first compound (figure 4-34). 
 
IMS detected an abundance of other masses, which originate from the colony. A 
considerable number of them are localised at the edge of the culture. Furthermore, 
the evaluation of the images revealed two masses (m/z = 318 and m/z = 342), which 
did not show even distribution, but were only present at the left and upper edge of the 
culture. While several products were detected, which exhibit a wider distribution over 
the colony, one compound (m/z = 861) seems to be tightly restricted to the centre of 
the culture.  
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Figure 4-34: False-colour images from IMS 
Empty MALDI-plate is depicted in the upper left corner; colours were assigned manually to 
visualise the spatial distribution of one specific mass; m/z ratios are given in the 
corresponding pictures; +Na denominates the putative sodium adduct of siphonazole 
 
4.11 Heterologous expression of the complete gene cluster in E. coli 
The reconstitution of the complete putative siphonazole cluster on one fosmid 
construct (4.8.3) provided the base for the expression of the cluster in a heterologous 
host. BAP1 E. coli cells were used as expression system in a first trial. These cells 
contain the promiscuous phosphopantetheinyl transferase Sfp from B. subtilis, which 
is known to prime also heterologous ACPs and PCPs with their cofactor (Quadri et 
al., 1998). As the fosmid backbone is designed for maintenance in E. coli, no further 
modifications were conducted for the expression in the host cells.  
 
Fosmid pCC1FOS-siphonazole with the completed gene cluster was isolated from an 
E. coli culture by standard methods (3.4.4) and electroporated into freshly prepared 
electro-competent BAP1 cells as described before (3.3.2 and 3.3.4) using 3 – 15 µl 
isolated fosmid. Generated clones were tested by PCR (3.4.1) for the presence of the 
gene cluster and a positive clone was picked for the inoculation of 30 ml LB pre-
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culture (3.2.3). To ensure that the fosmid was maintained in the cells, PCR tests 
were repeated with the pre-culture. The expression culture was prepared analogous 
to the cultivation of Herpetosiphon sp. 060 for subsequent siphonazole extraction 
(3.2.4). 1.5L LB medium containing 2% (w/v) Amberlite XAD16 adsorber resin were 
inoculated with 15 ml pre-culture and incubated on a horizontal shaker at 30°C three 
days. The resin was extracted according to the described protocol (3.2.4), which 
yielded 178.9 mg crude extract. Unlike the Herpetosiphon pellet the E. coli cells were 
not retained in the frit. As it was possible that siphonazole was produced, but not 
excreted, the cells were harvested by centrifugation and the pellet extracted 
separately, yielding another 193.8 mg crude extract. Samples of the extracts were 
subjected to LC-MS analysis (3.6.9) and the spectra screened for the mass of 
siphonazole. However, a mass corresponding to the compound could not be 
detected in either of the extracts. 
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5 Discussion 
5.1 Genetic accessibility of Herpetosiphon sp. 060 
The increasing availability of genome sequences and the development of sequence 
analysis and prediction tools for NRPS and PKS systems have greatly facilitated the 
elucidation of new biosynthetic clusters. Nevertheless, these in silico studies are no 
replacement for an experimental proof of concept. Still, assembly lines like the 
siphonazole cluster rise new questions on biosynthesis that cannot be answered by 
mere sequence analysis. For a certain alignment of a gene cluster to its 
corresponding product the genetic knock-out of biosynthetic genes remains an 
indispensable tool. Equally, detailed studies of specific enzyme functions benefit from 
the possibility to erase and reconstitute their function by genetic in vivo manipulation, 
which is also a crucial requisite for combinatorial biosynthesis (Galm et al., 2011).  
 
The mentioned experiments all require the introduction of foreign DNA, e.g. plasmid 
derivatives or linear DNA, into the cell and either the individual maintenance in the 
host or the integration into the genome. As only few bacteria are naturally competent 
to take up external DNA, different methods of inducing this competence have been 
developed over the past decades (Yoshida & Sato, 2009). The physiological 
characteristics of different bacterial classes and genera have resulted in a great 
number of protocols, which are available for the transformation of mainly E. coli, 
Bacillus, Pseudomonas or myxobacterial cells. As to the date of this study no 
protocols are described for the transformation of Herpetosiphon or related 
Chloroflexi, it was necessary to test different methods and conditions to establish a 
suitable protocol for the introduction of plasmid DNA into Herpetosiphon sp. 060. 
 
Extensive experiments with vegetative Herpetosiphon cells (4.1) did, however, not 
result in any successful transformation neither by electroporation, conjugation, 
sonication nor chemical treatment. There are several possibilities at which point 
these transformations were unsuccessful. First, the applied methods failed to deliver 
the plasmid DNA into the cells. It is likely that features like the unusual cell wall 
composition, the presence of a sheath-like structure or the filamentous growth 
contribute to an impaired DNA uptake. The usage of liquid cultures of different age 
showed that the cell filaments tend to form large clots in fully grown cultures, which 
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can only be partly separated by pipetting or treatment in a homogeniser. These clots 
greatly interfere with the electroporation process and lead to arcing at high voltage. 
Therefore, only cultures that have been grown for one day at maximum seem to be 
suitable for electrophysical transformations. Additionally, it seems reasonable to 
assume that cells which are intertwined in a tight knot are less accessible for external 
DNA in general. The problem of the cell wall was addressed by various methods. As 
the cell wall structure resembles that of Gram-positive bacteria, protocols for 
actinomycetes were employed for transformation. The cell wall-weakening agent 
glycine was shown to prevent the formation of long filaments and thus also reduced 
clotting, which makes glycine treatment prior to transformation recommendable 
(4.1.2). It was also shown that protoplasts of Herpetosiphon cells can readily be 
produced by standard methods (4.1.3). Still, a method for a clean separation from 
remaining vegetative cells has to be found. Observation of lysozyme treated cultures 
showed that the rod-shaped cells within the filaments lose their shape, revealing a 
translucent sheath-like structure in the intercellular spaces. This finding supports the 
presence of such a structure, which would represent an additional barrier for the 
introduction of DNA. The effect of the glycine on the filaments, however, indicates 
that this structure should rather be associated with the cell wall. Therefore, the 
existence of a sheath remains unclear. 
 
A second possibility for the unsuccessful transformation is that the plasmids were not 
integrated into the genome after uptake into the cell. As the constructs are all based 
on plasmids designed for the reproduction in E. coli cells, they are probably not 
maintained within Herpetosiphon. The integration into the genome by a crossing over 
event is a statistical process, thus it is possible that this event did not occur due to 
low transformation efficiency. Further experiments on the transformation of 
Herpetosiphon should therefore include the development of either an integrative 
plasmid or an E. coli - Herpetosiphon shuttle-vector. Suitable promoters and origins 
of replication may be obtained from the genome and natural plasmids of H. 
aurantiacus. 
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5.2 Elucidation of the putative siphonazole biosynthetic pathway 
The complete sequence of the putative siphonazole cluster was resolved by 
sequence alignments of subclones from a fosmid library with draft genomic data 
(4.2). Thus, six contigs were identified carrying the putative genes for the 
biosynthesis of siphonazole. A subsequent PCR-based approach allowed alignment 
of the contigs and completion of the cluster sequence (4.3.1). 
 
The putative siphonazole gene cluster comprises ten open reading frames (sphA – 
sphJ), which cover approx. 50 kB and encode a hybrid PKS/NRPS assembly line. 
Using BLASTp and the NRPSPredictor software together with detailed studies of 
conserved signature motifs, the domain structure of the biosynthetic enzymes was 
elucidated (4.7). They comprise 12 modules, four of which are of modular NRPS type 
and eight are trans-AT type PKS modules. 
 
5.2.1 NRPS modules 
The NRPS part of the putative siphonazole gene cluster is represented by four 
modules, which are all separated from each other by one to three PKS modules  
(figure 5-1). The NRPS portion comprises the initiation module, the two cyclisation 
units, and the glycine incorporating module encoded by sphC, sphE and sphF, 
respectively. All of them are hybrid genes, which encode NRPS and PKS modules 
side by side in the same ORF. 
 
5.2.1.1 The cyclisation modules 
In the two cyclisation modules the C domain is replaced by tandem Cyc domains. A 
peculiarity of these modules is that they do not only contain two consecutive Cyc 
domains, but also a double arrangement of PCP and Ox domains (4.4.4). Only the 
threonine specific A domains are not duplicated. Commonly, a single Cyc domain is 
responsible for both the peptide bond formation and the cyclisation (Roy et al, 1999), 
but the unusual arrangement of tandem Cyc domains has its precedence in the 
biosynthesis of vibriobactin and leinamycin. Marshall and co-workers (Marshall et al., 
2002) examined the two domains by site-directed mutagenesis on the catalytic D-x-x-
x-x-D-x-x-S core motif and thus found out that the first domain was responsible for 
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the heterocyclisation, while the second catalysed the peptide bond formation. A 
similar mechanism was proposed for the Cyc tandem in the leinamycin cluster 
(Cheng et al., 2002). This provides a rationale for the assumption that 
heterocyclisation in siphonazole biosynthesis works in a comparable way. Sequence 
analyses of the Cyc domains revealed an intact catalytic core in all four of them. 
Deviations only occurred in the other signature motifs (4.4.4.1).  
 
Ox domains are in most cases associated with Cyc domains and are typically found 
at two characteristic positions (Du et al., 2000; Schwarzer & Marahiel, 2003). The 
domain can be either inserted into the A domain of the module like in the case of 
epothilone biosynthesis (Molnar et al., 2000) or positioned downstream of the PCP. 
The latter case was reported for leinamycin, whereas in the myxothiazole cluster both 
options are realised (Silakowski et al., 1999). The C-terminal placement of the Ox 
domains in the siphonazole cluster hence follows this second arrangement. The 
occurrence of tandem Ox domains, however, has not been reported before. The Ox 
domains are known to require a FMN cofactor, but only little biochemical data is 
available. Analysis of the signature motifs (4.4.4.2) revealed that the second Ox 
domain of both cyclisation modules significantly lacks homology to the K-Y-x-Y-x-S-x-
G-x-x-Y-(PG)-V-Q motif. According to the conserved domain database (Marchler-
Bauer et al., 2011) the second conserved tyrosine is constituent of a NADPH-binding 
site (Kobori et al., 2001). This moiety is not conserved in SphC-Ox2 and SphE-Ox2, 
giving rise to the assumption that these domains may be non-functional due to 
impaired cofactor binding. This hypothesis would have to be proved by knock-out 
experiments. Otherwise, it is possible that these additional domains are either 
redundant or perform hitherto unknown tasks during the siphonazole biosynthesis.  
 
5.2.1.2 The initiation module 
The initiation module contains an A domain whose substrate specificity could not be 
clarified by bioinformatic methods (4.4.1). A further peculiarity is the presence of two 
ACPs instead of a PCP. Although there are differences between the two types of 
carrier proteins, which will be discussed later (5.2.3.3), it is imaginable that the 
domains in this module were confused by the prediction software. The two ACPs 
were only marginally discriminated from PCPs by CLUSEAN in a hidden Markov 
model (4.7.1). Thus, these domains could as well be annotated as PCP domains. 
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5.2.1.3 The glycine incorporating module 
The fourth NRPS module contains an A domain with a predicted specificity for 
glycine (4.4.1). It is the only NRPS module of the putative siphonazole gene cluster 
that follows the canonical C-A-T domain arrangement. The thiolation domain is, 
however, annotated as ACP by CLUSEAN. Different from the initiation module, the 
hidden Markov model clearly distinguishes the ACP with a score of 41.2 (E-value 8.2 
x 10-12) from a PCP with a score of 30.5 (E-value 1.5 x 10-8).  
 
5.2.2 NRPS-PKS interfaces 
Notably, both of the ACP-containing NRPS modules are located at an interface, 
where the NRPS module is followed by a PKS module, which possesses in each 
case the same domain architecture KS-DH-KR-ACP. Comparable idiosyncrasies can 
be observed at the other changeovers from NRPS to PKS and vice versa (figure 5-1). 
The first cyclisation module (module 4) is preceded by a PKS module, whose 
thiolation domain is annotated as PCP instead of ACP (5.2.3.3) and followed by a 
putatively non-elongating PKS module (5.2.3.2). The other two KS0 containing 
modules number 7 and 9 flank the second cyclisation module (module 8), while 
module 9 also precedes the fourth NRPS module (module 10). Additionally, the three 
non-elongating modules are all located at the termini of the respective enzymes with 
module 5 actually being split between SphC and SphD. Regarding this position, it is 
possible that these modules have their function in providing the docking domains for 
correct protein-protein recognition of the hybrid subunits (Koglin & Walsh, 2009) than 
in performing catalytic steps. These small docking elements at the protein termini are 
known to play an important role in mediating the specific protein interaction (Richter 
et al. 2008). 
 
Remarkable as these findings are, from the bioinformatic data alone it cannot be told 
if the arrangement of unusual modules actually contributes to the PKS-NRPS 
interface and facilitate the switching from one assembly system to the other. It is as 
well possible that this architecture is just a concurrent result of the mosaic-like 
structure of the gene cluster (5.2.4). Further insights may be attained by an analysis 
of docking and communication-mediating domains of the modules in question. 
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Figure 5-1: PKS-NRPS interfaces 
Modules are marked by solid bars and corresponding numbers above; NRPS modules are 
shaded red; PKS modules are shaded yellow; black arrows indicate idiosyncrasies of carrier 
proteins; non-elongating KS
0
 domains are marked by green arrows; A, adenylation; ACP, acyl 
carrier protein; C, condensation; Cyc, cyclisation; DH, dehydratase; KR, ketoreductase; Ox, 
oxidation; PCP, peptidyl carrier protein; ACP0 is non-functional 
 
5.2.3 trans-AT PKS modules 
The PKS part comprises eight modules of the trans-AT type distributed on sphC to 
sphH, which are presumably all loaded by the acyltransferase SphA. The AT shows 
all signature motifs that indicate malonyl-CoA specificity, which is in agreement with 
the siphonazole structure, as previous feeding studies showed that the polyketide 
chains were all assembled from acetate units (Nett et al., 2006).  
 
5.2.3.1 The oxidoreductase of SphA 
The AT SphA is fused to an oxidoreductase (OR), which is supposed to act as an ER 
domain (Bumpus et al., 2008). The siphonazole structure, however, indicates no 
need for the activity of an ER, as complete reduction of the polyketide chain does not 
occur in the molecule. Trans-AT clusters are known to sometimes encode domains 
which are apparently superfluous and whose function cannot be explained by the 
product structure (Piel, 2010). This may as well be the case for the OR, as it was 
already a hypothesis for the before mentioned Ox domains (5.2.1.1).  
 
ERs usually reduce double bonds, formed by the consecutive action of a KR and a 
DH. Hence, there are theoretically two possible occasions for the OR to act as an 
ER, i.e. on the double bonds, generated by the KR and DH domains in modules 2 
and 11. Yet both double bonds remain in the structure of siphonazole. Consequently, 
the question arises why complete reduction of the polyketide chain in these positions 
does not take place, since the fused AT-ER supposedly has the capability to interact 
with each PKS module. Indeed, the latter ability is a prerequisite for the loading of the 
ACPs by the AT. Therefore, it seems reasonable to question the catalytic activity of 
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the OR. Analysis of the primary structure revealed that the histidine moiety, which is 
putatively essential for the catalytic activity (Ha et al., 2006), is replaced by a tyrosine 
residue in SphA. A multiple sequence alignment with other AT-OR proteins showed 
similar deviations in the corresponding proteins of the chivosazole (Perlova et al., 
2006) and disorazole (Carvalho et al., 2005) biosynthesis. In both cases, the function 
of the OR could not be deduced and is still unknown. In contrast, the catalytic 
histidine is present in the OR domains of the respective AT-ORs encoded in the gene 
clusters for dihydrobacillaene (Bumpus et al., 2008), mupirocin (Gurney & Thomas, 
2011) and corallopyronin A (Erol et al., 2010), for all of which a role as 
enoylreductase was proposed in agreement with the molecule structures (figure 5-2).  
 
             
Figure 5-2: Natural products produced by pathways with putative OR domain fused to a trans-
type AT; chivosazole a R1 = Me, R2 = glycoside side chain; mupirocin R = H in the main product 
(92%) of P. fluorescens 
 
This precedence corroborates the role of the putative catalytic histidine (Ha et al., 
2006) and allows the hypothesis that the OR domain of SphA is indeed inactive and 
has no function in the biosynthesis of siphonazole. Until this assumption is either 
verified or rejected by experimental data, the possibility cannot be excluded that the 
domain performs hitherto unidentified steps or has retained its catalytic capabilities, 
chivosazole A 
disorazole A1 
corallopyronin A 
mupirocin 
dihydrobacillaene 
116  Discussion 
 
but is not needed for the assembly of siphonazole, as it was similarly hypothesised 
for the Ox domains (5.2.1.1). 
 
5.2.3.2 Elongating and non-elongating modules 
Modules 5, 7 and 9 all contain KSs, in which an essential histidine moiety of the 
catalytic triad is replaced by another residue (4.5.2). These KS0 termed domains are 
a common feature of trans-AT PKS clusters and are supposed to merely pass on the 
growing intermediate to the next module instead of performing an elongation step (El-
Sayed et al., 2003). As mentioned before, these three modules are all adjacent to 
NRPS-modules and might therefore be involved in the changeover from PKS to 
NRPS and vice versa. The presence of only one elongating PKS module between 
the two NRPS cyclisation modules explains the unusual two-carbon bridge between 
the oxazole moieties. Modules 6 and 12 both contain two ACP domains. In the first 
module they are arranged as a tandem, of which the first domain is non-functional 
due to the lack of the critical serine-moiety. In module 12 another inactive ACP is 
placed in an unusual position between the KS and an inactive DH. It can be 
speculated whether the reductive domains were added later to an already existing 
module by horizontal gene transfer. Only modules 2 and 11 show a canonical domain 
arrangement. Three of the PKS modules are distributed on different proteins. Module 
5 is split between SphC and SphD after the KS0. The KS and DH of module 11 are 
part of SphF, while the rest belongs to SphG, and module 12 spreads over SphG and 
SphH (figure 4-22).  
 
5.2.3.3 The cryptic module 3 
Especially intriguing is the presence of module 3, which consists of a KS and a PCP 
instead of an ACP. With regard to the siphonazole structure, this module is 
apparently not needed for the biosynthesis of the compound. Although the KS 
domain contains an intact catalytic core and all signature motifs (4.5.2), it seems to 
perform no elongation step. It was already hypothesised that the PCP in this module 
may be involved in the mediation of a PKS-NRPS interface. This, however, does not 
explain the obvious lack of catalytic activity in this module. Carrier domains are small 
flexible peptides that share similar tertiary structure and are usually classified as PCP 
or ACP according to their accepted substrate. Despite of their shared structure, there 
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are also distinguishing features. ACPs are generally acidic proteins with a negatively 
charged surface, whereas PCPs have a more neutral pI value and a non-polar 
surface (Finking & Marahiel, 2004). The latter ones also cluster according to their 
substrates and protein partners (von Döhren et al., 1999). Analysis of the protein 
properties of the PCP in module 3, however, yielded a pI and content of charged 
amino acids that are very similar to those of the ACPs from the remaining PKS 
modules. It is nevertheless possible that the carrier domain of module 3 is not 
recognised by the AT and thus not loaded with an extension unit. Another possibility 
is that the interaction between the KS and the carrier protein is impaired.  
 
The topic of protein-protein recognition has already been addressed by the Walsh 
group. By in vitro assays it was demonstrated that the iteratively acting cysteine-
specific A domain of HMWP2 in yersiniabactin biosynthesis aminoacylates all PCPs, 
but not an ACP containing fragment (Suo et al., 2001). The same discriminative 
loading of carrier proteins could also hold true for the AT SphA. They also showed 
that “hot spots” in the primary sequence of carrier proteins determine the interaction 
with catalytic partners (Lai et al., 2006). Thus, it is equally possible that the PCP is 
not recognised by the upstream KS. In both scenarios the intermediate could be 
passed on to the next module without an elongation taking place. 
 
5.2.4 The mosaic structure of the siphonazole gene cluster 
It was suggested that trans-AT PKS clusters mainly develop by extensive horizontal 
gene transfer (Piel, 2010). These events are often reflected by mosaic-like cluster 
architecture and can be traced back by looking at phyletic clustering, codon usage or 
GC-content of the gene in question (Lopez, 2003). The latter criterion applies for the 
two cyclisation module of the siphonazole cluster (4.4.4). Each of them comprises 
about 5 kb, whose GC-content exceeds 65% in contrast to a ratio of around 50% for 
the rest of the cluster. Furthermore, the two modules share an almost identical DNA 
sequence, which adds to the conclusion that they may have their origin in horizontal 
gene transfer. It is likely that the cyclisation modules are a younger part of the 
cluster, as the GC-content has not yet been adapted by amelioration (Lawrence & 
Ochmann, 1997). These hints may indicate that the NRPS parts were inserted into 
an already existing PKS cluster without loss of function. This event could also explain 
118  Discussion 
 
some of the carrier protein aberrations and give an answer to the question where the 
unusual C2-bridge between the oxazole rings originates from. 
 
It was already noted that the modules encoded by siphonazole biosynthetic gene 
cluster also comprise non-canonical domain arrangements and KS0 domains, which 
are distributed around the NRPS parts. These idiosyncrasies are typical for trans-AT 
type PKSs and also hint to recombination events by horizontal gene transfer. This 
kind of genetic rearrangement and the inherent structure of trans-AT type PKSs are 
supposed to favour the generation of new functional clusters, whereas cis-AT PKSs 
generated this way are more likely to be inactive and get lost over time (Nguyen et 
al., 2008).  
 
5.3 Postulated biosynthesis of siphonazole 
With regard to the elucidated domain structure of the PKS/NRPS system, the 
following way of siphonazole biosynthesis is proposed (figure 4-22). A 3,4-
dihydroxybenzoic acid starter unit or its 4-methoxylated derivative is recruited by the 
A domain of the initiation module and transferred to either of the thiolation domains of 
the first module. Addition of the methyl group is catalysed by the O-methyltransferase 
SphB. Following the colinearity rule, the consecutive PKS module elongates the 
starter by an acetate moiety followed by reduction and dehydration through the 
corresponding KR and DH domains. As mentioned before, the third module is 
supposed to merely pass on the intermediate without an elongation step for some 
unknown reason. The Cyc tandem domains of the fourth module catalyse the 
condensation with a threonine unit and its consecutive cyclisation. The formed 
oxazoline ring is converted into an oxazole moiety by either the concerted action of 
the Ox domain tandem or only one active domain. Of the following three PKS units 
only module 6 performs an elongation with another acetate moiety. The other two 
modules contain KS0 domains, which do not exert catalytic functions, but may again 
simply pass on the intermediate. This is followed by the addition of the second 
threonine derived oxazole ring by the second cyclisation module, which is virtually 
identical to the first. After another non-elongating PKS unit, NRPS module 11 
elongates the intermediate by a glycine moiety. PKS module 12 is congruent with 
module 2 and adds, reduces and dehydrates a further acetate unit. The last module 
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condenses the chain with the final acetate unit. As the DH domain of the module is 
probably inactive, the keto group is only reduced to a hydroxyl before the chain is 
decarboxylated and dehydrated and the product released by the TE yielding 
siphonazole. 
 
This reaction scheme follows almost precisely the predicted pathway proposed by 
Nett and co-workers (Nett et al., 2006), which was based mainly on the results from 
feeding experiments with labelled precursors. The accuracy of this prediction 
demonstrates the power and utility of such experiments. The bioinformatic data of the 
current study support the previous hypothesis and add valuable information on the 
participating enzymes and additional elements that were not deducible by feeding 
experiments only. 
 
5.3.1 Nature and origin of the starter unit 
Nett and co-workers performed feeding experiment which showed that the styrene 
residue of the starter unit is derived from the shikimate pathway (Nett et al., 2006). 
Branching from the key intermediate chorismic acid (Bentley, 1990), this versatile 
pathway is not only responsible for the production of the aromatic amino acids 
tyrosine, tryptophan and phenylalanine, but also provides the aromatic building 
blocks for a number of secondary metabolites including enterobactin, pyochelin and 
yersiniabactin (van Lanen et al., 2008). Chorismate can be converted to 4-
hydroxybenzoic acid by the elimination of pyruvate through chorismate lyase. In vitro 
experiments with the O-methyltransferase SphB showed that the enzyme readily 
methylates 3,4-dihydroxybenzoic acid (protocatechuic acid). From experiments on 
the biosynthesis of phenazines it is known that the incubation of chorismic acid with 
cell-free extracts from E. coli clones, which are overexpressing phz genes, leads to 
the complete conversion of the substrate to aromatic acids including predominantly 
protocatechuic acid (McDonald et al., 2001). Furthermore, protocatechuic acid is a 
major metabolite in the degradation of aromatic compounds and can be directly 
generated from 4-hydroxybenzoic acid by p-hydroxybenzoate hydroxylase (Buchan 
et al., 2004). This compound is therefore proposed as the substrate for the 
adenylation domain of the initiation module of the siphonazole gene cluster. This 
hypothesis will have to be proved by suitable experiments on the A domain substrate 
specificity like e.g. an ATP-PPi exchange assay (Phelan et al., 2009). 
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5.3.1.1 The O-methyltransferase SphB 
The gene sphB encodes a SAM-dependent O-methyltransferase, whose apparent 
function is the methylation of the 4-hydroxy group of the aromatic starter unit. The 
occurrence of C-, N-, or O-methylations is widespread in the biosynthesis of 
polyketides and non-ribosomal peptides. In NRPS systems MT domains are often 
inserted into the A domain of the corresponding module, as this is e.g. the case in 
pyochelin biosynthesis (Patel et al., 2001). PKSs can also insert α–methyl branches 
through MT domains, which is usually the case in trans-AT type PKS systems, where 
all modules are loaded with the same extender unit (Piel, 2010), but can also be 
observed e.g in epothilone biosynthesis (Molnar et al., 2000). Apart from that, methyl 
groups can also be introduced by trans-acting enzymes. The biosynthetic clusters of 
melithiazole (Weinig et al., 2003) and bryostatin (Sudek et al., 2007) both contain O-
MT domains inside the modules, as well as distinct methyltransferases, which are 
supposed to perform O-methylations.  
 
The in vitro assay (4.9.1.1) demonstrated that SphB accepts protocatechuic acid as a 
substrate for a SAM-dependent methylation. These results support its putative 
function in the biosynthesis of siphonazole. The exact position of the introduced 
methyl group was not determined, but in consideration that no siphonazole derivative 
with a single methylation at the 3-hydroxy group has been found, it is probable that 
SphB acts quite selectively on the 4-OH. It is, however, known that a dimethoxy-
congener of siphonazole is produced in very small quantities by Herpetosiphon sp. 
060 (Nett et al., 2006). As no other methyltransferases have been found in the 
vicinity of the putative siphonazole gene cluster, it seems likely that SphB also acts 
on the 3’-OH at a very small rate. The existence of a 3-methoxy variant of 
siphonazole can therefore not completely be excluded. More studies on the 
enzymatic activity and analysis of the methylation products will be needed to fully 
clarify the specificity of SphB. A comparison with other possible precursors could also 
help in verifying the identity of the starter unit.  
 
It remains unclear, whether the methylation takes place before or after the starter unit 
is tethered to the carrier protein of the initiation module. It would seem plausible to 
first withdraw the starter unit from the shikimate pathway and adjoining metabolism 
and tether it to the multienzyme complex before adding further modifications. This 
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way, the assembly could proceed without interruption after securing the first building 
block. Concomitantly, this would ensure that only those precursors are methylated 
which have already entered the siphonazole pathway and are thus needed for 
biosynthesis. Otherwise, the methyltransferase would have to act on the free 
substrate which would then have to be discriminated and recruited by the first A 
domain from a pool of predominantly unmethylated units. The assay showed that the 
methyltransferase itself readily accepts free substrate. Clarification of the point of 
methylation could arise from comparative experiments with free substrates and 
carrier protein-bound moieties or from determination of the substrate specificity of the 
initial A domain. If the starter unit was methylated prior to recruitment by the A 
domain, the activity of SphB could act as a limiting step for the siphonazole 
biosynthesis. In this case, addition of a further copy of the gene should lead to 
increased siphonazole production rates (see also 5.3.1.2). 
 
5.3.1.2 The DAHP synthase SphI 
DAHP synthase is the first enzyme of the shikimate pathway and ubiquitously 
present in bacteria, fungi and plants, but with no known counterpart in animals. The 
enzyme generates 3-deoxy-D-arabino-2-heptulosonic acid 7-phosphate (DAHP) 
through the aldol-like condensation of erythrose-4-phosphate (E4P) and 
phosphoenolpyruvate (PEP). Several classifications for DAHP synthases exist. Birck 
and Woodard proposed a separation into the metalloenzymes class II and the metal 
independent class I proteins (Birck & Woodard, 2001). In a homology based 
approach Jensen and co-workers distinguished between the plant-like AroAII, which 
is typical for higher plants, and family AroAI. The latter one can be further subdivided 
into subfamilies AroAIα, exemplified by the E. coli DAHP synthases and AroAIβ, 
represented by the B. subtilis DAHP synthase. These subfamilies correspond to 
Birck’s class II and class I, respectively (Jensen et al., 2002).  
 
DAHP synthases are known to be tightly controlled either by transcriptional regulation 
(Walker et al., 1996) or by feedback regulation through products or intermediates of 
the shikimate pathway. Members of the AroAIα are usually inhibited by one of the 
three aromatic amino acids, while AroAIβ enzymes are allosterically affected by 
prephenate or chorismate (Wu & Woodard, 2006). Organisms often contain different 
paralogs of DAHP synthases. E. coli e.g. contains three isoforms of this enzyme, 
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which are each inhibited by one of the aromatic amino acids, thus allowing a 
response to the exogenous availability of these products (Bentley, 1990).  
 
Multiple sequence alignment shows excellent consensus of SphB with the conserved 
motifs of B. subtilis AroA and other members of the AroIβ subfamily, as defined by the 
Jensen group (Subramaniam et al., 1998). The presence of shikimate pathway 
homologues has already been discovered in the biosynthetic gene clusters of  
secondary metabolites like rifamycin, chloramphenicol and balhimycin (He et al., 
2001; Thykaer et al., 2010). Balhimycin contains the non-proteinogenic amino acids 
hydroxytyrosine and 4-hydroxyphenylglycine, which are both derived from the 
shikimate pathway. It was shown that overexpression of the dahp gene at the border 
of the cluster led to a threefold increase of balhimycin production, while a dahp 
deletion mutant produced significantly decreased amounts. These additional copies 
of shikimate pathway genes are hypothesized to ensure precursor supply for the 
secondary metabolite. The same function can therefore be assumed for SphI in the 
siphonazole cluster. As the aromatic starter unit of the siphonazole biosynthesis is 
derived from chorismate, an additional DAHP synthase could attribute to a sufficient 
production of this building block. Additionally, the PEP synthase Orf1 was found 
upstream of the cluster, which possibly supplies the DAHP synthase with one of its 
substrates, thus adding to the precursor formation. These assumptions could be 
clarified in an analogous way to the balhimycin enzymes, i.e. by insertion of an 
additional copy or deletion of orf1 and sphI and subsequent observation of 
siphonazole production rates. 
 
5.3.2 Substrate specificity of the A domain of the initiation module 
The substrate specificity of the first A domain could not be reliably predicted by 
bioinformatic methods. An alignment of the Stachelhaus-code, as derived by the 
NRPSPredictor software, found no counterpart in the database of known specificities. 
This lack of significant homology to known A domains underlines the unique position 
of this domain. The software tool provided two specificity predictions based on the 
assumption that either several or only few substrates share the same properties 
(Rausch et al., 2005). These predictions yielded contradicting results and proposed 
either specificity for polar amino acids like aspartate or glutamine or for hydrophobic 
amino acids like valine or leucine. Prediction scores, though, were very low in both 
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cases. The NRPSPredictor2 provided additional information and suggested an 
affinity for a hydrophilic substrate, based on the separation into three clusters of 
chemically similar substrates. The deduced Stachelhaus-code shows closest 
similarity to a sequence specific for phenylalanine, which, however, clusters with 
hydrophobic aromatic substrates. This would concur with the predictions for a 
hydrophobic amino acid and is supported by the finding that the starter unit 
incorporated in the siphonazole biosynthesis is indeed an aromatic acid. 
 
5.3.2.1 ATP-PPi exchange assay with the initiation module A domain 
The generally contradicting results and weak predictions of the software tools 
demonstrate that the substrate specificity of this domain can only be clarified by 
experimental analysis. Though the A domain of the initiation module was successfully 
expressed, the ATP-PPi exchange assay (Phelan et al., 2009) failed to provide 
experimental data for a specificity, as no activity could be measured with any of the 
tested substrates.  
 
It was shown that many NRPS clusters also encode small (~ 70 amino acids) MbtH-
like proteins, which sometimes influence amino acid activation (Thomas et al., 2010), 
though cases are known, where the knock-out of these proteins did not impair 
metabolite production (Stegmann et al., 2006). An MbtH-like protein was not detected 
within the siphonazole gene cluster or in its vicinity, but their presence is known in 
the fully sequenced genome of the closely related bacterium H. aurantiacus. It is 
therefore possible that the siphonazole producer Herpetosiphon sp. 060 also 
contains MbtH-like proteins that interact with the siphonazole biosynthetic enzymes, 
but are encoded elsewhere. As these proteins are usually encoded within the 
corresponding gene cluster, it seems more likely that the enzyme activity of the A 
domain was lost during purification and concentration procedure. It is therefore 
recommended to test this possibility in further enzyme assays. Furthermore, the gene 
cluster and its adjoining regions should be carefully scanned again to search for 
sequences encoding MbtH-like proteins, which might have escaped attention due to 
their small size. Further experiments could include co-expression with an MbtH-like 
protein from H. aurantiacus to test its influence on the A domain activity. Apart from 
that, the Challis group observed that in clusters where no MbtH-like protein is 
encoded nearby, the ATP-exchange assay often yields better results when the 
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investigated A domain is expressed together with its respective carrier protein (S. 
Bouhired and G. Challis, personal communication). Hence, the construction of a new 
expression construct that includes one or both ACPs (figure 4-22) of the first module 
should be considered. An application of various similar compounds like 3- and 4-
methoxybenzoic acid and 3-hydroxybenzoic acid as substrates would be interesting, 
but the realisation is probably limited by the poor solubility of these substances in 
aqueous solutions. 
 
5.3.3 Decarboxylation of the terminal acetyl moiety 
The siphonazole structure comprises an unusual alkene terminus, which is, 
according to feeding studies, the product of a decarboxylation of the last acetate unit. 
The formation of a similar olefinic terminus in the biosynthesis of curacin A was 
investigated by the Sherman group (Gu et al., 2009). Curacin A is a mixed PKS-
NRPS natural product from the cyanobacterium Lyngbya majuscula with potent 
anticancer properties. The curacin gene cluster comprises an unusual termination 
module with an ACP–sulfotransferase (ST)–TE tridomain. According to the described 
mechanism, the ST domain first sulfonates the β-hydroxyl of the curacin intermediate 
with adenosine 3′-phosphate 5′-phosphosulfate (PAPS) as donor group. This turns 
the hydroxyl into a much more favourable leaving group. The curacin TE represents 
a new subfamiliy of thioesterases, which is specifically adapted for β-sulfated 
substrates. It catalyses not only thioester hydrolysis, but is also responsible for the 
decarboxylation and concomitant sulfate elimination and thus for the formation of the 
terminal olefin (Gehret et al., 2011). This ACP – ST – TE tridomain arrangement and 
the conserved features of the specialised TE were also found in other putative 
biosynthetic gene clusters. A similar mechanism is therefore proposed for other 
metabolites like kalkitoxin, also produced by L. majuscula, or haliangicin from 
Haliangium luteum (LePage et al., 2005; Fudou et al., 2001).  
 
The putative siphonazole gene cluster, however, does not encode an ST in the 
termination module or at any other position. Furthermore, the TE SphJ is not related 
to the TE subfamily determined by the curacin TE and shows none of the specific 
sequence motifs. A decarboxylation mechanism similar to the curacin A biosynthesis 
can therefore probably be excluded. 
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A different mechanism was discovered in the biosynthesis of the immunomodulator 
tautomycetin from Streptomyces sp. CK4412 (Choi et al., 2007). Herein, terminal 
alkene formation is catalysed by the concerted action of the dehydratase TtnF and 
the decarboxylase TtnD (Luo et al., 2010), which both work as tailoring enzymes 
after precursor release by the TE. Gene inactivation studies revealed that TtnF 
eliminates a β-hydroxyl group, which results in the formation of a diene intermediate. 
This dehydration step is apparently critical for the decarboxylation by TtnD, which 
does not occur in the absence of TtnF.  
 
A similar reaction could be proposed for the siphonazole biosynthesis. Analogous to 
the structures of leinamycin and tautomycetin, the predicted full length precursor of 
siphonazole harbours a β-hydroxyl group at its terminus. The siphonazole cluster 
encodes a putative cysteine-hydrolase located in the terminal module. As members 
of this enzyme class catalyse a variety of hydrolytic reactions, the hydrolase in SphH 
could very well act as decarboxylating enzyme. Nevertheless, if the reaction 
proceeds in an analogous way as in tautomycetin biosynthesis, there is still a 
dehydration step required. This could readily be accomplished if the DH domain of 
the terminal module is, against the prediction from the analysis of the catalytic 
residues, active after all. Another possibility is that dehydration and decarboxylation 
are both catalysed by the hydrolase. Enzymes of the α/β – hydrolase superfamily are 
known for their catalytic promiscuity and many members can perform more than one 
chemical reaction (Li et al., 2008). A case of a hydrolase with dehydration activity, 
however, is not reported so far. Putative hydrolases are also known to be present in 
other gene clusters for secondary metabolites like mupirocin (El-Sayed et al., 2003) 
and leinamycin (Tang et al., 2004). In the latter case, the sequence for the putative 
hydrolase is located at the same position, i.e. after the carrier protein of the 
termination module. The only difference in the siphonazole cluster is the presence of 
the DAHP synthase SphI encoded between the hydrolase and the TE SphJ. A 
function for the hydrolases in the other named gene clusters has not been proposed 
so far, neither has the involvement of a decarboxylation reaction been reported. An 
elucidation of the decarboxylation reaction in siphonazole biosynthesis could arise 
from gene inactivation studies with the SphH-hydrolase and the DH domain of the 
terminal module. Analogous to the studies on tautomycetin biosynthesis, deletion of 
the hydrolase gene should result in the production of a siphonazole intermediate with 
126  Discussion 
 
a carboxyl terminus instead of an olefin and possibly a β–hydroxyl if the enzyme 
catalyses both reactions. Similarly, a deactivation of the DH gene should yield a 
hydroxylated derivative, either without or with a carboxyl group if the dehydration is 
also a prerequisite for decarboxylation. Concomitantly, it would be clarified if the DH 
domain exerts catalytic activity at all or if dehydration is catalysed otherwise. 
 
5.3.4 Transcriptional organisation of the gene cluster 
By PCR-probing with RNA transcripts of the putative biosynthetic genes it was shown 
that sphC – sphJ are part of one transcriptional unit and are transcribed as a single 
polycistronic mRNA. The missing PCR fragment between sphB and sphC indicates 
that the first two genes are part of a different operon. It should be noted that the 
transcript apparently starts upstream of sphA. This implies that sphA and sphB are 
either the final part of a longer transcript together with other genes or that they are at 
least under control of a more distant promoter site. The only ORF in the upstream 
region that was hypothesized to be possibly related to siphonazole biosynthesis is 
orf1 encoding a PEP synthase. The assumed involvement in the precursor formation 
of the starter unit would justify a regulation together with the sph gens, yet orf1 is 
oriented in the opposite direction and therefore has to be part of a different 
transcriptional unit than sphA and sphB. Further mRNA studies of the upstream 
region may help to elucidate the boundaries of this first transcript. The discovery of 
only two operons is consistent with the fact that all genes of the putative siphonazole 
cluster are oriented in the same direction. Similar observations were made in the 
gene clusters for the antibiotics novobiocin and clorobiocin (Eustáquio et al., 2005).  
 
5.4 Spatiotemporal biosynthesis of siphonazole 
The gene expression of ORFs sphA – sphJ from the putative siphonazole cluster was 
examined by RT-PCR from the corresponding mRNA transcripts. Thereby it was 
demonstrated that mRNA from these genes was only detected in the first three days 
of cultivation, indicating that siphonazole biosynthesis does only occur in that period. 
The temporal maximum appears to lie on the second day. 
 
The findings from the mRNA analysis are supported by the IMS results (4.10.2). The 
spectrometry images depict a mass which matches that of siphonazole and whose 
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spatial distribution is restricted to the edge of the Herpetosiphon culture. Due to the 
gliding motility of Herpetosiphon, the growing cells swarm from the centre of the 
colony to the rim, where in consequence younger cells are located. Thus, the spatial 
distribution of siphonazole at the growing edge concurs with its biosynthesis in an 
early phase of the culture.  
 
The putative siphonazole cluster is flanked by genes whose predicted functions can 
be assigned to the primary metabolism. It was already mentioned that the first cluster 
genes belong to a longer operon and might hence be co-expressed with primary 
metabolism enzymes, which would explain a siphonazole production from the first 
day on. Likewise, it is possible that siphonazole is produced directly at the transition 
from growth phase to stationary phase, which may be reached early by 
subpopulations. Further studies should include monitoring of cell growth to establish 
a correlation between siphonazole production and growth phase. 
 
5.4.1 Biological role of siphonazole 
The analysis of the spatiotemporal distribution of siphonazole allows speculations 
about its physiological role in Herpetosiphon sp. 060. In general, secondary 
metabolites can take over a variety of functions for their natural producer and may 
act as pigments, virulence factors, defence mechanisms or messengers (Hertweck, 
2009). Nevertheless, the actual role of a metabolite in its natural context is often 
unclear. Likewise, no biological role could be attributed to siphonazole so far. From a 
structural point of view, the function of the two heterocycles may be considered. 
Oxazole or thiazole rings are frequently found in siderophores like vibriobactin or 
yersiniabactin, where they participate in the chelation of metal ions (Roy & Walsh, 
1999). These metabolites are, however, mostly expressed in an iron deficient 
environment, whereas siphonazole is also produced in the presence of a supply of 
metal ions. Furthermore, heterocycles create interaction sites for RNA, DNA or 
proteins. The thiazoles in the antibiotic and antitumor agent bleomycin for example 
have been shown to intercalate into the DNA double helix (Vanderwall et al., 1997). 
For siphonazole a function as defensive agent is admittedly rendered unlikely due to 
the lack of cytotoxicity and antibiotic activity against other microorganisms. An 
intracellular ligand of siphonazole is not known to the present date.  
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The results from the RNA expression analysis and the image mass spectrometry 
(IMS) suggest that siphonazole plays a role in the early growth phase and is 
expressed at the edge of a growing culture on solid medium. It is also known that 
siphonazole is excreted into the medium, as it can be readily isolated from the culture 
supernatant (3.2.4). Therefore, one could imagine a role as messenger or 
intercellular communication agent. Herein, siphonazole might affect the swarming 
direction of the growing culture or participate in the interaction with other 
microorganisms. Small molecules can mediate a great number of responses in 
interspecies signalling. These are not restricted to growth inhibition, but can also 
induce changes in metabolism, phenotype or development like sporulation or the 
formation of fruiting bodies (Shank & Kolter, 2009). A function for siphonazole in 
intra- or interspecies crosstalk would accord with the absence of an obvious 
beneficial effect for the producer and missing antibiotic activity. More insights could 
be gained by further IMS studies, which should address the siphonazole production 
at the boundary points between a Herpetosiphon sp. 060 colony and other bacteria 
on the same plate (Esquenazi et al., 2008 and 2011). 
 
5.5 Complete assembly of the putative siphonazole cluster 
The in silico completion of the sequence of the putative siphonazole gene cluster 
provided the basis for the subsequent assembly of a fosmid construct harbouring the 
complete sequence of genes sphA – sphJ. By directed re-screening of the genomic 
library complementary clones were detected and recombined with the already 
identified fosmids, thus yielding a vector with a size of 71 kb carrying the complete 
sequence information.   
 
5.5.1 In silico and genomic library screening 
In a previous study, the fosmid library of Herpetosiphon sp. 060 was screened with 
degenerate primers based on conserved motifs from A, Cyc and KS domains         
(Ö. Erol, personal communication). This screening led to the identification of three 
cosmids harbouring parts of the putative siphonazole cluster. For the 
complementation of the whole cluster, the follow-up fosmids IC2 and IC3 were 
identified by screening the genomic library with specific primers for the TE and its 
adjacent region. These fosmids had obviously escaped discovery in the original 
Discussion  129 
 
screening, although they encode not only one A domain, but also three KSs of the 
putative siphonazole cluster. Derivation of the specific primer sequences was 
enabled by the sequence data from the genome sequencing. Apart from providing 
workable DNA constructs for subsequent experiments, the genomic library can in 
turn complement the information of a draft genome. The two Cyc domain tandems 
encoded in the putative siphonazole cluster were both located in gaps between the 
contigs from the genome assembly and were first discovered by the library 
screening. These findings supported the selection of the fosmid clones and facilitated 
the following identification of the correct cluster in the genome data. This interplay 
clearly illustrates the usefulness of combining the approaches of a genomic library 
and an in silico screening of genomic data. The incorrect sequences in contig 1462 
demonstrated, however, that results from a genome sequencing project cannot 
always be adopted unaudited, but sometimes require revision and should therefore 
be carefully evaluated. 
 
5.5.2 Assembly by λ–Red recombination 
PKS and NRPS assembly lines frequently comprise immense sizes that excel the 
average insert size of common fosmids or cosmids (Binz et al., 2008). These size 
limitations can be overcome by the use of BAC libraries with a bigger insert capacity 
or coexpression of compatible expression plasmids with subsets of the gene cluster 
(Pfeifer, 2001; Pfeifer et al., 2003). Another possibility is the reconstitution of the 
gene cluster from several parts on different fosmid or cosmid clones. Λ-Red 
mediated recombination has been established as an appropriate method for 
rebuilding gene clusters for secondary metabolites (Wenzel et al., 2005). This 
technique is based on proteins from the bacteriophage λ, which greatly increase the 
recombination rate of linear DNA by homologous recombination without having to 
rely on restriction sites (Stewart et al., 1998). The target region in the genome or on a 
circular DNA construct is defined by short homology extensions at the ends of the 
linear DNA-fragment. Concomitantly, the same method allows the introduction of 
modification like the insertion of promoters and homology regions, which are required 
for the expression in a heterologous host, as well as deletions for gene inactivation 
studies (Datsenko et al., 2000).  
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By employing λ-Red recombination techniques, it was possible to stitch the putative 
siphonazole gene cluster from overlapping parts on three fosmids, thus generating a 
construct carrying the sequences of sphA – sphJ. The fosmids were based on the 
pCC1FOS vector backbone and contained their DNA inserts all in the same direction. 
This allowed, after insertion of selectable markers, a direct isolation of the 
complementing DNA fragments by restriction digestion. Although the generated 
fragments had a considerable size of up to ~20 kb, they were readily isolated, 
electroporated and recombined by standard techniques (Gust et al., 2004). This is in 
accordance with previous achievements of Müller and co-workers, who utilised a 
similarly large fragment in the completion of the phenalinolactone cluster (Binz et al., 
2008). Recombination of the cluster parts resulted in a fosmid which harbours an 
insert with a total size of ~63 kb. Even though this exceeds the usual insert size of 
fosmids, the construct proved to be stable and was readily isolated from an E. coli 
culture. The consistency of the recombined fosmid was proved by restriction and 
PCR. The straightforward complementation of the putative siphonazole gene cluster 
clearly demonstrates the effectiveness of λ-Red based recombination methods. The 
generated construct provides a base for a functional analysis of cluster genes and 
subunits. Further modifications, to prepare the cluster for an expression in a 
heterologous host, may be introduced by the described methods. 
 
5.5.3  Assembly by yeast recombinational cloning 
Plasmid construction in yeast by homologous recombination is a technique that has 
been known for over 25 years (Ma et al., 1987) and which has been successfully 
applied for the assembly of DNA constructs up to artificial genomes from as many as 
38 fragments (Gibson et al., 2008; Gibson, 2009). Therefore, recombinational cloning 
in yeast can be seen as a highly appropriate method for the reconstitution of 
secondary metabolite gene clusters from several parts. In this study, experiments 
aimed at the recombination of three overlapping cluster parts with a linearised vector 
backbone. The PCR screening results suggest that successful recombination in 
yeast was accomplished repeatedly and that recombinant plasmid constructs could 
be isolated from yeast cultures, yet the transformation of a plasmid with the complete 
cluster sequence into E. coli cells remained unsuccessful. The occurrence of E. coli 
clones on selective plates and the results from the PCR screening for the vector 
backbone imply that at least partial constructs were introduced into E. coli cells. In 
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this screening also some clones appeared which did not yield any product. This can 
either hint to the spontaneous development of antibiotic resistance or to the uptake of 
plasmids which contained at least fragments of the cluster insert.  
 
Repeated screening of yeast clones on different days point at the possibility that 
complete plasmid constructs were first generated, but not maintained in the cells. It is 
known from studies in E. coli cells that the “metabolic burden” caused by plasmid 
maintenance can also affect plasmid stability, but as the utilised pENTRC1FOS is a 
low copy plasmid, the restraints for the cell should have been kept at a minimum 
level. Besides, there are also structural factors that can cause plasmid instability like 
size, polyA sequences or repeated motifs that are prone to deletions, duplications or 
insertions (Silva et al., 2012). Furthermore, instability can be conferred by 
environmental stress like antibiotic concentrations or medium composition. The PCR 
results might therefore indicate that the generated plasmid construct is not stable. 
This finding would be surprising with regard to the plasmid backbone, which is 
designed to maintain large inserts, and the fact that a stable fosmid of similar size 
and the same insert sequence could readily be created by λ-Red recombination. It is 
therefore questionable if the fragments were actually correctly recombined by the 
yeast cells. In view of these uncertainties, λ-Red mediated homologous 
recombination proved to be the more reliable and therefore preferential method for 
the reconstitution of the gene cluster. 
 
5.6 Heterologous expression of the siphonazole gene cluster 
In the previous chapters a number of experiments have been proposed that could 
help gaining more insights into some of the still unravelled processes in siphonazole 
biosynthesis. These experiments include the inactivation of certain genes or single 
domains, which requires several preconditions to be met. Prerequisites include the 
availability of the gene cluster, genetic systems for in vivo modifications of the cluster 
sequence and the possibility of expressing the altered assembly line in either the 
native or a suitable heterologous host (Galm et al., 2011). As Herpetosiphon sp. 060 
seems to be unamenable to genetic manipulation (5.14.1), the heterologous 
expression of siphonazole remains the only alternative for further studies. For this 
purpose, the choice of a suitable host strain is critical, as the potential producer must 
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meet a number of criteria. Apart from genetic accessibility a suitable host needs to 
provide all necessary precursors and perform the posttranslational modification of the 
carrier proteins (Pfeifer & Khosla, 2001). While the phosphopantetheinyl transferase 
(PPTase) Sfp from B. subtilis is known to accept virtually all types of ACPs and 
PCPs, other PPTases are more scrupulous about their substrates. Members of the 
genus Streptromyces have been frequently used as heterologous expression system 
for natural products. Not only are genomes and metabolism of several species like S. 
coelicolor well characterised, but Streptomycetes are also prolific producers of 
secondary metabolites themselves. Strains like M. xanthus (Julien & Shah, 2002) or 
P. putida (Wenzel et al., 2005) are also used for similar reasons. Due to its robust 
expression system and the well developed genetic tools, E. coli remains an attractive 
heterologous host. Several natural products like erythromycin and yersiniabactin 
(Pfeifer 2001; Pfeifer et al., 2003) have been successfully produced in E. coli strains. 
These heterologous expressions often require extensive metabolic engineering of the 
host strain (Watanabe et al., 2006) and insertion of additional genes like the 
mentioned sfp to adapt the organism to the production of the foreign compound. It is 
long since known that codon usage greatly influences gene expression. 
Heterologous genes with a codon bias different from the host organism are more 
likely to be prone to frame shifts, translational errors or decreased expression (Kane, 
1995). These difficulties can be overcome by choosing a closely related expression 
strain, supplementing tRNAs for rare codons or optimising the heterologous genes 
for the preferred codon bias (Menzella et al., 2006). Gene clusters for natural 
products are usually explored in genetic libraries based on fosmids, cosmids or 
BACs, which are designed for E. coli and are usually not replicated in other host 
organisms. The transfer to a heterologous host therefore requires either a specific 
integrative shuttle vector or the insertion of suitable promoters and homology regions 
for the integration into the genome. These modifications can readily be performed by 
the implementation of recombination methods like λ – Red (5.5.2). 
 
The choice of a heterologous host for the expression of the siphonazole cluster is 
hindered by the isolated genealogical position of Herpetosiphon. To the present date, 
no expression host within the Chloroflexi group has been established and none of the 
available, well researched expression strains is somehow related to Herpetosiphon. 
On the other hand, siphonazole does not require any unusual building blocks with the 
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exception of the aromatic precursor derived from the shikimate pathway, which in 
turn is very common in bacteria. From this point of view, an expression in E. coli may 
well be considered, but taking all the limiting factors mentioned above into account, it 
is not surprising that the attempted expression in the sfp containing BAP1 cells was 
not successful (4.11). The phylogenetic distance between Herpetosiphon and 
potential host strains is also reflected in the codon bias. A measure for the similarity 
of the codon usage of two organisms is the codon adaptation index (CAI), which 
represents the codon bias of a set of highly expressed genes (Sharp & Li, 1987). The 
CAI for the siphonazole cluster and several potential host organisms was calculated 
with the JCat tool of the University of Braunschweig (Grote et al., 2005, Carbone et 
al., 2003). With a CAI of ~ 0.2 the comparisons revealed only a very low similarity to 
E. coli K12, but showed even lower values for M. xanthus, S. coelicolor and P. putida 
(table 5-1). It is therefore questionable if these other strains are more suited for a 
heterologous siphonazole production, as the expression of even single proteins 
proved to be difficult in E. coli (4.9). It can be assumed that the protein expression 
would deteriorate in a host with an even more different codon usage. The moderate 
GC-content of Herpetosiphon does also not necessitate a high GC-content host like 
S. coelicolor.  
 
Table 5-1: Codon adaptation index of the sph genes 
Values were calculated with JCat by comparison of the siphonazole cluster sequence with 
selected organisms from the software’s database 
Organism Codon Adaptation Index 
E. coli K12 0.199 
Myxococcus xanthus (strain DK 1622) 0.130 
Pseudomonas putida (strain KT 2440) 0.174 
Streptomyces coelicolor (strain A3(2)) 0.060 
Bacillus subtilis (strain 168) 0.332 
Bacillus licheniformis ATCC 14580 0.488 
 
It was found that Bacillus licheniformis has one of the best CAI values with a 
similarity of over 0.48. In the industry, this organism has been used for decades for 
the production of extracellular enzymes, lipopetide surfactants and organic acids and 
polymers (Waschkau et al., 2008). Some stains are as well producer of the NRPS 
derived peptide antibiotic bacitracin (Kleinkauf & von Döhren, 1987). The average 
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GC-content of B. licheniformis is with 46.2 % close to that of Herpetosiphon sp. 060 
(55.7%) (Rey et al., 2004). Regarding these criteria and the fact that transformation 
and cultivation methods for B. licheniformis are well established, this organism 
should be considered as a possible host for the heterologous expression of the 
siphonazole gene cluster. Expression and shuttle plasmids for B. licheniformis are 
available (Niu & Wang, 2007), which would facilitate the construction of an 
appropriate expression vector for the siphonazole production. 
 
5.6.1 Heterologous protein expression 
In the course of this study the O-methyltransferase SphB, the DAHP synthase SphI 
and the A domain of the initiation module encoded by SphC have been successfully 
expressed as heterologous proteins in E. coli. The successful expression of 
functionally active proteins from Herpetosiphon species in E. coli has already been 
reported in the early 1990s (Düsterhöft et al., 1993). The performed experiments, 
however, made several challenges in the heterologous expression of proteins 
apparent, and only SphB could be expressed as soluble protein in high quantities in a 
straightforward manner. In contrast, the heterologous expression of the A domain of 
the initiation module proved to be more difficult.  
 
In contrast to the expression of distinct ORFs, where start and stop codon mark the 
borders of the gene, the expression of a single domain out of a multimodular protein 
leaves more freedom for the positioning of start and end. Expression experiments 
with proteins from a Pseudomonas NRPS cluster showed that moving the position of 
a primer site for as little as five amino acids can have a decisive impact on the 
production of the heterologous protein construct (T. Höver, unpublished results). 
Therefore, the primer sites for the A domain were altered repeatedly, without yielding 
any detectable product. Other significant factors are the choice of vector and 
expression strain. By changing to the pET151 vector and BL21 star™ E. coli cells, 
the expression of the A domain was accomplished with one of the same DNA insert 
that failed to produce any protein in pET28a(+) and regular BL21 cells. In the same 
way expression of SphI was achieved.  
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It was shown that, amongst other parameters, the mRNA levels and mRNA stability 
are important factors in protein expression and also affect production of proteins from 
genes with rare codons (Wu et al., 2004). The problem of diverging codon usage has 
been discussed before (5.6) and can be answered by the use of optimised 
expression strains, which either improve RNA stability or contain extra copies of rare 
codon tRNAs. The BL21 star™ cells are deficient of two protease genes and contain 
a truncated RNase E gene, which contributes to an increased stability of the 
produced protein and the mRNA, respectively (Grunberg-Manago et al., 1999; Lopez 
et al., 1999). The expressed proteins from SphC and SphI turned out to be mainly 
insoluble. Rosano and Ceccarelli observed in their experiments with codon bias-
adjusted E. coli strains that overcoming the effects of different codon usage had a 
detrimental effect on the solubility of the expressed proteins (Rosano & Ceccarelli, 
2009). They concluded that the elimination of translation difficulties leads to 
increased production rates of the heterologous protein, which promotes misfolding 
and aggregation. The increased mRNA stability in the BL21 star™ cells has most 
likely similar effects and is probably the cause for the large portion of insoluble 
protein in the expression of the A domain and SphI. The overproduction of proteins 
can be sufficient by itself to cause the formation of insoluble aggregates designated 
as inclusion bodies (Schumann & Ferreira, 2004). Nevertheless, the BL21 star™ 
cells proved to be the best choice, as both regular BL21 and ArcticExpress cells, 
which contain special cold-adapted chaperons to promote the correct folding of 
heterologous proteins (Ferrer et al., 2003), failed to produce a detectable amount of 
the soluble target proteins. Optimisation of culture and induction condition may help 
to increase the rate of soluble protein.  
 
5.7 Metabolic potential of Herpetosiphon 
Members of the Chloroflexi group have been the object of interest with regard to their 
photosystem for some time (Xin et al., 2011), but apart from the discovery of a 
diterpenoid from Chloroflexus aurantiacus (Hefter et al., 1993) and the 
characterisation of pigments in Herpetosiphon species (Kleinig & Reichenbach, 1977; 
Reichenbach et al., 1978), a closer examination of their metabolic capabilities has 
been neglected. The predictions by CLUSEAN and the NaPDos database provided 
evidence that the genome of Herpetosiphon sp. 060 comprises a number of yet 
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cryptic PKS and NRPS gene clusters. Sequence comparisons showed that the mixed 
PKS/NRPS cluster found in contig 0805 and the adjoining lantibiotic biosynthetic 
genes are shared with the closely related H. aurantiacus, indicating that the 
metabolic machinery for the production of secondary metabolites may be more 
widespread in this bacterial group.  
 
The structure of siphonazole and its putative biosynthetic gene cluster have revealed 
several peculiarities and raised questions that are still not completely answered. 
Considering this and the fact that none of the other predicted clusters have been 
linked to any natural product yet, Herpetosiphon and other Chloroflexi may still 
harbour a lot of untapped potential. An increasing number of these so-called “orphan 
clusters” (Gross, 2007) from different bacterial classes has been discovered by 
genome mining approaches, which can and already did provide the basis for the 
discovery of new natural products. A number of methods have been developed for 
the awakening of “silent” gene clusters (Chiang et al., 2011) involving, e.g. 
heterologous expression, gene inactivation and the genomisotopic and OSMAC 
(one-strain-many-compounds) approach. Refinement of the present bio-informatic 
data in combination with these techniques may therefore lead to the discovery of 
further metabolites from Herpetosiphon. 
 
The discovery of carotenoids in Herpetosiphon, which are common in myxobacteria 
(Kleinig & Reichenbach, 1977), gave rise to the hypothesis that the two groups may 
share biosynthetic pathways (Nett, 2007). Database comparisons of the sph genes 
and predicted A and C domains did not provide further evidence for this assumption. 
Regarding the highest homology of the corresponding proteins, it was rather 
illustrated that no relationship to a specific bacterial group emerged, but that 
similarities were distributed over a wide range of phyla including Bacilli, 
Streptomycetes and Clostridiae, Pseudomonads and Cyanobacteria. Sequence 
identities were generally below 60%, pointing out the evolutionary distance of 
Herpetosiphon to these other groups. Albeit this rather unspecific alignment allows 
no further conclusions on metabolic relationships, it may be taken as another 
indicator for the unique position of this phylum. In view of this, unlocking the 
metabolic potential of Herpetosiphon and Chloroflexus species still has the capability 
of coming up with new surprises. 
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6 Summary 
Polyketides (PKs) and non-ribosomal peptides (NRPs) are two major classes of 
natural products. They comprise a vast variety of structurally and functionally diverse 
compounds, which include a great number of clinically important substances. These 
metabolites are the product of giant multienzymes termed polyketide synthases 
(PKSs) and non-ribosomal peptide synthetases (NRPSs), respectively.  
 
The present study investigated the putative biosynthetic gene cluster of siphonazole. 
This compound is produced by the Herpetosiphon strain 060, which belongs to the 
deep rooted phylum of Chloroflexi, and is the first secondary metabolite described 
from this group. Siphonazole is composed of building blocks derived from acetate, 
amino acid and shikimate pathways. The gross structure comprises a styrene moiety, 
two oxazole rings connected by a C2-bridge and an unusual diene side chain.  
 
Based on a fosmid library from previous work, it was attempted to identify the gene 
cluster by knock-out experiments. The application of various transformation methods, 
including heat shock, electroporation, sonoporation, conjugation and chemical 
transformation of protoplasts, showed that the Herpetosiphon strain is unamenable to 
genetic modification. 
 
In a second approach, genomic DNA of Herpetosiphon sp. 060 was subjected to 454 
sequencing yielding draft genomic data of the strain. The application of bioinformatic 
tools led to the identification of several PKS and NRPS cluster parts. Through a 
comparison with subclones from the fosmid library, six genome fragments were 
identified carrying partial sequence information of a hybrid PKS/NRPS gene cluster. 
By employing a combination of PCR and sequencing reactions the gaps between the 
fragments were closed. The completed sequence information comprises a gene 
cluster of 50 kb with ten open reading frames (sphA – sphJ), which encode the 
putative enzymes for the biosynthesis of siphonazole. 
 
Through a detailed bioinformatic analysis of the encoded proteins, it was revealed 
that they include eight PKS modules, which are assumably all loaded in trans by the 
acyltransferase (AT) SphA, and four NRPS modules (figure 6-1). The AT has a 
predicted specificity for malonyl-CoA, which is consistent with the siphonazole 
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structure, and is fused to an oxidoreductase domain with hitherto unknown function. 
Two of the NRPS units are heterocyclisation modules, in which tandem pairs of 
cyclisation and oxidation domains catalyse the formation of the oxazole rings from 
threonine moieties. The first NRPS module initiates the biosynthesis probably by 
incorporation of a dihydroxybenzoic acid, although ATP-PPi exchange assays failed 
to determine the substrate specificity of the corresponding A domain. One module, 
consisting of the unusual arrangement of a ketosynthase (KS) and a peptidyl carrier 
protein (PCP), is inconsistent with the molecule structure of siphonazole. It is 
suggested that no elongation is performed on this module due to unsolved protein-
protein recognition issues between its carrier protein and either the KS or the AT. A 
hydrolase is encoded downstream of the last module, which presumably participates 
in the formation of the diene terminus of siphonazole. However, the mechanism 
leading to this unusual terminus is still unsolved. 
 
 
Figure 6-1: Organisation of the putative siphonazole PKS/NRPS system derived by 
bioinformatic analyses; modules are marked by black bars; A, adenylation domain; ACP, acyl 
carrier protein; Cyc, cyclisation domain; C, condensation domain; DH, dehydratase; Hyd, 
hydrolase; KR, ketoreductase; KS, ketosynthase; KS0, non-elongating KS; MT, 
methyltransferase; OR, oxidoreductase; Ox, oxidation domain; PCP, peptidyl carrier protein; 
TE, thioesterase; domains marked with ‘0’ are non-functional; functionality of DH* in module 12 
is uncertain; ‘?’ marks module with uncertain function 
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In vitro studies with purified protein showed that the potential precursor molecule 
protocatechuic acid is readily methylated by the O-methyltransferase SphB. The 
DAHP synthase SphI, encoded upstream of the thioesterase, is likewise assumed to 
be involved in the formation of this precursor. This enzyme was successfully 
expressed and is available for further investigations.  
 
The analysis of total mRNA from Herpetosiphon by RT-PCR revealed that sphA – 
sphJ are only expressed in the first three days of cultivation. The genes are 
organised in two transcriptional units, one of them containing sphA and sphB and the 
other one sphC – sphJ. In agreement with this early gene expression, the application 
of imaging mass spectrometry (IMS) showed that siphonazole is located exclusively 
at the edge of a growing colony. Hence, it was hypothesised that siphonazole might 
play a role in intercellular communication. 
 
On the basis of the obtained sequence information, ensuing working steps aimed at 
the assembly of a vector carrying the complete gene cluster. By λ-Red recombination 
methods, cluster fragments of three overlapping fosmids from the genomic library 
were successfully recombined. Thus, a fosmid construct of 71 kb was generated 
harbouring genes sphA – sphJ. This vector was readily transformed into E. coli BAP1 
cells, yet heterologous expression of the cluster was not achieved. 
 
In conclusion, this study led to the discovery and elucidation of the putative 
PKS/NRPS system for the biosynthesis of siphonazole, revealing some unusual 
structural features. First steps towards a more detailed characterisation of 
siphonazole biosynthesis were taken by analysis of the spatiotemporal expression 
profile and purification of several of the biosynthetic enzymes. The reconstitution of 
the complete cluster on a fosmid laid the groundwork for a subsequent expression in 
a heterologous host. Thus, the present study provides a basis for further analyses 
directed at a proof of function of the gene cluster and the unravelling of some still 
unsolved mechanisms in the biosynthesis of siphonazle. The presence of further 
gene clusters and likewise the inherent metabolic potential of Herpetosiphon were 
shown by bioinformatic tools. The works presented in this study should therefore 
encourage a further investigation of the siphonazole pathway and the consideration 
of Herpetosiphonales and Chloroflexi as potential producers of new chemical entities. 
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8 Appendix 
8.1 Primary sequences of the proteins SphA – SphJ 
8.1.1 SphA 
MLMRAFIFPGQGSQKQGMGEDLFEAFPELTDQASQILGYSIRELCLRDPQRQLAQT
QYTQPALYVICVLSYLAEVSRGIRPDFVAGHSVGEYSALFAADVFDFETGLRLVQKR
GELMAKAQNGGMAAVGGLSEAQIRSILNQHQLYSLDIANLNAPTQVVLSGPNDDIIA
AQAVFEAAQAQLYIKLNVSGAFHSRYMNKSRDEFGTFIASMQFAEPRIPVIANLDAN
PYTASTIKRNLVEQITHSVRWVESIEYLLHAGVNEFKEIGPGTVLTKLNQRITANQAA
TPTVSTTPTPQPLPNKPATPTPPTQPTLNGSPTLRAINPLSLGSEAFRRAYGVKYAY
AAGGMHHGIASIAMIERLAQAKIMSFFGTGGLALSEIEQALQQLQQRLGTAPYGVNL
LWADMQNPEHEAQVFACLERYSIHHIEVAGYLDVTPALLRFRAKGLTQHADGSINST
RTIMAKITRPEIAEVFLSPPTTEQIQGLVAAKLLTSQQAQYVASLPIADDICVEADSGG
TTGLGSAYALLPTIIQLRDRAQGAVRIGGAGGIGTPAAAAAAFMLGADFILTGSINQC
TVEAKTSNAAKELLQDVNPQDTIHIPNIDLLSPGSKTQVLKKGVFFHVRANRLYDISR
FYENLEQLDQTVRQQIEEKYFKRTLADIWRELCTTTASQIIERAERNPRQKLALTFKW
YFDQSIQWAIHGDLSRKVDFQIACGPALGAFNQWVKGTPLERWQARHVDTIADSLM
HGTADYLNQRMHILHHQ 
 
8.1.2 SphB 
MAKASLNLTDQLYEYLLQHSLREPELVRELREETARMLMYAMQTPPEETQFIAWLL
TLTNAKRMLEIGTFTGYTTLWAALTMPDDAKIVACDVADKWVNVGKKYWQQAGVA
HKIDLRIAPALQTLDQLLQNHFANYFDFVYIDADKENYWNYYERALMLVRPGGIIGID
NVLWGGSVVNELNQSADVKAIREFNQRLHQDQRIAAMSLHPIGDGLTLVIRK 
 
8.1.3 SphC 
MVQQDLQSQSQNDLYTLFTNQARQTPQAEALRWCIDEQWQSLSFEQLAKHIEQLA
AALAATGIGVGSVVGVLAERSPAIVTSILALFKLGAIYVPLDLGYSAANIAQISAQTAM
ALIITRHAYVAKIANVPINYADIEELIVRENPTPASVMPDPARPALLLYTSGTTGQPKG
ALHCQRQLLNRFNWLWQNYPFAAGDLMVQRTSINFMPSLWEWLGGLVCGVATLII
DDTTIKNPRRFLKTLAEQRATHLAAVPSLLGMFLEGGNIADLAGLRLLICGGEPLLPG
LRSQLRANLPTTTILNDYGATEMNGVLFNEYQPQQPATETGMRPIANVEVLILDHDL
NLITDGSSGQIYIGGPCLAYGYVNQANLTAERFIPHPAATLPGSRLYRTGDVGRQLA
DGSIVISGRQDHQVKIRGMRVELAGIEQTLAQHPEVRIAVVVAHEAKSGQKSLAGYV
VTRGAITTAELHTYLTDNLPNYMVPAQLVILDEMPRLPNGKIDRMALTRRETVKSLTA
NSVIDQLCQIAATVLETDPTTLEPERKFYELGFDSVNVVSFVRAINQHLGCDIDVSAIY
NYATLADLASALATIVPAQVPAPQPIAIEKHLESTSAVAPIQSTAKPLIVPTQPIAASSVI
DQLCQIAAIVLETDPALLEPERKFYELGFDSVNVVSFVRLINQHLGCDIDVSAIYNYAT
LADLALALATEHGVILQQTSVAAPILKAPVAIPAAPVPTFNSPSIATTTPVESPQQPQI
MTVADTAQGTEPTEVAIIGLAGRFPGAASVAEFWELLAAGQSAIREVPADRWSNQT
YFDPNPQTPQHTTSKWGGFLDQIDYFDHSFFNISKSEAAGMDPQQRLCLEEGWKA
LEDAGYVEDAVAGKTVGVFVGMRPGDYLERIRSQANELTAYNLLGSDSAILAARLAY
YLNLKGPSIAIDTACSSSLVAIHLACQSIRAGESELALAGGVSILSTPSLYITSSKMGM
LSATGQCKTFDNQADGFVPGEAVGFVVLKALSQAQRDGDRIYGVIKGSGINQDGKT
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NGITAPSGQAQTTLERAVYAQAKLSPRSISYIEAHGTGTRLGDPIEIRALTESFRHWT
EDRQFCAIGSVKTNMGHALAAAGIAGLAKVLLSLQQRQIPPSLNFVSPNEHIPFADS
PFFVATQLQPWLTPAGEPRRAAISSFGFSGTNSHLVLEEFAQPRVDRPESQWHLIV
LSAKTETALRQQIVALSQALEQPKQTYRLDDIAYTLLVRRAAFAVRCAMIVRDYSDLQ
HQLRLLQQPQTQFTKAPKAQPLHTTLTFQRSPDDLASLKECFLSNQVVDWQHLYP
QTEHNLLSLPHYCFERERFWIDTDQPLATNQAPNTAQLHPLIEANCSTLQGIRFNTV
LQPTDFYVADHRWEGQALLPGVVYAEIARVASSLALNQPVSHIEQLLWLRPLIVEQTI
NLQSRIYADEHDVLVEIGVADPADQLTIHAKARIPLAKQNVDSQYMAALDLPAIRAICV
EQIDQAEFYQHFSQLGLNYGSRLQAIKSISYNAQQALAELELPTELSADFARYSLHP
ALLDAALQTVLVLQAKQAGRDKADLPFELAAIDLIQPLERQCVAYVQRNAEQGRLKR
SQIVIANLQGEPLVVLHGFAQGAPKATTGNEVEALQRGEIAYYSATEYETALVQGSIA
QGTMLVFGSSQVQKLLNSSGANVQVTYGTSYRQIDRYTYTIDWLNPNDYHQLFATL
EREGLVPSSILQLANLETKQSSSLEQTVEATIYPLIYLYQALGMLKFMPNLRILWAWQ
EFVHNSSSAAAQAALSGVLQTLANEYPALPCKLVSFVQQTDLQLIVASLLNELQTTD
FTFETINYVNQKRLSQGYQRQPASAEPTTTPFRSGGTYLITGGLGGVGLLCAHHLAK
HYRAKLALVGRSQPTPAIEAQLAELANAGAEVCYIRADIGATQQAHAAIAQAKAQFG
QIHGIIHSAGVLHDQPLRNARRAEIEAVLHPKVYGTAALDQATASENLDFLALFSSITT
VVGNFGQTAYGYANGFLDQFAMQRERLRQAGQRFGRTVSINWPYWQAGGMRMS
AQAEQLMETLIGAMPLETSSAIEALYHALTAPASQIVVFAGDRSTFEAAMGTRLYQP
SIRSEAMSYPSPIITESNPFSRQIQADLLRMAADILRARPEDIDPQIELTEFGLDSISM
MEFANHINKQFKLKVTPTLFLEHLTLASVANYLAQQARPTDQAIPPMPEVVARTATK
VETPISKPIAPVVIAQPLPAPTLSQSINTFVAQPVVPQPKNQPIAVIGMSGRFPQADDL
NEFWELLRSGTSAISEIPSDRWNWQEYHGDSRLDSSKTSVKWGGFLRDIAGFDAA
FFNISPTEAQLMDPQQRLFLETVWQTIEDAGYRPSAFNGSRTAVFVGAFTKDYAELL
QAHGINAAHTTTGTDHSIIANRVSYFFDWRGPSEAIDTACSSAFVAIHRAVQALRNG
EADLAIAGGVNALLAPQGFLRSTQAGMLSQSGTIRSFDQSADGYLRGEGVGAVLLK
PLAQAERDGDIIHGVIRGSAVNHNGRSYSLTAPNPAAQTDVIIRAYANAEIDPASVSYI
EAHGTGTVIGDPAEIQAFQRAFEQLAEQSSLPSNSCGIGSIKPNIGHLEAASGIAAFIK
VLLALRHATIPATLNLETINPQIDLAETPFQLIRTAGPWQAQHGQRRASLHSFGFGGT
NAHIVLDEYPQVRASAAAAKPVIVPCSAKHPKSLRAGLAALHQHVVNNPQLRLDDLA
YTLQIGREAFDERVAFVVQSNAELITLLESYLNNTITPDQAIYVGSMQHNDRTLKTILA
GKLGQSLLQELHTPQELSQIALLWTKGVDVAWEQLDQTERRQRLALPTYRFNHQS
YWIPTNPDDHNPSNNGDPEASNPAPKPEHAPTSVIGQLQQLFSQVLGISAEQLDPY
GNLEAYGLDSILATKARYLIEQRFGINVPMNIFKQQEHIAALAQQIPADASFAEDLETE
SVEALKVGTTFGLSAVQEAFVVGQHLLPFDHLGCHFFLTFPLTTTDPQTVAAAWLTL
CQRHPMLTMQLVPPAAQTIRDPRDLPAPTIRDCTSADDATIAAACAEHTDRLSHAAY
PLDAWPRWSLQILALPHHACRVFLSVDETLLDAASLVILLHEWHTLVLDPATVLPPAS
TAFPAFLQRLQTRAAAAAAADLAYWRTRLHGITGGPALPWIPLQPHHATTAPDGRR
FLPRTRLAACLPAPAWSALQALAQQHAVAPSTLLLAVFAHILRSATADPRAPFALILT
LANRVPLIPASEQLVAPVVSTTLVRLDPADSLATLLPSLQAQLWDTLDHPFTSGIAVL
RDLKHQQLLPATTTIPVVFTAMLNAFGNHAQQPSFFPAVDTALTQTPNVWLDHQLL
ERNGALHFNWDILPAAFPRGLAEALFSRYTAALQTLACDPAALHAAALGLPDPTPLP
LSAVQRSYLLARPAAPARFYQEFRLPQHAIPRLAAAWLRVAAAHPGLRMTLHTDHL
VCASASPTPLDLPITPERGPAAITATRTAMQHAPLQPIAVRLTHDTDATTVLHCAIDAL
YLDGRSLMTLFREWAACAAAPFAPFAPPATSPHALRAALAAATSPTAADWATVWA
DRPLGPTLPSGTAQAARYNVPIVQPHALAQAAAAHGLSLNTLLLTSFAAVLAAWLPA
TPWSLTVVSWDRPTTLPDAHRVIGDFTALRWLTLPLPAADWTTAAHAVAAALAADA
ARPGDPIAALRPRLRHASQQTPFPLVFTELLDYDPSSWAVGAGWSQTPGVAIDCLP
QWTTTDTLLLQWDVAAQISDPQTLQQLLATQAAWLDRLATDPTAWTLLVPTSLPAG
APSTNHAQLLPALATAVNHTPSAAAPAPQVAWTEHRSVPAVIAAVAHATPHAIALSF
RDAHCSYADLETRATALAHTLIAAGAAPGQLIGLLAHRSLDLPIAILAILKTGAAYLPLD
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PHAPADRLTFILHDAQVALILHDPTIDSTPFAAPQRTFVPIHTTPSPSSTPLPRIDPTA
DAYVIYTSGSTGQPKGVPITHRHILRLLSTTHPWFRFQPTDVWTLFHSVAFDFSVWE
LFGALCHGARLVIVPAAITRDFPAFYRLVAAEGVTILNQTPTAFAQFAAADAHHPLPL
ALRTIVFGGEALDLRLLAPWFDRHGDQQPQLINMYGITETTVHVTYRPITTADLAHAR
SVIGVPLPDLQLAVWQPDGSPTPVGEVGELVVFGAGVSRGYLRRPALTAQKFVTDP
HRGSGYRSGDLVRVLPDGDLEYLGRNDLQVKVRGFRIELGDIEAALRRDPAVAAAV
ATVVRTGVAEPTLVGYLVPHPGATIDLPRLRAQAATWLPPYMVPSVLGILPAVPLTV
NGKLDRRALPWPLPTTPTSAAPSEVAPHPDVAAITATISGLVTTLLHGTRVAPTADLF
SAGATSLTIVTLVQQLADLYPVSVPIAQILEFPTISAIAAWLAAQLPAPAPVTTPAMAV
APQPELAAITATVSGLVTTLLHGTPVAPTADLFSAGATSLTIVTLVQQLADHYPVSVPI
AQILEFPTISAIAAWLATQLSAAQPAASPTAPPIPAASIKLAVAPNSELFGATWNTNVK
ANQPINLTQIAGLLSTIQRLEIAGEAKYLHASAGGKYAIQVYLAVRAGGIEGLAAGCYY
YHPEEQALILLSTEIPAMPTAPFMLILAGHLNILRPIYQDGSPVFGLLDAGYLSQVLRS
RSGNHGIGLTPWVDLDQTAIRHACQLDADDQIALCFGGGNLAATAQPTQIIPHQYG
GATVTTAEIAALSGPMKYHQTDASTALAEPKRMHAIRNFPTEQARQILPTFKYAPEE
YLVRTCQRRYEARPVAFNDFSRFLSFLQPDSTKLDHLTLEALEAITIYLSINQQGVIGV
DAGIYRYDRASHSLIAINDQFSYPLQSCHIPFNRQQLSQAAFCGYFVIDSHALPSHYA
ATSALIAAGALSQYLLEQQSKVNIGMVPIGGLHFERVKQDFGLTEQHVLLHSFIAGAF
THQVQRSESTQFAQQPVILTKPQTSNGLAIVGYSGLYPGASNLEQFWVNLASGTSTI
SLPPSERWSLEQGFDQDQRAGKIYSWAGGYLENIMQFDHLLFNISPLEARSLDPQE
RLLLQAVWECLEQAGYTNESLLDDAPRVGVFVGAMWNDYQLQGLEGWQASHKAA
TAALHSSLANRISHYFNFNGPSMAVNTSCSSAITALHLAAESIQRGECDAAIVGGVNL
ILHPYHHAALCAMNLVATDGHSRAFSAQGTGLVPGEGVGALLIRPVAQAQANNTIH
GIIRSTAISHYGRTNQFGMANTKSQTQLILQAFERAKLRPQTVNYIEAAATGSALADA
SEIAALSNTFKHYGATTNSLIGSIKPNIGHLEAASGLSQITKVLLQLKHRRLAPSINYEP
INPLLQLETSPFTIVHDQQDWVTTRDDHGVIQPRRALINAFGATGSGGCVIIEEYCDE
E 
 
8.1.4 SphD 
MHLGQLVQAAVSSLKNIATRSKLMFQNLFILSAASSNQLVLTTQRLYDFLTQAEQDA
PDLTAIAYTLQVGRRALAYRLALMAATQSELLAGLQAFLAGDHSNPQLIIGKADHGV
SEVAKPQTALEAAHAWVAGSPIAWQQLWNQVSQRPKRIPLPTYPFAEASHSIAIANA
ASNQAKPQPAQQPKPAQPELVLRVAEYLRGHFCAVAELAESIVDLQAPLEIYGINSQ
LMTQTLARLEHDLGSLSKTLFFEHQTLFDLATHLSKTHATRWATLLGIESQPEQPPQ
PVALPQPQTQAPSLNNEPIAIIGLAGRYPQADSIAEFWQLLANGNDCIREIPLERWDY
RPLFNPNKAARGSIYAKWGGFLNNIAGCDPRFFNIAPREMELTDPQERLFLEVAWE
TFEDAGYTRSRLRQHFNGQIGVFVGVMYAEYQLWGAQEALKGHNVALGSSPGSIA
NRISHFFNLNGPSLAIDTMCSSTLMGLHLAVQSIRNRECQAALVGGVNLSLHPNKYL
MHSQMNMLSTDGHCRSFGAGGDGFVPGEAVGAVLLKPLSQAERDGDHIYGLIKAS
AVNNDGKTNGYTVPNPVAQTAVIKQALVQAAIDPRTISYIEAHGTGTALGDPIEIVGL
NNAFRDFTTDRQFCAIGSVKSNIGHCEAAAGIAGLTKVLLQLKHQQLVPSLHAEQLN
PNIDFEQSPFFVQQGLTAWQSQTPRRAGISSFGAGGVNTHVIIEEYPAAVAPTSTQP
EQPYLVVLSAKTPAQLQLYAQRLADFIAQSSGSGAPANLEQQILNSLSDVLRVDPAA
IDPAEALEEYGFDAIMLAELARNLSIQLEREILPAAIIEYGSLNALVSGLNPSKSIQQPS
TEPLNLRDLAYTLQIGREAFEERLTIIASNLQTLQQQLTDFAIHELVQAESMARATIKR
NHQAVDFRTEEVAGNDWHALAQHWLSGASIDWAALPQNQQARRISLPTYPFAREQ
HWIEIVPMPQIGSNVQALHPLIDANQSTFERQCFQKSLVANDPLLLAGSQGGYLHSG
LLLEMALAAARISSQQPSHMITLTIDECEPRLTDQQLWIQLTPTSAGCEYYISLDSVE
HPAIAWGNVNSSEPQPQATLDLAALERDYRSANAQFLSQQEVYQQLQTLDIACQP
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WLEQVAINGNQAWSSLAVAFTNSDYSDFVVVPAVWEATCQAVALLSNQAVEATLLV
NYATIKLVQSLAETKHIVIVQTEAGYTLNFADQQGLILGIAELELRQSPSDVIAEIELNP
SNRIDNPTQTTIDLPRIAATILKYDPAQLDLHVPISEYGFDSVMLTEFINQINREYGQKL
VLAQILQLNQPTLAAIGALIPSQTPPPMAAPPARPKPTKVQKSMPQPKTIQRQRPTM
SDAAEPIAVIGMSGRFPQADDLNEFWEVLRSDTSAIGEIPAERWDWQAYAGDPQQ
GNKTRIKWGGFLRDIAGFDAAFFNISPTEARLMDPQQRLFLETVWHTIEDAGYRPSA
LNGSRTGVFVGVNAHDYERLMLEQGITIEAHSATGNAHAILANRVSYLFDWHGPSE
AIDTACSSSAVAIHHAIQALRNGDADLALAGGVHLLLSPHDFISYNKAGMLSESGRVK
TFDAAADGYLRGEGVGAVLLKPLAQAERDGDPIYAVILGSAVNHNGRGFALTVPNP
NGQADVIARAYQNAGVDPASVSYIEAQGTGTTLGDPVEIMAFTEVFKTTSTVMDQP
CLIGSLKPHIGHLEAASGVAALIKLILALRHSSIPATLNLETINPQIELTETRFQLAQQPQ
AWQAQPNTMRRAGLHSFGVGGSNAHLIVEEYSSPQHSSNQHEPALIVLSAKQPTSL
RAMLIRLQNELASQPELNLHELAYTLQVGREAFEHRVAFIAESVATLSALIERYLAGE
PASEAQSVFEGALRTIDPALKRLLTGKSGELLITAALAERDLGQVAQLWTQGAFVSW
NSLYPANTVQRLHLPGYHFEHQQFWFDQTPNSTPTTQPISLMPVMSISTELAELQAI
FGNVLGIPATQIDPSEPLENYGIDSVLMTKVKYLIEEKFAITIPLALLSQQATLETLSQHI
PTNAQKTIPDLTTLSGTALDDLFIQIQGR 
 
8.1.5 SphE 
MLTMQLVPPAAQTIRDPRDLPAPTIRDCTSADDATIAAACAEHTDRLSHAAYPLDAW
PRWSLQILALPHHACRVFLSVDETLLDAASLVILLHEWHTLVLDPATVLPPASTAFPA
FLQRLQTRAAAAAAADLAYWRTRLHGITGGPALPWIPLQPHHATTAPDGRRFLPRT
RLAACLPAPAWSALQALAQQHAVAPSTLLLAVFAHILRSATADPRAPFALILTLANRV
PLIPASEQLVAPVVSTTLVRLDPADSLATLLPSLQAQLWDTLDHPFTSGIAVLRDLKH
QQLLPATTTIPVVFTAMLNAFGNHAQQPSFFPAVDTALTQTPNVWLDHQLLERNGA
LHFNWDILPAAFPRGLAEALFSRYTAALQTLACDPAALHAAALGLPDPTPLPLSAVQ
RSYLLARPAAPARFYQEFRLPQHAIPRAGGGLAARGRRPSRPAHDPPYRPPRLCQ
RQPHHGGFADHARAGSGWPLLATGTAKQHAPFQPIAVRLTQDTDATTVLHCAIDAL
YLDGRSLMTLFREWAACAAAPFAPFAPPATSPHALRAALAAATSPTAADWATVWA
DRPLGPTLPSGTAQAARYNVPIVQPHALAQAAAAHGLSLNTLLLTSFAAVLAAWLPA
TPWSLTVVSWDRPTTLPDAHRVIGDFTALRWLTLPLPAADWTTAAHAVAAALAADA
ARPGDPIAALRPRLRHASQQTPFPLVFTELLDYDPSSWAVGAGWSQTPGVAIDCLP
QWTTTDTLLLQWDVAAQISDPQTLQQLLATQAAWLDRLATDPTAWTLLVPTSLPAG
APSTNHAQLLPALATAVNHTPSAAAPAPQVAWTEHRSVPAVIAAVAHATPHAIALSF
RDAHCSYADLETRATALAHTLIAAGAAPGQLIGLLAHRSLDLPIAILAILKTGAAYLPLD
PHAPADRLTFILHDAQVALILHDPTIDSTPFAAPQRTFVPIHTTPSPSSTPLPRIDPTA
DAYVIYTSGSTGQPKGVPITHRHILRLLSTTHPWFRFQPTDVWTLFHSVAFDFSVWE
LFGALCHGARLVIVPAAITRDFPAFYRLVAAEGVTILNQTPTAFAQFAAADAHHPLPL
ALRTIVFGGEALDLRLLAPWFDRHGDQQPQLINMYGITETTVHVTYRPITTADLAHAR
SVIGVPLPDLQLAVWQPDGSPTPVGEVGELVVFGAGVSRGYLRRPALTAQKFVTDP
HRGPGYRSGDLVRVLPDGDLEYLGRNDLQVKVRGFRIELGDIEAALRRDPAVAAAV
ATVVRTGVAEPTLVGYLVPHPGATIDLPRLRAQAATWLPPYMVPSVLGILPAVPLTV
NGKLDRRALPWPLPATPTSAAPSVVAPHPDVAAITATVSGVVTTLLHGTPVAPTADL
FSAGATSLTIVTLVQQLADHYPVSVPIAQILEFPTISAIAAWLAAQLPAPAPVTAPAVA
VAPHPDVATITTTVSDLVTTLLHGTPVAPTADLFSAGATSLTIVTLVQQLADHYPVSV
PIAQILEFPTISAIAAWLAAQLSAAQPAAPPTAPPIPAAASLLNLNGLSNLLGLLQPTEI
AGKRKYLYASAGGKYAVQVYLAVRTGAIQGLVAGCYYYHPEQHGLVCLSNEEPDFL
LESAAPFGFLLVGQLAALRPVYQDFSPMFAALDAGYISQLLINYADNQGINLTPNHTI
TTQNLNSALQLSPDHRVVQCLLGGTANAGISKQQSGQAIEFVSLESLAEIYGQMTYS
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QLSQEELARLDEQKLHLRPIVPNQQLIDLPEALIDSDRYLRRGCQRCYEQSPIQTTNF
HGLLKSLSKLLSSDAGIEAYLYLKAERIAGYTGGVYRYNVATQLLEPIVQELSYPLQN
CHTPFNRPHLSSAGFCLYLIGDINRLRERFGPAAFHGGLLSAGAIGQHLLEQQANHK
LGLVPIGGMNFERIKQDFGLSEQHVLLHSFLGGSYQHQTNASQPSPSMPTANPVQP
DQPMAIAVVGISGRYPQAATIQEFWQNLLAGKNCISEIPAERWDHTPYFDPKAQPG
KTRSKWGSFLADIDQFDPLLFNIAPAEAELLDPQVRLFLETVWRLFEDAGYSREALK
ALNVAGALPVGLFVGSMYQHYQLLANDPQSQALLAIQSYSSIANRTSFFFDLRGPSI
AIDTACSSSLIALHLACESIRKQESGMAVVGGINLHLHPAKYLALSELGLVGGDELSR
SFGQGQGFVPGEGVGAVLLKPLAAAERDGDRIYCVIKGGAINHSGHGSIYALPQAS
AYTSLIQNALKQAEVDPRTISYLEAAANGTPLADSIEIAGLTRAFQASTSDQQFCAIGS
VKSNIGHLEAASGISQLIKVALQLHHRTLVPTLNAEPLNPLIELHNSPFYLQQTQQPW
QRPTIEVAGRVEQQPLRAALGSYGAGGSSAFVIVEEYAPSPVLAPSGDTPTIIALSAQ
NRQSLVLQAENLRDALATAPLLDVATTLLRGREPLAERLAFIASNRHEAISKLEQFIN
GTLTEKEGSVGHANETHVVSSLFDSADEFQAFIASQIAEQRSAKLARLWTVGAISNQ
VLRSVIPAGQIVSLPGYLFEHQRCWLPNPAQHQPSPIAAQSRQSAKPTDDLQEIVAD
LLKIPVASLDRKTKLQRYGFNSLLAMRLLHVLSELYGCEIPTREFLRLESVAAISDWLT
QAGFTRTSLEQAEPNPAHPDSWDADLDDHQLLHLLHAIADGKISPSDALNYEYTLN
GSEN 
 
8.1.6 SphF 
MPILMITNYCICYTLSPMAKLAQAMLLIMNIPSMGRRISAMHRSKATIYQQVARGELS
VGMALQALRELASLPAISNQSQQFALSEGQKALWMAYQLDPNQYAYNVPLAYILAP
NTQPVLLEQALNDLIKRHPLLAARLVETDQGQIEQVWDGATTSISLERQQLSNVDWV
QEVRQIAHQPFDLLKGPLFKATLFELPNRELLLLLNVHHIMFDGVSIQILLGELQAVYA
AYAQGQSPQLAPLTTDFGDFVAWQQTMLASPNGQRQRRYWLEQLAGRVTPLELP
YDRQPSGQPSFKGAMWEFELDTQLTAHIRSLGLEHNRSYFSLIMSGFSMLLARYGR
QQSIYLGTPLSGRPEARFDNLIGYFMNMVVIGADLSDNPSYLELSRRIYETALDAMD
HGDYPLFAIADELGGNMPFHAAFYFQNWVAPLAEQTNANATLLTKPVLSIHQEGEF
SLTLEVIELGDRYSCYFKYNPDYFDQATIQGMAEHLIQLLGAAINQPEQPIHSLPSLLA
AEQRLLTAWNQTQTTYPRELALPSLVAQQAAATPDAIAIIGSTLAKPNQTINYRTLMA
AVDQIAAHLQSHGIGPGQRVAVLLNRSIEMVLSLLAIAKTGAAYIPLDPIYPAERLAAM
LDDSQASLILLHGELAVHLPTTSIAQLEIEQLLAKQPAKPLVAVEIDPNSPVYLIYTSGS
TGTPKGVVISHSGLTNFLWAMREQLVFSAKDRILAITTICFDIAGLELYLPLISGGSVEI
LPAEVTRDGYLLKQAIANSDATWLQATPATWTMLLAAEWEQPLQTILCGGERLSYD
LAQQLVARASTVWNLYGPTETTIWSTASRIQANTPITIGQPISNTTLYILDQAMQAVPI
GVAGELYIGGAGVALEYWQQPALTNARFIDYPDANQQISRIYKTGDLARFRPDGQL
EHLGRLDEQVKVRGFRIELMEIETTLRRQPEVREAVVVQRAEASQQLIGFVMLEDPR
IGVERPFNSEALRQALAQSLPEYMLPTKIIGLREFPLTLNQKIERKVLKSLPLATIINRY
GYPQTNIEQPKQPVKTQPSAPLLAELAELASTIVAIAPNEIDPLLPFGNYGFDSIRFTQ
FSTLLRKRFSLPIMPNIFYLKPTLQELAQHLQSLLPQQPEPVNQQVIEQPTLTQPTTK
ANAAIAIIGIAGTLPQSRDLAEFWQHLVAGADLITPVPANREAWTTPASANLNATERQ
SINWGGFIPAVDTFDAAFFGISPREAALMDPQQRLMLETVWKAIEDAGYRASSLQAA
NVGVFIGASGADFLGMTEDSIDGYTLTGIARSVIANRISYLLNFHGPSEPVDTACSSS
LVAVHRAAQAIRNGECELALAGGVNVMLSDFASAAASKVGMLSPDGRCKTFDASA
NGYVRGEGAAVILLKPLELALRDRDHIYAVIRGSAVNHGGRANSLTAPNPNAQSALI
YQAYRNAGIDPASVGYIETHGTGTALGDPIEVDGLKSAFQKLYHDADQAWIDGHCA
LGSVKSNIGHLEAAAGIAGLIKTVLALKQRYIPATIHLQTLNPYIEVEASPFSISRFGRD
WNTSGVRRAGVSSFGFGGSNAHIILEEAPVQSSSSVSDQPTLIVLSAKTATSLQLAA
HQLATHIQRLQSDQPLWFGATSLRDLAYTLLTGREAFRERLAIVASDFAELAVALNA
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YLAGNSAANIYSNTSAQTAAEATMLHSLAQQWVAGATIEWSQLDTVNAPLPQRQPV
PSYAFMPDHYPIARRNQAQAVLHPLVERNSSTFNTTQFSTRLLAEAFYLRDHIVQGQ
RVLPGVTYLEIARAAGSFAAEKPVQRISNLIWASPCVVEQVRELTISLQPQPNAAGFS
ITTQSATGSKITHAEGTLRYDRPDDQPNMAKIDLAPVRSRLTHQKTAAECYHLFAEH
QFAYGPSFQVIEQIAYNADESLATIKLPAAQQSQFADFGLHPSLLDGALQTVILLLSD
ASDSESRLALPFAIGELVIFGQLAPECLVHAIRNQAKAGEKGLVKYTIQICTPDGQSLI
QINDYTIRAMPNQASVQPASSNLSTIAYYTPQWEQVGIYETYEGV 
 
8.1.7 SphG 
MVPETIVYLWSEQASANQPASASLDLTLYPLFLLSQAFIHHKRAAMRVLYCYSDAPQ
PIAPFIMGLAGFARSLQMEHQQYWIQLLALQSSDVAMNRQVLAAIIRDELADTTSRE
FELRYQEGKKFARRFLPHAAPTPTADPQQLVLRPHGCYVIAGGKGALGAIFARYFAS
QAKVQLVLLGRSPIDQPTQKLISELEQTGSQAHYLQVDISDQAALSLALAPFGTIHGII
QAAGISNDSLLVHKTKASIDQTIAAKVQGTLALDAITAKQPLDFFILFGSSSGAFGNLG
QADYAYANSFLNGFAAYREYLATKALRHGKTIAINWPLWADGGMGHNQATQQRLA
QLGLSPLATEQGLRAFELSLHTNQLQMIVLGGDRQRIANLVNPMPTPQPIQPNLVVD
TPSMSETPITPTTTEPTMAETPSIDAALQHYTRDYLRALLADATKLSAQRINPNEPFE
SYGVDSVMILGLNNQLGDRFGELPKTLFFEYQTLEQLTGYFVENHRTTLLKDVRLPE
PASVVAAKPTPQPTSVNPNPPSAPELSQLAPAQPATPKGEVDIAIIGVSGRYPLAAN
LDEFWQNLQTGRNCVTTIPAERWDYRRYFHPEKGTYGKTYSIWGGFLDDIDKFDPL
FFNISPLEAEMLDPQERIFIQTVWHTLEDAGYTRNALSRYQVGVYVGVMWGQYQLY
GAAEPDDGVILTPASSYASIANRVSYFFNFRGPSIALDTMCSSSLTTIHLACESIKRGE
IEVALAGGVNLTLHPNKHIFLSQTKFASSEGLCRSFGDGGDGYVPSEGVGAILLKAL
PQAIQDGDRIYGVIKASAVNHGGKTNGYTVPNPRQQEDLIRQAFRKAQIDPQTISYIE
AHGTGTALGDPIEITGLTKAFNLPANQRHVVAVGSVKSNIGHCESAAGIAGITKVLLQ
MQHGQLVPSIHAETLSSNINFAESPFYIQRNLSAWNSAGLRRAGVSSFGAGGANGH
IVLEEYQTEIQPEPNDQRPQLIVLSARDNERLRANAAALEAYLVKQTGSNQATNRAF
AGTNLQHELAELVANTLNVASSELDPGEPLHEYGLDAPAIFQLQKQFEQAYQLTLPS
NNPIDAFSIDQLAEYLQAEYPQRFTHAHSAFQAPNLAPPQLRLADIAYTLQVGREAM
EARVAFVVSSIEVLIERLHAFAGGATAIANCYLSATPKPSGD 
 
8.1.8 SphH 
MDYQVADSQRLPAELLLAMLHTATQIALPATPIEMQRLQLSAPQLLSEPDQEIIVNLT
PQADGSITAIVGQSTNQPWLQATIQTNAASAEQRVALEPILARCSNQATLSQQSNGV
SYGPAYAGLERIVWNDSEALGYYTLDPFQPKQLGKTAFTPAHGAIMLRLASEFHQR
HGLASEFRKLGSVQIVADCPAEGLVYLKRAGNSNHLAILDHSGRVYAKFQGLSTHS
EATPVQALPAPSTSQAPSDAEQILERFFYAPRWQPTLANAQSTPQVGKLVIIASAES
QALVSALCANQTAAINLIWLDSTLKHPTIPTWLVRSNDPNALSHALAAIGSIDSIYLLS
GLEQASTTFDLGHFEQQQERGVLSLFRLLKALQEQQLLDQELSLKIITANTNHVVAN
DQVQPFAASMFGLAKSAAREYRRLRIACIDLEQHDLAPETVAATAAFIHGEAPLAPL
QEVAQRQGQRYQRILEPVKLAPSNLAFRKGGVYMVLGGAGNVGFKLCCYLAEQCQ
AKVVITGRRAITPAIEAQLQSIEERGGRAIYIAADMSDLDSMRSAVATTKQHFGGLHG
VFHSAMSFEYTPLNGLTEAQLYQDLAPKARGSVVLHHALVDEALDFKLYFSSGEAF
TGNIGWGSYAAGCTFEDAFAHAERAQVNYPVQVINWGFWESERDQYLDALKAKGI
NPIETAIGMQAVSRVVAAGIPQVMALNVADKVLELMGVVLPKPNVASATPAISQAAT
PIPAAATPPVAPVAVPLVTSQPVAANPQNQREQLYGYILGQLAAVLKIDPSRIDVTSE
LTNYGVDSLVVTDIHKRFEQDLGSMPVTLLLENTTVAAIANFLQQDYADRVAAFFSP
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MVAATVTSQATSNTHEQLIDTADLFALEVGSNQPSSATQPPTAPASITLLRQIEPAAI
ASELDRYGDQYAQKLFPAWKQNGGSLVNLTELDANPQLLKHLLVNVADKTQAEVW
MIGNGPPLVLIPAIGLTAPVWINQIQQWAADYRVIVIHQQGYGMTDLTSDISTAAVAK
LFISTLDQLGINRPCHVIGSCFGGVAAQYLTQAYPERVCSLTLCGTFNKNFGLPDIDV
SELTIDQMIEGAKMIGSSINRDFDAVAEGLASDQAQPIVEQARSLLLKSQCVSPLVVM
RYITQILTLNGQAWLPRIQAPTLCLSGNLDTIVAPETSRTISQQIPAGRYIEIPGAGHYP 
FLTHVDLFEQAVRPFLREQEAQLMSTLV 
 
8.1.9 SphI 
MIVTIEHAAGFEPIEQVLRCCDEYEASLNLTRDKRYTRIRITVDQAYSELFVRLKSIVG
VAKVETTGKPYPLAAREAKSAASVINVRGIEIGGSDLVVMAGPCSVESREQILATAH
AVRAAGARILRGGAYKPRTSPYDFRGLGEEGLQLLAEAREATGLAIVTEVMSIADLE
LGAYYADIIQIGARNMQNFSLLHACGSINRPILLKRGPSATIEEWLLAAEYILAAGNEQ
VILCERGIRTYEPFTRNTFDVSAIASIKHLSHLPIIGDPSHGVGKAELVPQMARAAIAA
GADGLIIEVHPNPAQAWSDGQQSLTFEHFEQLMNDLAPIANALGRQLNPNVQALVV
S 
 
8.1.10 SphJ 
MASLIKALAPDPQLPQLFLFPFAGGTANSYRGLANALKSHFSVYAIDPQGHINRQEP
LLDDLETMVEAYLAALLPLIKPDFTLFGHSLGGAVVYRLTQRLEQLGHAPVTVFISGY
HPPHISDKSTAYLNDDQFLEHIEAMGGVPPEIGQDQSFMRYFLPIFRADFRATETFIH
SDRTKIKAPVFVLNGDKDDDAIKHMQEWSYWLNQVRYRIFSGPHMYLSSQPELIAT
YIIECNQAISIVDE 
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8.2 Search results from the NaPDos Database 
8.2.1 C domains in contigs from the genome sequencing 
Table 8-1: C domains encoded on contigs from 454 sequencing 
Domains were identified and annotated with NaPDos; contigs with parts of the putative 
siphonazole cluster are printed in bold letters 
Contig Database  
match id 
Identity 
(%) 
align  
length 
pathway  
product 
domain  
class 
00282 syrin1_C5_LCL 40 300 syringomycin LCL 
00282 micro2_C1_DCL 47 297 microcystin DCL 
00282 syrin1_C7_LCL 45 296 syringomycin LCL 
00282 syrin1_C6_LCL 46 299 syringomycin LCL 
00282 ituri3_C1E 43 295 iturin epim 
00462 Sare2407_1 33 298 pksnrps2 C 
00462 syrin1_C9_LCL 39 300 syringomycin LCL 
00462 syrin1_C5_LCL 45 299 syringomycin LCL 
00585 syrin1_C9_LCL 30 274 syringomycin LCL 
00585 fengy2_C1_DCL 30 208 fengycin DCL 
00689 micro1_C2E 41 303 microcystin epim 
00689 fengy2_C1_DCL 30 288 fengycin DCL 
00738 bacil2_C1_start 43 293 bacillibactin start 
00782 syrin1_C7_LCL 50 300 syringomycin LCL 
00782 micro2_C1_DCL 44 301 microcystin DCL 
00782 syrin1_C7_LCL 41 300 syringomycin LCL 
00782 cyclo1_C8_LCL 42 201 cyclosporin LCL 
00782 syrin1_C9_LCL 43 303 syringomycin LCL 
00782 micro1_C2E 38 304 microcystin epim 
00805 micro2_C1_DCL 41 298 microcystin DCL 
00805 mycos3_C1E 36 299 mycosubtilin epim 
00805 micro2_C1_DCL 41 297 microcystin DCL 
00805 micro5_C1 38 292 microcystin C 
00805 syrin1_C9_LCL 41 302 syringomycin LCL 
00805 fengy2_C1_DCL 39 297 fengycin DCL 
00805 syrin1_C6_LCL 43 300 syringomycin LCL 
00805 mycos3_C1E 34 295 mycosubtilin epim 
00874 micro1_C1 44 298 microcystin C 
00874 syrin1_C9_LCL 46 297 syringomycin LCL 
00897 Sare2407_1 33 296 pksnrps2 C 
01402 syrin1_C7_LCL 42 299 syringomycin LCL 
01515 micro2_C1_DCL 49 298 microcystin DCL 
01515 micro1_C2E 47 303 microcystin epim 
01517 Sare2407_1 30 297 pksnrps2 C 
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Table 8-2: C and Cyc domains from the putative siphonazole cluster 
Alignment and classification by NaPDos 
gene Database  
match id 
Identity 
(%) 
align length pathway  
product 
domain  
class 
sphC pyoch3_C1_cyc 30 434 pyochelin cyc 
sphE bleom9_C3_cyc 32 331 bleomycin cyc 
sphF bacit3_C5_LCL 29 438 bacitracin LCL 
 
8.2.2 KS domains in contigs from the genome sequencing 
Table 8-3: KS domains encoded on contigs from 454 sequencing 
Domains were identified and annotated with NaPDos; contigs with parts of the putative 
siphonazole cluster are printed in bold letters 
Contig Database 
match id 
Identity 
(%) 
align 
length 
pathway 
product 
Domain 
class 
00180 FabF_Bacillus_FAS 42 405 fatty acid 
synthesis 
FAS 
00282 bleom_AAG02357_RH 56 427 bleomycin RH 
00330 FabF_Bacillus_FAS 53 408 fatty acid 
synthesis 
FAS 
00433 FabB_Ecoli_FAS 61 403 fatty acid 
synthesis 
FAS 
00585 KirAIV_CAN89634_11T 44 426 kirromycin trans 
00668 LnmJ_AF484556_2T 52 423 leinamycin trans 
00668 KirAII_CAN89632_5T 50 435 kirromycin trans 
00805 yersi_YP_070123_RH 48 423 yersiniabactin RH 
00805 CALO5_12183629_i1 49 424 calicheamicin iterative 
00838 FabF_Ecoli_FAS 48 418 fatty acid 
synthesis 
FAS 
00863 FabF_Bacillus_FAS 51 417 fatty acid 
synthesis 
FAS 
01348 FabF_Bacillus_FAS 35 407 fatty acid 
synthesis 
FAS 
01517 LnmJ_AF484556_4T 55 437 leinamycin trans 
01517 KirAIV_CAN89634_7T 58 423 kirromycin trans 
01517 LnmJ_AF484556_3T 49 440 leinamycin trans 
01518 LnmI_AF484556_2T 55 435 leinamycin trans 
01518 LnmJ_AF484556_4T 52 434 leinamycin trans 
01518 LnmI_AF484556_2T 43 435 leinamycin trans 
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Table 8-4: KS domains from the putative siphonazole cluster 
Alignment and classification by NaPDos 
gene Database 
 match id 
Identity 
(%) 
align length pathway  
product 
domain  
class 
sphC KirAII_CAN89632_5T 50 435 kirromycin trans 
sphC KirAII_CAN89632_5T 46 437 kirromycin trans 
sphC KirAII_CAN89632_5T 36 438 kirromycin trans 
sphD LnmI_AF484556_2T 56 437 leinamycin trans 
sphD LnmI_AF484556_2T 46 434 leinamycin trans 
sphE LnmJ_AF484556_3T 49 444 leinamycin trans 
sphF LnmJ_AF484556_4T 54 428 leinamycin trans 
sphG KirAIV_CAN89634_7T 58 423 kirromycin trans 
 
8.3 Primer sequences 
8.3.1 Gap closure 
Primer Sequence (5’ – 3’) Purpose 
Cb1462_f TGTGCCAATTGCCCAGATTC gap closure 1462-1517 
Cb1517_r CGCCAGCAGAAGCATAGAG gap closure 1462-1517 
Cb1518_r GGCCAGCAATTTGGGTCAG gap closure 1462-1517 
1462ktr-f 
1462ktr-r 
CCAAGTGTGCTGGTATC 
TAGGAAATCCGGTTCCTC 
gap closure 1462-1517 
Gap1_f 
Gap1_r 
CGGTGGGAACGACATTTG 
TTGGAGGGACGGTAGAAG 
gap closure 1462-1518 
Gap2_f 
Gap2_r 
CCGTCTTTGCCCACATTC 
TCGAGGAGTTCGGTAAAG 
gap closure 1462-1518 
Gap3_f 
Gap3_r 
TGCTGCTCACCAGCTTTG 
AGACGGAGAAGTCGAAG 
gap closure 1462-1518 
1518-1517 
1462seq 
GGCTGCCATTTCTTCCTGAC 
GCATAAGGCTTGACGTAAGG 
gap closure 1462-1518 
1462-A-fwd 
1462-A-rev 
GGCAGCTCATTGGGTTG 
GCACCAAGGTGACGATG 
Control primers for  
contig 1462 A domain 
1280seq_neu 
668seq-1280 
GCGCAATTTACGTTCCG 
CCGCATTCCAGTTTCGG 
Gap closure 1280-0668 
1518-1517 
1357seq_f 
GGCTGCCATTTCTTCCTGAC 
CCGCCTTGCCTTGGATTAC 
gap closure 1518-1357 
1518seq GTTGCGCCAAATAACTCG gap closure 0668-1518 
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668seq CGACGTTTGGGTTATCG gap closure 0668-1518 
1518seq_neu CCAGCAATTTGGGTCAG gap closure 0668-1518 
1518-EC10-fwd GCCCAGAAATTCGTGAC gap closure 0668-1518 
EC10seq-rev GCCATTGACGGTCAAGG gap closure 0668-1518 
EC10seq2-fwd 
EC10seq2-rev 
CTCGACCATCCCTTCAC 
TCGGCATAGGAGCAGTG 
gap closure 0668-1518 
 
8.3.2 Protein expression 
Primer Sequence (5’ – 3’) Target 
OMt-fwd-BamHI 
OMt-rev-HindIII 
GCGGATCCATGGCAAAGGCATCATTGAAC 
CGAAGCTTGTTATTTGCGAATAACGAGAG 
SphB 
A-fwd-BamHI 
A-rev-HindIII 
GCGGATCCATGGTGCAACAAGATTTAC 
GCAAGCTTTCATGCAGTTAGGCTCTTCAC 
SphC-A1 
A-PCP-rev GCAAGCTTTCAAAGGGCGCTGGCCAAATC SphC-A1 
DHB A-Dom fwd 
DHB A-Dom rev 
TAGGATCCAGCCTGAGCTTTGAAC 
GCAAGCTTCTAATCAATTTTGCCATTGGGAAG 
SphC-A1 
A-dom orfstart CGCATATGGTGCAACAAGATTTACAATCAC SphC-A1 
A Domain fwd 
A Domain rev 
TAGAATTCGCCCGCCAAACTCCGCAAG 
TAAAGCTTTCAGAGCGCCATGCGATC 
SphC-A1 
sphC-a-fwd  
sphC-a-rev 
CACCATGGTGCAACAAGATTTAC 
CTAATCAATTTTGCCATTGGGAAG 
SphC-A1 
sphI-fwd 
sphI-rev 
CACCATGATCGTAACGATAGAGC 
CTAACTGACCACAAGTGC 
SphI 
 
8.3.3 Fosmid library screening 
Primer Sequence (5’ – 3’) 
TE-end-fwd 
TE-end-rev 
GCGTACCACCAGAAATTG 
GCGGTAGGTCTTACCAAC 
CF4-end-fwd 
CF4-end-rev 
GGCCTGTGAGAGTATTCG 
CACCAACGTGCGATGATG 
EC9-end-fwd 
EC9-end-rev 
CGGTGATGATTCTTGGACTC 
AGCCAAGTGGATCGTAG 
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8.3.4 Yeast recombinational cloning 
5’-Homology extensions to the vector backbone are underlined 
Primer Sequence (5’ – 3’) 
Hefe-start-fwd 
Hefe-start-rev 
TGTACAAAAAAGCAGGCTCCGGGACGGCCATCATATAG 
CGCCAAATGGTTGTTCTC 
TE-end-fwd 
Hefe-end-rev 
GCGTACCACCAGAAATTG 
AGCTGGGTCGGCGCGCCCACAAGGCTCCACTTTCTACG 
Ura3P mid fwd 
Cat mid rev 
GGCGGCAGAAGAAGTAAC 
TCGCTCTGGAGTGAATACC 
 
8.3.5 λ-Red mediated recombination 
5’-Homology extensions to the fosmid inserts are underlined 
Primer Sequence (5’ – 3’) 
Str-FRT-fw-EC10 
 
Str-FRT-re+EC10 
CAGCGTCGCAGGATTCTCGCTCCAGCGAGTTCTGGTTATG
GATCCGTCGACCTGCAGTTC 
TAGAGCAGAATCATCAATGCTTAAGACCGCGAACGGCTCG
GCAGGAATTCGATGTGTAGG 
Apr-FRT-fwd+IC2 
 
Apr-FRT-rev+IC2 
ATGATTGGCTGGATTGCACGCTGCGATGGCAGTAACCTTC 
GATCCGTCGACCTGCAGTTC 
GCGATGCAGTTGCCGCATGGAACGAAGAAGAAGAACGCAA
GTGTAGGCTGGAGCTGCTTC 
 
8.3.6 Sequencing primers 
Primer Sequence (5’ – 3’) 
T7 
Epi-RP 
SP6 
TAATACGACTCACTATA 
CTCGTATGTTGTGTGGAATTGTGAGC 
ATTTAGGTGACACTATAGAA 
16S rDNA fwd 
16S rDNA rev 
AGAGTTTGATCCTGGCTCAG 
AAGGAGGTGATCCAGCCCCA 
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8.3.7 mRNA screening primers 
Primer Sequence (5’ – 3’) 
A-fwd 
A-rev 
GCGAGGCATACCATGAAAGG 
CCTGCTTCTGTGATCCTTG 
B-fwd 
B-rev 
CAGGCTCGTCATGTCGATAC 
TTCTGGTGGCGTTTGCATGG 
C-fwd 
C-rev 
TTGGTGATGGCTTGACTCTC 
CGGGCTTGGTTGGTAAACAG 
D-fwd 
D-rev 
TGGCGTAATTCAGCCACGTC 
GCAATCGCGGTTAAATCAGG 
E-fwd 
E-rev 
TTCAGGAACTGCGCTTGATG 
GCAGTCGCGAATGGTTGGTG 
F-fwd 
F-rev 
AATCCCGCCCACCCAGATTC 
AATGCCATGCCGACGCTAAG 
G-fwd 
G-rev 
GGAGCAGGTTGGCATCTACG 
GTTTCAGGCACCATCCCTTG 
H-fwd 
H-rev 
TTGTTATTTGAGCGCCACCC 
AACGCTGACTATCAGCAACC 
I-fwd 
I-rev 
TTCTGCGCGAGCAAGAAGCC 
CTTTGGCAACGCCCACAATG 
J-fwd 
J-rev 
CCGACAACTCAATCCCAATG 
TCAAGCAGCGGCTCTTGACG 
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8.4 Complete sequence alignment of the DAHP synthase SphI 
S. thermophilus     HPDDTVIHVG-DVAVGGNEVVVIAGPCSVESEAQIIQTAHAVKAAGASML 126 
T. roseum           YPLDTVIQVR-DVTIGGNEVVVIAGPCSVENERQILETARAVKAAGASML 126 
SphI                KSAASVINVR-GIEIGGSDLVVMAGPCSVESREQILATAHAVRAAGARIL 126 
B. subtilis_AroA    KPEDTIVDIK-GEKIGDGQQRFIVGPCAVESYEQVAEVAAAAKKQGIKIL 149 
S. xylosus_AroA     KPEDTIVQFDNGGIIGDGNKSFVFGPCSVESQEQVDAVAANLQARGEKFI 54 
                     .  :::..  .  :*..:  .: ***:**.  *:  .*   :  *  :: 
 
S. thermophilus     RGGAFKPRTSPYDFRGLGEEGLRLLAKARAETGLPIVTEVLSVADLDMVA 176 
T. roseum           RGGAFKPRTSPYEFRGLGEQGLKLLAKAREETGLPIVTEVLSAQHVDLVA 176 
SphI                RGGAYKPRTSPYDFRGLGEEGLQLLAEAREATGLAIVTEVMSIADLELGA 176 
B. subtilis_AroA    RGGAFKPRTSPYDFQGLGVEGLQILKRVADEFDLAVISEIVTPAHIEEAL 199 
S. xylosus_AroA     RGGAFKPRTSPYDFQGLGVEGLKILKNTKDKYGLNVVSEIVNPADFEVAD 104 
                    ****:*******:*:*** :**::* ..    .* :::*::.  ..:    
 
S. thermophilus     EYADVLQIGARNTQNFLLLEAVGKTQKPVLLKRGMSTQIEEWLLAAEYIM 226 
T. roseum           EYADLLQIGARNCQNYLLLEAVGRAKKPVLLKRGMAVQIEEWLLAAEYIV 226 
SphI                YYADIIQIGARNMQNFSLLHACGSINRPILLKRGPSATIEEWLLAAEYIL 226 
B. subtilis_AroA    DYIDVIQIGARNMQNFELLKAAGAVKKPVLLKRGLAATISEFINAAEYIM 249 
S. xylosus_AroA     EYLDVFQIGARNMQNFELLKEAGRSNKPVLLKRGLSATIEEFIYAAEYIA 154 
                     * *::****** **: **.  *  ::*:***** :. *.*:: *****  
 
S. thermophilus     AQGNEQVMLCERGIRTFETITRNTLDLSAVPVVKRLSHLPIIVDPSHGTG 276 
T. roseum           AQGNEQVLLCERGIRTFETFTRNTLDLNAVPAVKHLSHLPIIVDPSHGTG 276 
SphI                AAGNEQVILCERGIRTYEPFTRNTFDVSAIASIKHLSHLPIIGDPSHGVG 276 
B. subtilis_AroA    SQGNDQIILCERGIRTYETATRNTLDISAVPILKQETHLPVFVDVTHSTG 299 
S. xylosus_AroA     SQGNENIILCERGIRTYEKATRNTLDISAVPILKQGTHLPVMVDVTHSTG 204 
                    : **::::********:*  ****:*:.*:. :*: :***:: * :*..* 
 
 
 
S. thermophilus     KWYLVPSMMLAAVASGADGLIVEVHPNPDHALSDGSQSLTFENFSAAMPK 326 
T. roseum           RWFMVPAMMLAAVAAGADGLIVEVHPNPDHALSDGAQSLTPENFAAVMPK 326 
SphI                KAELVPQMARAAIAAGADGLIIEVHPNPAQAWSDGQQSLTFEHFEQLMND 326 
B. subtilis_AroA    RRDLLLPTAKAALAIGADGVMAEVHPDPSVALSDSAQQMAIPEFEKWLNE 349 
S. xylosus_AroA     RKDIMIPTAKAGLAVGADGIMAEVHPDPSVALSDSGQQMDFNEFDKFYNE 254 
                    :  ::     *.:* ****:: ****:*  * **. *.:   .*     . 
 
Figure 8-1: Multiple sequence alignment of SphI with other DAHP synthases from subclass 
AroAIβ; conserved residues are shaded yellow; possible motif regions for catalytic activity of 
DAHP synthases are shaded green; conserved regions were defined as reported by 
Subramaniam et al., 1998; reference sequences from Sphaerobacter thermophilus DAHP (S. 
thermophilus; YP_003320125), Thermomicrobium roseum DAHP (T. roseum; YP_002521366), 
Bacillus subtilis chorismate mutase (B. subtilis AroA; P39912) and Staphylococcus xylosus 
chorismate mutase (S. xylosus AroA; CAA64712) 
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8.5 HPLC UV-spectra 
 
 
 
 
 
 
Figure 8-2: UV-absorption spectra from methylation assay;  
(a) Protocatechuic acid standard; (b) isovanillic acid standard; (c) methylation reaction; 
absorbance on the left side shows UV spectrum of the product peak 
 
(a) 
(b) 
(c) 
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8.6 Chromatograms from ATP-PPi exchange assay 
 
Figure 8-3: Chromatograms from MALDI-TOF-MS measurements 
Marked are fully labeled ATP (m/z 514), unlabelled ATP (m/z 506), partially labelled ATP and 
monosodium-coordinated ions; the tested substrate is indicated at each chromatogram 
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